EP2921545A2 - Polymerisable compounds and the use thereof in liquid-crystal displays - Google Patents

Polymerisable compounds and the use thereof in liquid-crystal displays Download PDF

Info

Publication number
EP2921545A2
EP2921545A2 EP15000075.0A EP15000075A EP2921545A2 EP 2921545 A2 EP2921545 A2 EP 2921545A2 EP 15000075 A EP15000075 A EP 15000075A EP 2921545 A2 EP2921545 A2 EP 2921545A2
Authority
EP
European Patent Office
Prior art keywords
compounds
atoms
formula
denotes
denote
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
EP15000075.0A
Other languages
German (de)
French (fr)
Other versions
EP2921545B1 (en
EP2921545A3 (en
Inventor
Eveline Baron
Julian Vogt
Qiong TONG
Constanze Brocke
Helga Haas
Alexander Hahn
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Patent GmbH
Original Assignee
Merck Patent GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent GmbH filed Critical Merck Patent GmbH
Priority to EP15000075.0A priority Critical patent/EP2921545B1/en
Publication of EP2921545A2 publication Critical patent/EP2921545A2/en
Publication of EP2921545A3 publication Critical patent/EP2921545A3/en
Application granted granted Critical
Publication of EP2921545B1 publication Critical patent/EP2921545B1/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/52Liquid crystal materials characterised by components which are not liquid crystals, e.g. additives with special physical aspect: solvents, solid particles
    • C09K19/54Additives having no specific mesophase characterised by their chemical composition
    • C09K19/542Macromolecular compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/017Esters of hydroxy compounds having the esterified hydroxy group bound to a carbon atom of a six-membered aromatic ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/52Esters of acyclic unsaturated carboxylic acids having the esterified carboxyl group bound to an acyclic carbon atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/52Esters of acyclic unsaturated carboxylic acids having the esterified carboxyl group bound to an acyclic carbon atom
    • C07C69/533Monocarboxylic acid esters having only one carbon-to-carbon double bond
    • C07C69/54Acrylic acid esters; Methacrylic acid esters
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/76Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring
    • C07C69/84Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring of monocyclic hydroxy carboxylic acids, the hydroxy groups and the carboxyl groups of which are bound to carbon atoms of a six-membered aromatic ring
    • C07C69/90Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring of monocyclic hydroxy carboxylic acids, the hydroxy groups and the carboxyl groups of which are bound to carbon atoms of a six-membered aromatic ring with esterified hydroxyl and carboxyl groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/76Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring
    • C07C69/84Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring of monocyclic hydroxy carboxylic acids, the hydroxy groups and the carboxyl groups of which are bound to carbon atoms of a six-membered aromatic ring
    • C07C69/92Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring of monocyclic hydroxy carboxylic acids, the hydroxy groups and the carboxyl groups of which are bound to carbon atoms of a six-membered aromatic ring with etherified hydroxyl groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/63One oxygen atom
    • C07D213/64One oxygen atom attached in position 2 or 6
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08FMACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F20/00Homopolymers and copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical or a salt, anhydride, ester, amide, imide or nitrile thereof
    • C08F20/02Monocarboxylic acids having less than ten carbon atoms, Derivatives thereof
    • C08F20/04Acids, Metal salts or ammonium salts thereof
    • C08F20/06Acrylic acid; Methacrylic acid; Metal salts or ammonium salts thereof
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/04Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • C09K19/06Non-steroidal liquid crystal compounds
    • C09K19/08Non-steroidal liquid crystal compounds containing at least two non-condensed rings
    • C09K19/10Non-steroidal liquid crystal compounds containing at least two non-condensed rings containing at least two benzene rings
    • C09K19/12Non-steroidal liquid crystal compounds containing at least two non-condensed rings containing at least two benzene rings at least two benzene rings directly linked, e.g. biphenyls
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/04Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • C09K19/06Non-steroidal liquid crystal compounds
    • C09K19/08Non-steroidal liquid crystal compounds containing at least two non-condensed rings
    • C09K19/30Non-steroidal liquid crystal compounds containing at least two non-condensed rings containing saturated or unsaturated non-aromatic rings, e.g. cyclohexane rings
    • C09K19/3001Cyclohexane rings
    • C09K19/3003Compounds containing at least two rings in which the different rings are directly linked (covalent bond)
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/04Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • C09K19/06Non-steroidal liquid crystal compounds
    • C09K19/08Non-steroidal liquid crystal compounds containing at least two non-condensed rings
    • C09K19/30Non-steroidal liquid crystal compounds containing at least two non-condensed rings containing saturated or unsaturated non-aromatic rings, e.g. cyclohexane rings
    • C09K19/3001Cyclohexane rings
    • C09K19/3066Cyclohexane rings in which the rings are linked by a chain containing carbon and oxygen atoms, e.g. esters or ethers
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/04Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • C09K19/06Non-steroidal liquid crystal compounds
    • C09K19/32Non-steroidal liquid crystal compounds containing condensed ring systems, i.e. fused, bridged or spiro ring systems
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/04Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • C09K19/06Non-steroidal liquid crystal compounds
    • C09K19/34Non-steroidal liquid crystal compounds containing at least one heterocyclic ring
    • C09K19/3441Non-steroidal liquid crystal compounds containing at least one heterocyclic ring having nitrogen as hetero atom
    • C09K19/3444Non-steroidal liquid crystal compounds containing at least one heterocyclic ring having nitrogen as hetero atom the heterocyclic ring being a six-membered aromatic ring containing one nitrogen atom, e.g. pyridine
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/04Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • C09K19/38Polymers
    • C09K19/3833Polymers with mesogenic groups in the side chain
    • C09K19/3842Polyvinyl derivatives
    • C09K19/3852Poly(meth)acrylate derivatives
    • GPHYSICS
    • G02OPTICS
    • G02FOPTICAL DEVICES OR ARRANGEMENTS FOR THE CONTROL OF LIGHT BY MODIFICATION OF THE OPTICAL PROPERTIES OF THE MEDIA OF THE ELEMENTS INVOLVED THEREIN; NON-LINEAR OPTICS; FREQUENCY-CHANGING OF LIGHT; OPTICAL LOGIC ELEMENTS; OPTICAL ANALOGUE/DIGITAL CONVERTERS
    • G02F1/00Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics
    • G02F1/01Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour 
    • G02F1/13Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour  based on liquid crystals, e.g. single liquid crystal display cells
    • G02F1/133Constructional arrangements; Operation of liquid crystal cells; Circuit arrangements
    • G02F1/1333Constructional arrangements; Manufacturing methods
    • G02F1/1341Filling or closing of cells
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/04Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • C09K19/38Polymers
    • C09K19/3833Polymers with mesogenic groups in the side chain
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/04Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • C09K19/38Polymers
    • C09K19/3833Polymers with mesogenic groups in the side chain
    • C09K19/3838Polyesters; Polyester derivatives
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/04Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • C09K19/38Polymers
    • C09K19/3833Polymers with mesogenic groups in the side chain
    • C09K19/3842Polyvinyl derivatives
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/04Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • C09K19/38Polymers
    • C09K19/3833Polymers with mesogenic groups in the side chain
    • C09K19/3842Polyvinyl derivatives
    • C09K19/3847Polyvinylethers
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/04Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • C09K19/38Polymers
    • C09K19/3833Polymers with mesogenic groups in the side chain
    • C09K19/3876Polyoxyalkylene polymers
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/04Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • C09K19/38Polymers
    • C09K19/3833Polymers with mesogenic groups in the side chain
    • C09K19/3876Polyoxyalkylene polymers
    • C09K19/388Polyepoxides
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/04Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • C09K2019/0444Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit characterized by a linking chain between rings or ring systems, a bridging chain between extensive mesogenic moieties or an end chain group
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/04Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • C09K2019/0444Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit characterized by a linking chain between rings or ring systems, a bridging chain between extensive mesogenic moieties or an end chain group
    • C09K2019/0448Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit characterized by a linking chain between rings or ring systems, a bridging chain between extensive mesogenic moieties or an end chain group the end chain group being a polymerizable end group, e.g. -Sp-P or acrylate
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/04Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • C09K2019/0477Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit characterized by the positioning of substituents on phenylene
    • C09K2019/0481Phenylene substituted in meta position
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/04Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • C09K19/06Non-steroidal liquid crystal compounds
    • C09K19/08Non-steroidal liquid crystal compounds containing at least two non-condensed rings
    • C09K19/10Non-steroidal liquid crystal compounds containing at least two non-condensed rings containing at least two benzene rings
    • C09K19/12Non-steroidal liquid crystal compounds containing at least two non-condensed rings containing at least two benzene rings at least two benzene rings directly linked, e.g. biphenyls
    • C09K2019/121Compounds containing phenylene-1,4-diyl (-Ph-)
    • C09K2019/122Ph-Ph
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/04Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • C09K19/06Non-steroidal liquid crystal compounds
    • C09K19/08Non-steroidal liquid crystal compounds containing at least two non-condensed rings
    • C09K19/10Non-steroidal liquid crystal compounds containing at least two non-condensed rings containing at least two benzene rings
    • C09K19/12Non-steroidal liquid crystal compounds containing at least two non-condensed rings containing at least two benzene rings at least two benzene rings directly linked, e.g. biphenyls
    • C09K2019/121Compounds containing phenylene-1,4-diyl (-Ph-)
    • C09K2019/123Ph-Ph-Ph
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/04Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • C09K19/06Non-steroidal liquid crystal compounds
    • C09K19/08Non-steroidal liquid crystal compounds containing at least two non-condensed rings
    • C09K19/30Non-steroidal liquid crystal compounds containing at least two non-condensed rings containing saturated or unsaturated non-aromatic rings, e.g. cyclohexane rings
    • C09K19/3001Cyclohexane rings
    • C09K19/3003Compounds containing at least two rings in which the different rings are directly linked (covalent bond)
    • C09K2019/3004Cy-Cy
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/04Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • C09K19/06Non-steroidal liquid crystal compounds
    • C09K19/08Non-steroidal liquid crystal compounds containing at least two non-condensed rings
    • C09K19/30Non-steroidal liquid crystal compounds containing at least two non-condensed rings containing saturated or unsaturated non-aromatic rings, e.g. cyclohexane rings
    • C09K19/3001Cyclohexane rings
    • C09K19/3003Compounds containing at least two rings in which the different rings are directly linked (covalent bond)
    • C09K2019/3009Cy-Ph
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/04Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • C09K19/06Non-steroidal liquid crystal compounds
    • C09K19/08Non-steroidal liquid crystal compounds containing at least two non-condensed rings
    • C09K19/30Non-steroidal liquid crystal compounds containing at least two non-condensed rings containing saturated or unsaturated non-aromatic rings, e.g. cyclohexane rings
    • C09K19/3001Cyclohexane rings
    • C09K19/3003Compounds containing at least two rings in which the different rings are directly linked (covalent bond)
    • C09K2019/301Cy-Cy-Ph
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/04Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • C09K19/06Non-steroidal liquid crystal compounds
    • C09K19/08Non-steroidal liquid crystal compounds containing at least two non-condensed rings
    • C09K19/30Non-steroidal liquid crystal compounds containing at least two non-condensed rings containing saturated or unsaturated non-aromatic rings, e.g. cyclohexane rings
    • C09K19/3001Cyclohexane rings
    • C09K19/3003Compounds containing at least two rings in which the different rings are directly linked (covalent bond)
    • C09K2019/3016Cy-Ph-Ph
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/04Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • C09K19/06Non-steroidal liquid crystal compounds
    • C09K19/08Non-steroidal liquid crystal compounds containing at least two non-condensed rings
    • C09K19/30Non-steroidal liquid crystal compounds containing at least two non-condensed rings containing saturated or unsaturated non-aromatic rings, e.g. cyclohexane rings
    • C09K19/3001Cyclohexane rings
    • C09K19/3003Compounds containing at least two rings in which the different rings are directly linked (covalent bond)
    • C09K2019/3027Compounds comprising 1,4-cyclohexylene and 2,3-difluoro-1,4-phenylene
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/52Liquid crystal materials characterised by components which are not liquid crystals, e.g. additives with special physical aspect: solvents, solid particles
    • C09K19/54Additives having no specific mesophase characterised by their chemical composition
    • C09K19/542Macromolecular compounds
    • C09K2019/548Macromolecular compounds stabilizing the alignment; Polymer stabilized alignment

Definitions

  • the present invention relates to polymerisable compounds, to processes and intermediates for the preparation thereof, to liquid-crystal (LC) media comprising them, and to the use of the polymerisable compounds and LC media for optical, electro-optical and electronic purposes, in particular in LC displays, especially in LC displays of the polymer sustained alignment type.
  • LC liquid-crystal
  • liquid-crystal displays used at present are usually those of the TN ("twisted nematic") type. However, these have the disadvantage of a strong viewing-angle dependence of the contrast.
  • VA vertical aligned
  • the LC cell of a VA display contains a layer of an LC medium between two transparent electrodes, where the LC medium usually has a negative dielectric anisotropy.
  • the molecules of the LC layer are aligned perpendicular to the electrode surfaces (homeotropically) or have a tilted homeotropic alignment.
  • an electrical voltage to the two electrodes, a realignment of the LC molecules parallel to the electrode surfaces takes place.
  • OCB optical compensated bend
  • LC liquid crystal display
  • OCB displays which are based on a birefringence effect and have an LC layer with a so-called "bend" alignment and usually positive dielectric anisotropy. On application of an electrical voltage, a realignment of the LC molecules perpendicular to the electrode surfaces takes place.
  • OCB displays normally contain one or more birefringent optical retardation films in order to prevent undesired transparency to light of the bend cell in the dark state.
  • OCB displays have a broader viewing angle and shorter response times compared with TN displays.
  • IPS in-plane switching
  • FFS farnesoid-field switching
  • FFS displays have been reported (see, inter alia, S.H. Jung et al., Jpn. J. Appl. Phys., Volume 43, No. 3, 2004, 1028 ), which contain two electrodes on the same substrate, one of which structured in a comb-shaped manner and the other is unstructured.
  • a strong, so-called “fringe field” is thereby generated, i.e. a strong electric field close to the edge of the electrodes, and, throughout the cell, an electric field which has both a strong vertical component and also a strong horizontal component.
  • FFS displays have a low viewing-angle dependence of the contrast.
  • FFS displays usually contain an LC medium with positive dielectric anisotropy, and an alignment layer, usually of polyimide, which provides planar alignment to the molecules of the LC medium.
  • FFS displays can be operated as active-matrix or passive-matrix displays.
  • active-matrix displays individual pixels are usually addressed by integrated, non-linear active elements, such as, for example, transistors (for example thin-film transistors (“TFTs”)), while in the case of passive-matrix displays, individual pixels are usually addressed by the multiplex method, as known from the prior art.
  • TFTs thin-film transistors
  • FFS displays have been disclosed (see S.H. Lee et al., Appl. Phys. Lett. 73(20), 1998, 2882-2883 and S.H. Lee et al., Liquid Crystals 39(9), 2012, 1141-1148 ), which have similar electrode design and layer thickness as FFS displays, but comprise a layer of an LC medium with negative dielectric anisotropy instead of an LC medium with positive dielectric anisotropy.
  • the LC medium with negative dielectric ansiotropy shows a more favourable director orientation that has less tilt and more twist orientation compared to the LC medium with positive dielectric anisotropy, as a result of which these displays have a higher transmission.
  • the displays further comprise an alignment layer, preferably of polyimide provided on at least one of the substrates that is in contact with the LC medium and induces planar alignment of the LC molecules of the LC medium.
  • an alignment layer preferably of polyimide provided on at least one of the substrates that is in contact with the LC medium and induces planar alignment of the LC molecules of the LC medium.
  • These displays are also known as "Ultra Brightness FFS (UB-FFS)" mode displays. These displays require an LC medium with high reliability.
  • the term "reliability” as used hereinafter means the quality of the performance of the display during time and with different stress loads, such as light load, temperature, humidity, voltage, and comprises display effects such as image sticking (area and line image sticking), mura, yogore etc. which are known to the skilled person in the field of LC displays.
  • VHR voltage holding ration
  • VA displays of the more recent type uniform alignment of the LC molecules is restricted to a plurality of relatively small domains within the LC cell. Disclinations may exist between these domains, also known as tilt domains.
  • VA displays having tilt domains have, compared with conventional VA displays, a greater viewing-angle independence of the contrast and the grey shades.
  • displays of this type are simpler to produce since additional treatment of the electrode surface for uniform alignment of the molecules in the switched-on state, such as, for example, by rubbing, is no longer necessary. Instead, the preferential direction of the tilt or pretilt angle is controlled by a special design of the electrodes.
  • MVA multidomain vertical alignment
  • the slitted electrodes generate an inhomogeneous electric field in the LC cell on application of a voltage, meaning that controlled switching is still achieved.
  • the separations between the slits and protrusions can be increased, but this in turn results in a lengthening of the response times.
  • PVA patterned VA
  • protrusions are rendered completely superfluous in that both electrodes are structured by means of slits on the opposite sides, which results in increased contrast and improved transparency to light, but is technologically difficult and makes the display more sensitive to mechanical influences (“tapping", etc.).
  • a shortening of the response times and an improvement in the contrast and luminance (transmission) of the display are demanded.
  • PS polymer sustained
  • PSA polymer sustained alignment
  • a small amount for example 0.3% by weight, typically ⁇ 1% by weight
  • the polymerisation is carried out at a temperature where the LC medium exhibits a liquid crystal phase, usually at room temperature.
  • RMs reactive mesogens
  • PSA is used hereinafter when referring to displays of the polymer sustained alignment type in general, and the term “PS” is used when referring to specific display modes, like PS-VA, PS-TN and the like.
  • RM is used hereinafter when referring to a polymerisable mesogenic or liquid-crystalline compound.
  • PS(A) principle is being used in various conventional LC display modes.
  • PS-VA, PS-OCB, PS-IPS, PS-FFS, PS-UB-FFS and PS-TN displays are known.
  • the polymerisation of the RMs preferably takes place with an applied voltage in the case of PS-VA and PS-OCB displays, and with or without, preferably without, an applied voltage in the case of PS-IPS displays.
  • the PS(A) method results in a pretilt in the cell.
  • PS-OCB displays for example, it is possible for the bend structure to be stabilised so that an offset voltage is unnecessary or can be reduced.
  • the pretilt has a positive effect on response times.
  • a standard MVA or PVA pixel and electrode layout can be used.
  • posi-VA displays (“positive VA") have proven to be a particularly suitable mode.
  • the initial orientation of the LC molecules in posi-VA displays is homeotropic, i.e. substantially perpendicular to the substrates, in the initial state when no voltage is applied.
  • posi-VA displays LC media with positive dielectric anisotropy are used.
  • the two electrodes in posi-VA displays are arranged on only one of the two substrates, and preferably exhibit intermeshed and comb-shaped (interdigital) structures.
  • PS-VA displays are described, for example, in EP 1 170 626 A2 , US 6,861,107 , US 7,169,449 , US 2004/0191428 A1 , US 2006/0066793 A1 and US 2006/0103804 A1 .
  • PS-OCB displays are described, for example, in T.-J-Chen et al., Jpn. J. Appl. Phys. 45, 2006, 2702-2704 and S. H. Kim, L.-C-Chien, Jpn. J. Appl. Phys. 43, 2004, 7643-7647 .
  • PS-IPS displays are described, for example, in US 6,177,972 and Appl. Phys. Lett. 1999, 75(21), 3264 .
  • PS-TN displays are described, for example, in Optics Express 2004, 12(7), 1221 .
  • PSA displays can be operated as active-matrix or passive-matrix displays.
  • active-matrix displays individual pixels are usually addressed by integrated, non-linear active elements, such as, for example, transistors (for example thin-film transistors (“TFTs”)), while in the case of passive-matrix displays, individual pixels are usually addressed by the multiplex method, as known from the prior art.
  • TFTs thin-film transistors
  • the PSA display may also comprise an alignment layer on one or both of the substrates forming the display cell.
  • the alignment layer is usually applied on the electrodes (where such electrodes are present) such that it is in contact with the LC medium and induces initial alignment of the LC molecules.
  • the alignment layer may comprise or consist of, for example, a polyimide, which may also be rubbed, or may be prepared by a photoalignment method.
  • the PSA method can provide significant advantages here.
  • a shortening of the response times, which correlate with a measurable pretilt in test cells, can be achieved without significant adverse effects on other parameters.
  • the selected combination of LC host mixture/RM should have the lowest possible rotational viscosity and the best possible electrical properties. In particular, it should have the highest possible VHR.
  • a high VHR after irradiation with UV light is particularly necessary since UV exposure is a requisite part of the display production process, but also occurs as normal exposure during operation of the finished display.
  • Preferred materials here are those which produce a lower pretilt angle during polymerisation for the same exposure time than the materials known to date, and/or through the use of which the (higher) pretilt angle that can be achieved with known materials can already be achieved after a shorter exposure time.
  • the production time (“tact time”) of the display could thus be shortened and the costs of the production process reduced.
  • a further problem in the production of PSA displays is the presence or removal of residual amounts of unpolymerised RMs, in particular after the polymerisation step for production of the pretilt angle in the display.
  • unreacted RMs of this type may adversely affect the properties of the display by, for example, polymerising in an uncontrolled manner during operation after finishing of the display.
  • the PSA displays known from the prior art often exhibit the undesired effect of so-called "image sticking” or "image burn”, i.e. the image produced in the LC display by temporary addressing of individual pixels still remains visible even after the electric field in these pixels has been switched off or after other pixels have been addressed.
  • This "image sticking" can occur on the one hand if LC host mixtures having a low VHR are used.
  • the UV component of daylight or the backlighting can cause undesired decomposition reactions of the LC molecules therein and thus initiate the production of ionic or free-radical impurities. These may accumulate, in particular, at the electrodes or the alignment layers, where they may reduce the effective applied voltage. This effect can also be observed in conventional LC displays without a polymer component.
  • a further problem that has been observed in the operation of PSA displays is the stability of the pretilt angle.
  • the pretilt angle which was generated during display manufacture by polymerising the RM as described above, does not remain constant but can deteriorate after the display was subjected to voltage stress during its operation. This can negatively affect the display performance, e.g. by increasing the black state transmission and hence lowering the contrast.
  • RMs of prior art do often have high melting points, and do only show limited solubility in many currently common LC mixtures, and therefore frequently tend to spontaneously crystallise out of the mixture.
  • the risk of spontaneous polymerisation prevents the LC host mixture being warmed in order to dissolve the polymerisable component, meaning that the best possible solubility even at room temperature is necessary.
  • there is a risk of separation for example on introduction of the LC medium into the LC display (chromatography effect), which may greatly impair the homogeneity of the display. This is further increased by the fact that the LC media are usually introduced at low temperatures in order to reduce the risk of spontaneous polymerisation (see above), which in turn has an adverse effect on the solubility.
  • LC media for use in PSA displays do often exhibit high viscosities and, as a consequence, high switching times.
  • LC media containing alkenyl compounds often show a decrease of the reliability and stability, and a decrease of the VHR especially after exposure to UV radiation.
  • the photo-polymerisation of the RMs in the PSA display is usually carried out by exposure to UV radiation, which may cause a VHR drop in the LC medium.
  • PSA displays and LC media and polymerisable compounds for use in such displays which do not show the drawbacks as described above, or only do so to a small extent, and have improved properties.
  • PSA displays, and LC media and polymerisable compounds for use in such PSA displays which enable a high specific resistance at the same time as a large working-temperature range, short response times, even at low temperatures, and a low threshold voltage, a low pretilt angle, a multiplicity of grey shades, high contrast and a broad viewing angle, have high reliability and high values for the "voltage holding ratio" (VHR) after UV exposure, and, in case of the polymerisable compounds, have low melting points and a high solubility in the LC host mixtures.
  • VHR voltage holding ratio
  • the invention is based on the object of providing novel suitable materials, in particular RMs and LC media comprising same, for use in PSA displays, which do not have the disadvantages indicated above or do so to a reduced extent, polymerise as rapidly and completely as possible, enable a low pretilt angle to be established as quickly as possible, reduce or prevent the occurrence of "image sticking" in the display, and preferably at the same time enable very high specific resistance values, high VHR values, low threshold voltages and short response times, and have a high solubility in the LC media which are typically used as host mixtures in PSA displays.
  • a further object of the invention is the provision of novel RMs, in particular for optical, electro-optical and electronic applications, and of suitable processes and intermediates for the preparation thereof.
  • the invention is based on the object of providing polymerisable compounds like RMs which produce a lower pretilt after photopolymerisation, which results in the desired pretilt being achieved more quickly and thus in significantly shortened times for production of the LC display, and which are easily processable in an LC mixture.
  • pretilt measurements have been demonstrated in connection with an LC medium by means of pretilt measurements.
  • a pretilt has been achieved without the addition of photoinitiator.
  • the polymerisable compounds according to the present invention exhibit significantly faster generation of the pretilt angle compared with the compounds known from prior art, as demonstrated by exposure time-dependent measurements of the pretilt angle.
  • polymerisable compounds according to the present invention are especially suitable for use in LC host mixtures containing mesogenic or LC compounds with an alkenyl group.
  • the use of the polymerisable compounds according to the present invention in such LC host mixtures enables LC media with high VHR values and high reliability.
  • the polymerisable compounds according to the invention exhibit a high polymerisation rate, causing smaller unreacted residual amounts to remain in the cell.
  • the electro-optical properties of the cell are thus improved, and in addition controlled reaction of these residual amounts becomes simpler.
  • the polymerisable compounds are therefore suitable for creating a high pretilt in PSA type displays.
  • polymerisable compounds according to the invention show a low tendency towards crystallisation and high solubility in typical commercially available LC host mixtures.
  • US 7,060,200 B1 and US 2006/0172090 A1 disclose multireactive compounds with branched polymerisable groups for use in polymerisable LC materials and LC polymers, but do not disclose polymerisable compounds as disclosed or claimed hereinafter, or their use in LC media for PSA type LC displays.
  • the invention relates to compounds of formula I P 1 -Sp 1 -(A 1 -Z 1 ) n -A 2 -O-Sp 4 -CH(Sp 2 -P 2 )(Sp 3 -P 3 ) I in which the individual radicals have the following meanings:
  • the invention further relates to the use of compounds of formula I as polymerisable compounds in LC media and LC displays, especially in the LC medium, active layer or alignment layer of an LC display, wherein the LC displays are preferably PSA displays.
  • the invention further relates to methods for preparing compounds of formula I, and to novel intermediates used or obtained in these methods.
  • the invention furthermore relates to an LC medium comprising one or more compounds of formula I.
  • the invention furthermore relates to an LC medium comprising one or more polymerisable compounds, at least one of which is a compound of formula I.
  • the invention furthermore relates to an LC medium comprising
  • the liquid-crystalline component B) of an LC medium according to the present invention is hereinafter also referred to as "LC host mixture", and preferably comprises, or consists of, one or more, preferably at least two mesogenic or LC compounds selected from low-molecular-weight compounds which are unpolymerisable.
  • the invention furthermore relates to an LC medium as described above and below, wherein the LC host mixture or component B comprise at least one mesogenic or LC compound comprising an alkenyl group.
  • the invention furthermore relates to an LC medium or LC display as described above, wherein the compounds of formula I are polymerised.
  • the invention furthermore relates to a process for preparing an LC medium as described above and below, comprising the steps of mixing one or more mesogenic or LC compounds, or an LC host mixture or LC component B) as described above and below, with one or more compounds of formula I, and optionally with further LC compounds and/or additives.
  • the invention furthermore relates to the use of compounds of formula I and LC media according to the invention in PSA displays, in particular the use in PSA displays containing an LC medium, for the production of a tilt angle in the LC medium by in-situ polymerisation of the compound(s) of the formula I in the PSA display, preferably in an electric or magnetic field.
  • the invention furthermore relates to an LC display comprising one or more compounds of formula I or an LC medium according to the invention, in particular a PSA display, particularly preferably a PS-VA, PS-OCB, PS-IPS, PS-FFS, PS-UB-FFS, PS-posi-VA or PS-TN display.
  • a PSA display particularly preferably a PS-VA, PS-OCB, PS-IPS, PS-FFS, PS-UB-FFS, PS-posi-VA or PS-TN display.
  • the invention furthermore relates to an LC display comprising a polymer obtainable by polymerisation of one or more compounds of formula I or of a polymerisable component A) as described above, or comprising an LC medium according to the invention, which is preferably a PSA display, very preferably a PS-VA, PS-OCB, PS-IPS, PS-FFS, PS-UB-FFS, PS-posi-VA or PS-TN display.
  • a PSA display very preferably a PS-VA, PS-OCB, PS-IPS, PS-FFS, PS-UB-FFS, PS-posi-VA or PS-TN display.
  • the invention furthermore relates to an LC display of the PSA type comprising two substrates, at least one which is transparent to light, an electrode provided on each substrate or two electrodes provided on only one of the substrates, and located between the substrates a layer of an LC medium that comprises one or more polymerisable compounds and an LC component as described above and below, wherein the polymerisable compounds are polymerised between the substrates of the display.
  • the invention furthermore relates to a process for manufacturing an LC display as described above and below, comprising the steps of filling or otherwise providing an LC medium, which comprises one or more polymerisable compounds as described above and below, between the substrates of the display, and polymerising the polymerisable compounds.
  • the PSA displays according to the invention have two electrodes, preferably in the form of transparent layers, which are applied to one or both of the substrates.
  • two electrodes preferably in the form of transparent layers, which are applied to one or both of the substrates.
  • one electrode is applied to each of the two substrates.
  • both electrodes are applied to only one of the two substrates.
  • the polymerisable component is polymerised in the LC display while a voltage is applied to the electrodes of the display.
  • the polymerisable compounds of the polymerisable compoment are preferably polymerised by photo-polymerisation, very preferably by UV photo-polymerisation.
  • active layer and “switchable layer” mean a layer in an electrooptical display, for example an LC display, that comprises one or more molecules having structural and optical anisotropy, like for example LC molecules, which change their orientation upon an external stimulus like an electric or magnetic field, resulting in a change of the transmission of the layer for polarized or unpolarized light.
  • the tilt angle here denotes the average angle ( ⁇ 90°) between the longitudinal molecular axes of the LC molecules (LC director) and the surface of the plane-parallel outer plates which form the LC cell.
  • ⁇ 90° the average angle
  • a low value for the tilt angle i.e. a large deviation from the 90° angle
  • tilt angle values disclosed above and below relate to this measurement method.
  • reactive mesogen and "RM” will be understood to mean a compound containing a mesogenic or liquid crystalline skeleton, and one or more functional groups attached thereto which are suitable for polymerisation and are also referred to as “polymerisable group” or "P".
  • polymerisable compound as used herein will be understood to mean a polymerisable monomeric compound.
  • low-molecular-weight compound will be understood to mean to a compound that is monomeric and/or is not prepared by a polymerisation reaction, as opposed to a "polymeric compound” or a "polymer”.
  • unpolymerisable compound will be understood to mean a compound that does not contain a functional group that is suitable for polymerisation under the conditions usually applied for the polymerisation of the RMs.
  • mesogenic group as used herein is known to the person skilled in the art and described in the literature, and means a group which, due to the anisotropy of its attracting and repelling interactions, essentially contributes to causing a liquid-crystal (LC) phase in low-molecular-weight or polymeric substances.
  • Compounds containing mesogenic groups do not necessarily have to have an LC phase themselves. It is also possible for mesogenic compounds to exhibit LC phase behaviour only after mixing with other compounds and/or after polymerisation. Typical mesogenic groups are, for example, rigid rod- or disc-shaped units.
  • spacer group hereinafter also referred to as "Sp”, as used herein is known to the person skilled in the art and is described in the literature, see, for example, Pure Appl. Chem. 73(5), 888 (2001 ) and C. Tschierske, G. Pelzl, S. Diele, Angew. Chem. 2004, 116, 6340-6368 .
  • spacer group or “spacer” mean a flexible group, for example an alkylene group, which connects the mesogenic group and the polymerisable group(s) in a polymerisable mesogenic compound.
  • trans-1,4-cyclohexylene ring denotes a trans-1,4-cyclohexylene ring
  • 1,4-phenylene ring denotes a trans-1,4-cyclohexylene ring
  • organic group denotes a carbon or hydrocarbon group.
  • Carbon group denotes a mono- or polyvalent organic group containing at least one carbon atom, where this either contains no further atoms (such as, for example, -C ⁇ C-) or optionally contains one or more further atoms, such as, for example, N, O, S, B, P, Si, Se, As, Te or Ge (for example carbonyl, etc.).
  • hydrocarbon group denotes a carbon group which additionally contains one or more H atoms and optionally one or more heteroatoms, such as, for example, N, O, S, B, P, Si, Se, As, Te or Ge.
  • Halogen denotes F, Cl, Br or I.
  • a carbon or hydrocarbon group can be a saturated or unsaturated group. Unsaturated groups are, for example, aryl, alkenyl or alkynyl groups.
  • a carbon or hydrocarbon radical having more than 3 C atoms can be straight-chain, branched and/or cyclic and may also contain spiro links or condensed rings.
  • alkyl also encompass polyvalent groups, for example alkylene, arylene, heteroarylene, etc.
  • aryl denotes an aromatic carbon group or a group derived therefrom.
  • heteroaryl denotes “aryl” as defined above, containing one or more heteroatoms, preferably selected from N, O, S, Se, Te, Si and Ge.
  • Preferred carbon and hydrocarbon groups are optionally substituted, straight-chain, branched or cyclic, alkyl, alkenyl, alkynyl, alkoxy, alkylcarbonyl, alkoxycarbonyl, alkylcarbonyloxy and alkoxycarbonyloxy having 1 to 40, preferably 1 to 20, very preferably 1 to 12, C atoms, optionally substituted aryl or aryloxy having 5 to 30, preferably 6 to 25, C atoms, or optionally substituted alkylaryl, arylalkyl, alkylaryloxy, arylalkyloxy, arylcarbonyl, aryloxycarbonyl, arylcarbonyloxy and aryloxycarbonyloxy having 5 to 30, preferably 6 to 25, C atoms, wherein one or more C atoms may also be replaced by hetero atoms, preferably selected from N, O, S, Se, Te, Si and Ge.
  • hetero atoms preferably selected from N, O, S, Se, Te, Si
  • carbon and hydrocarbon groups are C 1 -C 20 alkyl, C 2 -C 20 alkenyl, C 2 -C 20 alkynyl, C 3 -C 20 allyl, C 4 -C 20 alkyldienyl, C 4 -C 20 polyenyl, C 6 -C 20 cycloalkyl, C 4 -C 15 cycloalkenyl, C 6 -C 30 aryl, C 6 -C 30 alkylaryl, C 6 -C 30 arylalkyl, C 6 -C 30 alkylaryloxy, C 6 -C 30 arylalkyloxy, C 2 -C 30 heteroaryl, C 2 -C 30 heteroaryloxy.
  • C 1 -C 12 alkyl Particular preference is given to C 1 -C 12 alkyl, C 2 -C 12 alkenyl, C 2 -C 12 alkynyl, C 6 -C 25 aryl and C 2 -C 25 heteroaryl.
  • R x preferably denotes H, halogen, a straight-chain, branched or cyclic alkyl chain having 1 to 15 C atoms, in which, in addition, one or more non-adjacent C atoms may be replaced by -O-, -S-, -CO-, -CO-O-, -O-CO-, -O-CO-O- and in which one or more H atoms may be replaced by fluorine, an optionally substituted aryl or aryloxy group having 6 to 30 C atoms, or an optionally substituted heteroaryl or heteroaryloxy group having 2 to 30 C atoms.
  • Preferred alkoxy groups are, for example, methoxy, ethoxy, 2-methoxy-ethoxy, n-propoxy, i-propoxy, n-butoxy, i-butoxy, s-butoxy, t-butoxy, 2-methylbutoxy, n-pentoxy, n-hexoxy, n-heptoxy, n-octoxy, n-nonoxy, n-decoxy, n-undecoxy, n-dodecoxy, etc.
  • Preferred alkyl groups are, for example, methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, s-butyl, t-butyl, 2-methylbutyl, n-pentyl, s-pentyl, cyclopentyl, n-hexyl, cyclohexyl, 2-ethylhexyl, n-heptyl, cycloheptyl, n-octyl, cyclooctyl, n-nonyl, n-decyl, n-undecyl, n-dodecyl, dodecanyl, trifluoromethyl, perfluoro-n-butyl, 2,2,2-trifluoroethyl, perfluorooctyl, perfluorohexyl, etc.
  • Preferred alkenyl groups are, for example, ethenyl, propenyl, butenyl, pentenyl, cyclopentenyl, hexenyl, cyclohexenyl, heptenyl, cycloheptenyl, octenyl, cyclooctenyl, etc.
  • Preferred alkynyl groups are, for example, ethynyl, propynyl, butynyl, pentynyl, hexynyl, octynyl, etc.
  • Preferred alkoxy groups are, for example, methoxy, ethoxy, 2-methoxy-ethoxy, n-propoxy, i-propoxy, n-butoxy, i-butoxy, s-butoxy, t-butoxy, 2-methylbutoxy, n-pentoxy, n-hexoxy, n-heptoxy, n-octoxy, n-nonoxy, n-decoxy, n-undecoxy, n-dodecoxy, etc.
  • Preferred amino groups are, for example, dimethylamino, methylamino, methylphenylamino, phenylamino, etc.
  • Aryl and heteroaryl groups can be monocyclic or polycyclic, i.e. they can contain one ring (such as, for example, phenyl) or two or more rings, which may also be fused (such as, for example, naphthyl) or covalently bonded (such as, for example, biphenyl), or contain a combination of fused and linked rings.
  • Heteroaryl groups contain one or more heteroatoms, preferably selected from O, N, S and Se.
  • aryl groups having 6 to 25 C atoms and mono-, bi- or tricyclic heteroaryl groups having 5 to 25 ring atoms, which optionally contain fused rings and are optionally substituted.
  • Preferred aryl groups are, for example, phenyl, biphenyl, terphenyl, [1,1':3',1"]terphenyl-2'-yl, naphthyl, anthracene, binaphthyl, phenanthrene, 9,10-dihydro-phenanthrene, pyrene, dihydropyrene, chrysene, perylene, tetracene, pentacene, benzopyrene, fluorene, indene, indenofluorene, spirobifluorene, etc.
  • Preferred heteroaryl groups are, for example, 5-membered rings, such as pyrrole, pyrazole, imidazole, 1,2,3-triazole, 1,2,4-triazole, tetrazole, furan, thiophene, selenophene, oxazole, isoxazole, 1,2-thiazole, 1,3-thiazole, 1,2,3-oxadiazole, 1,2,4-oxadiazole, 1,2,5-oxadiazole, 1,3,4-oxadiazole, 1,2,3-thiadiazole, 1,2,4-thiadiazole, 1,2,5-thiadiazole, 1,3,4-thiadiazole, 6-membered rings, such as pyridine, pyridazine, pyrimidine, pyrazine, 1,3,5-triazine, 1,2,4-triazine, 1,2,3-triazine, 1,2,4,5-tetrazine, 1,2,3,4-tetrazine, 1,
  • aryl and heteroaryl groups mentioned above and below may also be substituted by alkyl, alkoxy, thioalkyl, fluorine, fluoroalkyl or further aryl or heteroaryl groups.
  • the (non-aromatic) alicyclic and heterocyclic groups encompass both saturated rings, i.e. those containing exclusively single bonds, and also partially unsaturated rings, i.e. those which may also contain multiple bonds.
  • Heterocyclic rings contain one or more heteroatoms, preferably selected from Si, O, N, S and Se.
  • the (non-aromatic) alicyclic and heterocyclic groups can be monocyclic, i.e. contain only one ring (such as, for example, cyclohexane), or polycyclic, i.e. contain a plurality of rings (such as, for example, decahydronaphthalene or bicyclooctane). Particular preference is given to saturated groups. Preference is furthermore given to mono-, bi- or tricyclic groups having 5 to 25 ring atoms, which optionally contain fused rings and are optionally substituted.
  • Preferred alicyclic and heterocyclic groups are, for example, 5-membered groups, such as cyclopentane, tetrahydrofuran, tetrahydrothiofuran, pyrrolidine, 6-membered groups, such as cyclohexane, silinane, cyclohexene, tetrahydropyran, tetrahydrothiopyran, 1,3-dioxane, 1,3-dithiane, piperidine, 7-membered groups, such as cycloheptane, and fused groups, such as tetrahydronaphthalene, decahydronaphthalene, indane, bicyclo[1.1.1]-pentane-1,3-diyl, bicyclo[2.2.2]octane-1,4-diyl, spiro[3.3]heptane-2,6-diyl, octahydro-4,7-methanoindane
  • Preferred substituents are, for example, solubility-promoting groups, such as alkyl or alkoxy, electron-withdrawing groups, such as fluorine, nitro or nitrile, or substituents for increasing the glass transition temperature (Tg) in the polymer, in particular bulky groups, such as, for example, t-butyl or optionally substituted aryl groups.
  • R x denotes H, F, Cl, CN, or straight chain, branched or cyclic alkyl having 1 to 25 C atoms, wherein one or more non-adjacent CH 2 -groups are optionally replaced by -O-, -S-, -CO-, -CO-O-, -O-CO-, -O-CO-O- in such a manner that O- and/or S-atoms are not directly connected with each other, and wherein one or more H atoms are each optionally replaced by F, Cl, P-or P-Sp-, and
  • Y 1 denotes halogen
  • Substituted silyl or aryl preferably means substituted by halogen, -CN, R 0 , -OR 0 , -CO-R 0 , -CO-O-R 0 , -O-CO-R 0 or -O-CO-O-R 0 , wherein R 0 denotes H or alkyl with 1 to 20 C atoms.
  • substituents L are, for example, F, Cl, CN, NO 2 , CH 3 , C 2 H 5 , OCH 3 , OC 2 H 5 , COCH 3 , COC 2 H 5 , COOCH 3 , COOC 2 H 5 , CF 3 , OCF 3 , OCHF 2 , OC 2 F 5 , furthermore phenyl. is preferably in which L has one of the meanings indicated above.
  • the polymerisable group P 1-3 is a group which is suitable for a polymerisation reaction, such as, for example, free-radical or ionic chain polymerisation, polyaddition or polycondensation, or for a polymer-analogous reaction, for example addition or condensation onto a main polymer chain.
  • a polymerisation reaction such as, for example, free-radical or ionic chain polymerisation, polyaddition or polycondensation, or for a polymer-analogous reaction, for example addition or condensation onto a main polymer chain.
  • groups which are suitable for polymerisation with ring opening such as, for example, oxetane or epoxide groups.
  • polymerisable groups P 1-3 are selected from the group consisting of vinyl, vinyloxy, acrylate, methacrylate, fluoroacrylate, chloroacrylate, oxetane and epoxide groups, very preferably from acrylate and methacrylate groups.
  • the spacer groups Sp 1-3 are different from a single bond, they are preferably of the formula Sp"-X", so that the respective radical P i -Sp i -, like for example P 1 -Sp 1 -, conforms to the formula P-Sp"-X"-, where Sp" and X" have the meanings given below.
  • the spacer group Sp 4 is different from a single bond, it is preferably of the formula X"-Sp", so that the respective radical -A 2 -Sp 4 - conforms to the formula -A 2 -X"-Sp"-, where Sp" and X" have the meanings given below.
  • X" is preferably -O-, -S-, -CO-, -COO-, -OCO-, -O-COO-, -CO-NR 0 -, -NR 0 -CO-, -NR 0 -CO-NR 0 - or a single bond.
  • Typical spacer groups -Sp"-X"- are, for example, -(CH 2 ) p1 -, -(CH 2 CH 2 O) q1 -CH 2 CH 2 -, -CH 2 CH 2 -S-CH 2 CH 2 -, -CH 2 CH 2 -NH-CH 2 CH 2 - or -(SiR 00 R 000 -O) p1 -, in which p1 is an integer from 1 to 12, q1 is an integer from 1 to 3, and R 00 and R 000 have the meanings indicated above.
  • Particularly preferred groups -Sp"-X"- are -(CH 2 ) p1 -, -(CH 2 ) p1 -O-, -(CH 2 ) p1 -O-CO-, -(CH 2 ) p1 -O-CO-O-, in which p1 and q1 have the meanings indicated above.
  • Particularly preferred groups -X"-Sp"- are -(CH 2 ) p1 , -O-(CH 2 ) p1 -, -CO-O-(CH 2 ) p1 -, -O-CO-O-(CH 2 ) p1 -, in which p1 and q1 have the meanings indicated above.
  • Particularly preferred groups Sp are, for example, in each case straight-chain ethylene, propylene, butylene, pentylene, hexylene, heptylene, octylene, nonylene, decylene, undecylene, dodecylene, octadecylene, ethyleneoxyethylene, methyleneoxybutylene, ethylenethioethylene, ethylene-N-methyliminoethylene, 1-methylalkylene, ethenylene, propenylene and butenylene.
  • Preferred compounds of formula I are those in which A 1 , A 2 each, independently of one another, denote 1,4-phenylene, naphthalene-1,4-diyl or naphthalene-2,6-diyl, where one or more CH groups in these groups are optionally replaced by N, cyclohexane-1,4-diyl, in which, in addition, one or more non-adjacent CH 2 groups are optionally replaced by O and/or S, 1,4-cyclohexenylene, bicyclo[1.1.1]pentane-1,3-diyl, bicyclo[2.2.2]octane-1,4-diyl, spiro[3.3]heptane-2,6-diyl, piperidine-1,4-diyl, decahydronaphthalene-2,6-diyl, 1,2,3,4-tetrahydronaphthalene-2,6-diyl, indane-2,5-
  • Very preferred compounds of formula I are selected from the following subformulae wherein P 1 , P 2 , P 3 and L are as defined in formula I and r is 0, 1, 2, 3 or 4.
  • the invention furthermore relates to compounds of formula II Pg 1 -Sp 1 -(A 1 -Z 1 ) n -A 2 -O-Sp 4 -CH(Sp 2 -Pg 2 )(Sp 3 -Pg 3 ) II in which Sp 1 , Sp 2 , Sp 3 , Sp 4 , A 1 , A 2 , Z 1 and n have the meaning indicated in formula I or above and below, and Pg 1 , Pg 2 and Pg 3 denote independently of each other OH, a protected hydroxyl group or a masked hydroxyl group.
  • the compounds of formula II are suitable as intermediates for the preparation of compounds of the formula I and its subformulae.
  • the invention further relates to the use of the compounds of formula II as intermediates for the preparation of compounds of the formula I and its subformulae.
  • Suitable protected hydroxyl groups Pg 1-3 are known to the person skilled in the art.
  • Preferred protecting groups for hydroxyl groups are alkyl, alkoxyalkyl, acyl, alkylsilyl, arylsilyl and arylmethyl groups, especially 2-tetrahydropyranyl, methoxymethyl, methoxyethoxymethyl, acetyl, triisopropylsilyl, tert -butyl-dimethylsilyl or benzyl.
  • masked hydroxyl group is understood to mean any functional group that can be chemically converted into a hydroxyl group. Suitable masked hydroxyl groups Pg 1-3 are known to the person skilled in the art. A preferred masking group for CH(CH 2 -Pg 2 )(CH 2 -Pg 3 ) is a malonate group - CH(CO 2 Et) 2 .
  • Preferred compounds of formula II are selected from the following subformulae: wherein Pg 1 , Pg 2 and Pg 3 are as defined in formula II or have one of the preferred meanings given above, and L and r are as defined in formula I1.
  • compounds of formula I can be synthesised by esterification or etherification of the intermediates of formula II, wherein Pg 1-3 denote OH, using corresponding acids, acid derivatives, or halogenated compounds containing a polymerisable group P 1 .
  • acrylic or methacrylic esters (wherein Sp 1-4 , A 1-2 , Z 1 and n have the meanings given above, and "Acr” denotes an acrylate or methacrylate group) can be prepared by esterification of the corresponding alcohols with acid derivatives like, for example, (meth)acryloyl chloride or (meth)acrylic anhydride in the presence of a base like pyridine or triethyl amine, and 4-( N,N -dimethylamino)pyridine (DMAP).
  • acid derivatives like, for example, (meth)acryloyl chloride or (meth)acrylic anhydride in the presence of a base like pyridine or triethyl amine, and 4-( N,N -dimethylamino)pyridine (DMAP).
  • esters can be prepared by esterification of the alcohols with (meth)acrylic acid in the presence of a dehydrating reagent, for example according to Steglich with dicyclohexylcarbodiimide (DCC), N -(3-dimethylaminopropyl)- N'- ethylcarbodiimide (EDC) or N -(3-dimethylaminopropyl)- N' -ethylcarbodiimide hydrochloride and DMAP.
  • a dehydrating reagent for example according to Steglich with dicyclohexylcarbodiimide (DCC), N -(3-dimethylaminopropyl)- N'- ethylcarbodiimide (EDC) or N -(3-dimethylaminopropyl)- N' -ethylcarbodiimide hydrochloride and DMAP.
  • the polymerisable compounds cointained in the LC medium are polymerised or crosslinked (if one compound contains two or more polymerisable groups) by in-situ polymerisation in the LC medium between the substrates of the LC display, optionally while a voltage is applied to the electrodes.
  • the structure of the PSA displays according to the invention corresponds to the usual geometry for PSA displays, as described in the prior art cited at the outset. Geometries without protrusions are preferred, in particular those in which, in addition, the electrode on the colour filter side is unstructured and only the electrode on the TFT side has slots. Particularly suitable and preferred electrode structures for PS-VA displays are described, for example, in US 2006/0066793 A1 .
  • a preferred PSA type LC display of the present invention comprises:
  • the first and/or second alignment layer controls the alignment direction of the LC molecules of the LC layer.
  • the alignment layer is selected such that it imparts to the LC molecules homeotropic (or vertical) alignment (i.e. perpendicular to the surface) or tilted alignment.
  • Such an alignment layer may for example comprise a polyimide, which may also be rubbed, or may be prepared by a photoalignment method.
  • the LC layer with the LC medium can be deposited between the substrates of the display by methods that are conventionally used by display manufacturers, for example the so-called one-drop-filling (ODF) method.
  • ODF one-drop-filling
  • the polymerisable component of the LC medium is then polymerised for example by UV photopolymerisation.
  • the polymerisation can be carried out in one step or in two or more steps.
  • the PSA display may comprise further elements, like a colour filter, a black matrix, a passivation layer, optical retardation layers, transistor elements for addressing the individual pixels, etc., all of which are well known to the person skilled in the art and can be employed without inventive skill.
  • the electrode structure can be designed by the skilled person depending on the individual display type.
  • a multi-domain orientation of the LC molecules can be induced by providing electrodes having slits and/or bumps or protrusions in order to create two, four or more different tilt alignment directions.
  • the polymerisable compounds Upon polymerisation the polymerisable compounds form a crosslinked polymer, which causes a certain pretilt of the LC molecules in the LC medium.
  • a crosslinked polymer which causes a certain pretilt of the LC molecules in the LC medium.
  • at least a part of the crosslinked polymer, which is formed by the polymerisable compounds will phase-separate or precipitate from the LC medium and form a polymer layer on the substrates or electrodes, or the alignment layer provided thereon.
  • Microscopic measurement data like SEM and AFM have confirmed that at least a part of the formed polymer accumulates at the LC/substrate interface.
  • the polymerisation can be carried out in one step. It is also possible firstly to carry out the polymerisation, optionally while applying a voltage, in a first step in order to produce a pretilt angle, and subsequently, in a second polymerisation step without an applied voltage, to polymerise or crosslink the compounds which have not reacted in the first step ("end curing").
  • Suitable and preferred polymerisation methods are, for example, thermal or photopolymerisation, preferably photopolymerisation, in particular UV induced photopolymerisation, which can be achieved by exposure of the polymerisable compounds to UV radiation.
  • one or more polymerisation initiators are added to the polymerisable compounds.
  • Suitable conditions for the polymerisation and suitable types and amounts of initiators are known to the person skilled in the art and are described in the literature.
  • Suitable for free-radical polymerisation are, for example, the commercially available photoinitiators Irgacure651®, Irgacure184®, Irgacure907®, Irgacure369® or Darocure1173® (Ciba AG). If a polymerisation initiator is employed, its proportion is preferably 0.001 to 5% by weight, particularly preferably 0.001 to 1% by weight.
  • the polymerisable compounds according to the invention are also suitable for polymerisation without an initiator, which is accompanied by considerable advantages, such, for example, lower material costs and in particular less contamination of the LC medium by possible residual amounts of the initiator or degradation products thereof.
  • the polymerisation can thus also be carried out without the addition of an initiator.
  • the LC medium thus does not contain a polymerisation initiator.
  • the polymerisable component (component A) or the LC medium may also comprise one or more stabilisers in order to prevent undesired spontaneous polymerisation of the RMs, for example during storage or transport.
  • Suitable types and amounts of stabilisers are known to the person skilled in the art and are described in the literature. Particularly suitable are, for example, the commercially available stabilisers from the Irganox® series (Ciba AG), such as, for example, Irganox® 1076. If stabilisers are employed, their proportion, based on the total amount of RMs or the polymerisable component (component A), is preferably 10-500,000 ppm, particularly preferably 50-50,000 ppm.
  • the polymerisable compounds of formula I do in particular show good UV absorption in, and are therefore especially suitable for, a process of preparing a PSA display including one or more of the following features:
  • a preferred embodiment of the present invention relates to a process for preparing a PSA display as described above and below, comprising one or more of the following features:
  • This preferred process can be carried out for example by using the desired UV lamps or by using a band pass filter and/or a cut-off filter, which are substantially transmissive for UV light with the respective desired wavelength(s) and are substantially blocking light with the respective undesired wavelengths.
  • a band pass filter and/or a cut-off filter which are substantially transmissive for UV light with the respective desired wavelength(s) and are substantially blocking light with the respective undesired wavelengths.
  • UV exposure can be carried out using a wide band pass filter being substantially transmissive for wavelengths 300nm ⁇ ⁇ ⁇ 400nm.
  • UV exposure can be carried out using a cut-off filter being substantially transmissive for wavelengths ⁇ > 340 nm.
  • “Substantially transmissive” means that the filter transmits a substantial part, preferably at least 50% of the intensity, of incident light of the desired wavelength(s). “Substantially blocking” means that the filter does not transmit a substantial part, preferably at least 50% of the intensity, of incident light of the undesired wavelengths.
  • “Desired (undesired) wavelength” e.g. in case of a band pass filter means the wavelengths inside (outside) the given range of ⁇ , and in case of a cut-off filter means the wavelengths above (below) the given value of ⁇ .
  • This preferred process enables the manufacture of displays by using longer UV wavelengths, thereby reducing or even avoiding the hazardous and damaging effects of short UV light components.
  • UV radiation energy is in general from 6 to 100 J, depending on the production process conditions.
  • the LC medium according to the present invention does essentially consist of one or more polymerisable compounds of formula I and an LC host mixture as described above and below.
  • the LC medium or LC host mixture may additionally comprise one or more further components or additives, preferably selected from the list including but not limited to co-monomers, chiral dopants, polymerisation initiators, inhibitors, stabilizers, surfactants, wetting agents, lubricating agents, dispersing agents, hydrophobing agents, adhesive agents, flow improvers, defoaming agents, deaerators, diluents, reactive diluents, auxiliaries, colourants, dyes, pigments and nanoparticles.
  • LC media comprising one, two or three polymerisable compounds of formula I.
  • the proportion of the polymerisable component or component A) in the LC medium is from > 0 to ⁇ 5%, very preferably from > 0 to ⁇ 1%, most preferably from 0.01 to 0.5%.
  • the proportion of compounds of formula I in the LC medium is from >0 to ⁇ 5%, very preferably from >0 to ⁇ 1%, most preferably from 0.01 to 0.5%.
  • the proportion of the liquid-crystalline component or component B) in the LC medium is from 95 to ⁇ 100%, very preferably from 99 to ⁇ 100%.
  • polymerisable compounds of the polymerisable component (component B) are exclusively selected from formula I.
  • polymerisable component (component B) comprises, in addition to the compounds of formula I, one or more further polymerisable compounds ("co-monomers”), preferably selected from RMs.
  • Suitable and preferred mesogenic comonomers are selected from the following formulae: in which the individual radicals have the following meanings:
  • trireactive compounds M15 to M30 in particular M17, M18, M19, M23, M24, M25, M29 and M30.
  • the group is preferably wherein L on each occurrence, identically or differently, has one of the meanings given above or below, and is preferably F, Cl, CN, NO 2 , CH 3 , C 2 H 5 , C(CH 3 ) 3 , CH(CH 3 ) 2 , CH 2 CH(CH 3 )C 2 H 5 , OCH 3 , OC 2 H 5 , COCH 3 , COC 2 H 5 , COOCH 3 , COOC 2 H 5 , CF 3 , OCF 3 , OCHF 2 , OC 2 F 5 or P-Sp-, very preferably F, Cl, CN, CH 3 , C 2 H 5 , OCH 3 , COCH 3 , OCF 3 or P-Sp-, more preferably F, Cl, CH 3 , OCH 3 , COCH 3 oder OCF 3 , especially F or CH 3 .
  • the LC media for use in the LC displays according to the invention comprise an LC mixture ("host mixture") comprising one or more, preferably two or more LC compounds which are selected from low-molecular-weight compounds that are unpolymerisable. These LC compounds are selected such that they stable and/or unreactive to a polymerisation reaction under the conditions applied to the polymerisation of the polymerisable compounds.
  • host mixture comprising one or more, preferably two or more LC compounds which are selected from low-molecular-weight compounds that are unpolymerisable.
  • any LC mixture which is suitable for use in conventional displays is suitable as host mixture.
  • Suitable LC mixtures are known to the person skilled in the art and are described in the literature, for example mixtures in VA displays in EP 1 378 557 A1 and mixtures for OCB displays in EP 1 306 418 A1 and DE 102 24 046 A1 .
  • the LC medium according to the present invention comprises one or more mesogenic or liquid crystalline compounds comprising an alkenyl group, ("alkenyl compound”), where this alkenyl group is preferably stable to a polymerisation reaction under the conditions used for the polymerisation of the polymerisable compounds of formula I or of the other polymerisable compounds contained in the LC medium.
  • the polymerisable compounds of formula I are especially suitable for use in an LC host mixture that comprises one or more mesogenic or LC compounds comprising an alkenyl group (hereinafter also referred to as "alkenyl compounds"), wherin said alkenyl group is stable to a polymerisation reaction under the conditions used for polymerisation of the compounds of formula I and of the other polymerisable compounds contained in the LC medium.
  • alkenyl compounds an alkenyl group
  • the compounds of formula I do in such an LC host mixture exhibit improved properties, like solubility, reactivity or capability of generating a tilt angle.
  • the LC host mixture is preferably a nematic LC mixture.
  • the alkenyl groups in the alkenyl compounds are preferably selected from straight-chain, branched or cyclic alkenyl, in particular having 2 to 25 C atoms, particularly preferably having 2 to 12 C atoms, in which, in addition, one or more non-adjacent CH 2 groups may be replaced by -O-, -S-, -CO-, -CO-O-, -O-CO-, -O-CO-O- in such a way that O and/or S atoms are not linked directly to one another, and in which, in addition, one or more H atoms may be replaced by F and/or Cl.
  • Preferred alkenyl groups are straight-chain alkenyl having 2 to 7 C atoms and cyclohexenyl, in particular ethenyl, propenyl, butenyl, pentenyl, hexenyl, heptenyl, 1,4-cyclohexen-1-yl and 1,4-cyclohexen-3-yl.
  • the concentration of compounds containing an alkenyl group in the LC host mixture is preferably from 5% to 100%, very preferably from 20% to 60%.
  • LC mixtures containing 1 to 5, preferably 1, 2 or 3 compounds having an alkenyl group are especially preferred.
  • the mesogenic and LC compounds containing an alkenyl group are preferably selected from the following formulae: in which the individual radicals, on each occurrence identically or differently, each, independently of one another, have the following meaning:
  • R A2 is preferably straight-chain alkyl or alkoxy having 1 to 8 C atoms or straight-chain alkenyl having 2 to 7 C atoms.
  • L 1 and L 2 denote F, or one of L 1 and L 2 denotes F and the other denotes Cl, and L 3 and L 4 denote F, or one of L 3 and L 4 denotes F and the other denotes Cl.
  • the compounds of the formula AN are preferably selected from the following sub-formulae: in which alkyl and alkyl* each, independently of one another, denote a straight-chain alkyl radical having 1-6 C atoms, and alkenyl and alkenyl* each, independently of one another, denote a straight-chain alkenyl radical having 2-7 C atoms.
  • the compounds of the formula AY are preferably selected from the following sub-formulae: in which alkyl and alkyl* each, independently of one another, denote a straight-chain alkyl radical having 1-6 C atoms, and alkenyl and alkenyl* each, independently of one another, denote a straight-chain alkenyl radical having 2-7 C atoms.
  • Very preferred compounds of the formula AN are selected from the following sub-formulae: in which m denotes 1, 2, 3, 4, 5 or 6, i denotes 0, 1, 2 or 3, and R b1 denotes H, CH 3 or C 2 H 5 .
  • the LC medium contains an LC host mixture based on compounds with negative dielectric anisotropy.
  • Such LC media are especially suitable for use in PS-VA and PS-UB-FFS displays.
  • Particularly preferred embodiments of such an LC medium are those of sections a)-z) below:
  • the LC medium contains an LC host mixture based on compounds with positive dielectric anisotropy.
  • Such LC media are especially suitable for use in PS-OCB-, PS-TN-, PS-Posi-VA-, PS-IPS- or PS-FFS-displays.
  • an LC medium of this second preferred embodiment which contains one or more compounds selected from the group consisting of compounds of formula AA and BB and optionally contains, in addition to the compounds of formula AA and/or BB, one or more compounds of formula CC in which the individual radicals have the following meanings: each, independently of one another, and on each occurrence, identically or differently each, independently of one another, and on each occurrence, identically or differently
  • the compounds of formula AA are preferably selected from the group consisting of the following formulae: in which A 21 , R 21 , X 0 , L 21 and L 22 have the meanings given in formula AA, L 23 and L 24 each, independently of one another, are H or F, and X 0 is preferably F. Particularly preferred are compounds of formulae AA1 and AA2.
  • Particularly preferred compounds of formula AA1 are selected from the group consisting of the following subformulae: in which R 21 , X 0 , L 21 and L 22 have the meaning given in formula AA1, L 23 , L 24 , L 25 and L 26 are each, independently of one another, H or F, and X 0 is preferably F.
  • Very particularly preferred compounds of formula AA1 are selected from the group consisting of the following subformulae: In which R 21 is as defined in formula AA1.
  • Very preferred compounds of formula AA2 are selected from the group consisting of the following subformulae: in which R 21 , X 0 , L 21 and L 22 have the meaning given in formula AA2, L 23 , L 24 , L 25 and L 26 each, independently of one another, are H or F, and X 0 is preferably F.
  • Very particularly preferred compounds of formula AA2 are selected from the group consisting of the following subformulae: in which R 21 and X 0 are as defined in formula AA2.
  • Particularly preferred compounds of formula AA3 are selected from the group consisting of the following subformulae: in which R 21 , X 0 , L 21 and L 22 have the meaning given in formula AA3, and X 0 is preferably F.
  • Particularly preferred compounds of formula AA4 are selected from the group consisting of the following subformulae: in which R 21 is as defined in formula AA4.
  • the compounds of formula BB are preferably selected from the group consisting of the following formulae: in which g, A 31 , A 32 , R 31 , X 0 , L 31 and L 32 have the meanings given in formula BB, and X 0 is preferably F. Particularly preferred are compounds of formulae BB1 and BB2.
  • Particularly preferred compounds of formula BB1 are selected from the group consisting of the following subformulae: in which R 31 , X 0 , L 31 and L 32 have the meaning given in formula BB1, and X 0 is preferably F.
  • Very particularly preferred compounds of formula BB1a are selected from the group consisting of the following subformulae: in which R 31 is as defined in formula BB1.
  • Very particularly preferred compounds of formula BB1 b are selected from the group consisting of the following subformulae: in which R 31 is as defined in formula BB1.
  • Particularly preferred compounds of formula BB2 are selected from the group consisting of the following subformulae: in which R 31 , X 0 , L 31 and L 32 have the meaning given in formula BB2, L 33 , L 34 , L 35 and L 36 are each, independently of one another, H or F, and X 0 is preferably F.
  • Very particularly preferred compounds of formula BB2 are selected from the group consisting of the following subformulae: in which R 31 is as defined in formula BB2.
  • Very particularly preferred compounds of formula BB2b are selected from the group consisting of the following subformulae in which R 31 is as defined in formula BB2.
  • Very particularly preferred compounds of formula BB2c are selected from the group consisting of the following subformulae: in which R 31 is as defined in formula BB2.
  • Very particularly preferred compounds of formula BB2d and BB2e are selected from the group consisting of the following subformulae: in which R 31 is as defined in formula BB2.
  • Very particularly preferred compounds of formula BB2f are selected from the group consisting of the following subformulae: in which R 31 is as defined in formula BB2.
  • Very particularly preferred compounds of formula BB2g are selected from the group consisting of the following subformulae: in which R 31 is as defined in formula BB2.
  • Very particularly preferred compounds of formula BB2h are selected from the group consisting of the following subformulae: in which R 31 and X 0 are as defined in formula BB2.
  • Very particularly preferred compounds of formula BB2i are selected from the group consisting of the following subformulae: in which R 31 and X 0 are as defined in formula BB2.
  • Very particularly preferred compounds of formula BB2k are selected from the group consisting of the following subformulae: in which R 31 and X 0 are as defined in formula BB2.
  • the LC media may also comprise one or more compounds of formula BB3 as defined above.
  • Particularly preferred compounds of formula BB3 are selected from the group consisting of the following subformulae: in which R 31 is as defined in formula BB3.
  • the LC media according to this second preferred embodiment comprise, in addition to the compounds of formula AA and/or BB, one or more dielectrically neutral compounds having a dielectric anisotropy in the range from -1.5 to +3, preferably selected from the group of compounds of formula CC as defined above.
  • Particularly preferred compounds of formula CC are selected from the group consisting of the following subformulae:
  • R 41 and R 42 have the meanings given in formula CC, and preferably denote each, independently of one another, alkyl, alkoxy, fluorinated alkyl or fluorinated alkoxy with 1 to 7 C atoms, or alkenyl, alkenyloxy, alkoxyalkyl or fluorinated alkenyl with 2 to 7 C atoms, and L 4 is H or F.
  • the LC media according to this second preferred embodiment comprise, in addition or alternatively to the dielectrically neutral compounds of formula CC, one or more dielectrically neutral compounds having a dielectric anisotropy in the range from -1.5 to +3, selected from the group of compounds of formula DD.
  • a 41 , A 42 , Z 41 , Z 42 , R 41 , R 42 and h have the meanings given in formula CC.
  • the compounds of formula AA and BB are preferably used in the LC medium according to the invention in a concentration from 2% to 60%, more preferably from 3% to 35%, and very particularly preferably from 4% to 30% in the mixture as a whole.
  • the compounds of formula CC and DD are preferably used in the LC medium according to the invention in a concentration from 2% to 70%, more preferably from 5% to 65%, even more preferably from 10% to 60%, and very particularly preferably from 10%, preferably 15%, to 55% in the mixture as a whole.
  • the combination of compounds of the preferred embodiments mentioned above with the polymerised compounds described above causes low threshold voltages, low rotational viscosities and very good low-temperature stabilities in the LC media according to the invention at the same time as constantly high clearing points and high HR values, and allows the rapid establishment of a particularly low pretilt angle in PSA displays.
  • the LC media exhibit significantly shortened response times, in particular also the grey-shade response times, in PSA displays compared with the media from the prior art.
  • the LC media and LC host mixtures of the present invention preferably have a nematic phase range of at least 80 K, particularly preferably at least 100 K, and a rotational viscosity ⁇ 250 mPa ⁇ s, preferably ⁇ 200 mPa ⁇ s, at 20°C.
  • the molecules in the layer of the LC medium in the switched-off state are aligned perpendicular to the electrode surfaces (homeotropically) or have a a tilted homeotropic alignment.
  • a realignment of the LC molecules takes place with the longitudinal molecular axes parallel to the electrode surfaces.
  • LC media according to the invention based on compounds with negative dielectric anisotropy according to the first preferred embodiment, in particular for use in displays of the PS-VA and PS-UB-FFS type, have a negative dielectric anisotropy ⁇ , preferably from -0.5 to -10, in particular from -2.5 to -7.5, at 20°C and 1 kHz.
  • the birefringence ⁇ n in LC media according to the invention for use in displays of the PS-VA and PS-UB-FFS type is preferably below 0.16, particularly preferably from 0.06 to 0.14, very particularly preferably from 0.07 to 0,12.
  • the molecules in the layer of the LC medium have a "bend" alignment.
  • a realignment of the LC molecules takes place with the longitudinal molecular axes perpendicular to the electrode surfaces.
  • LC media according to the invention for use in displays of the PS-OCB, PS-TN, PS-IPS, PS-posi-VA and PS-FFS type are preferably those based on compounds with positive dielectric anisotropy according to the second preferred embodiment, and preferably have a positive dielectric anisotropy ⁇ from +4 to +17 at 20°C and 1 kHz.
  • the birefringence ⁇ n in LC media according to the invention for use in displays of the PS-OCB type is preferably from 0.14 to 0.22, particularly preferably from 0.16 to 0.22.
  • the birefringence ⁇ n in LC media according to the invention for use in displays of the PS-TN-, PS-posi-VA-, PS-IPS- oder PS-FFS-type is preferably from 0.07 to 0.15, particularly preferably from 0.08 to 0.13.
  • LC media according to the invention based on compounds with positive dielectric anisotropy according to the second preferred embodiment, for use in displays of the PS-TN-, PS-posi-VA-, PS-IPS- oder PS-FFS-type, preferably have a positive dielectric anisotropy ⁇ from +2 to +30, particularly preferably from +3 to +20, at 20°C and 1 kHz.
  • the LC media according to the invention may also comprise further additives which are known to the person skilled in the art and are described in the literature, such as, for example, polymerisation initiators, inhibitors, stabilisers, surface-active substances or chiral dopants. These may be polymerisable or non-polymerisable. Polymerisable additives are accordingly ascribed to the polymerisable component or component A). Non-polymerisable additives are accordingly ascribed to the non-polymerisable component or component B).
  • the LC media contain one or more chiral dopants, preferably in a concentration from 0.01 to 1%, very preferably from 0.05 to 0.5%.
  • the chiral dopants are preferably selected from the group consisting of compounds from Table B below, very preferably from the group consisting of R- or S-1011, R- or S-2011, R- or S-3011, R- or S-4011, and R- or S-5011.
  • the LC media contain a racemate of one or more chiral dopants, which are preferably selected from the chiral dopants mentioned in the previous paragraph.
  • LC media for example, 0 to 15% by weight of pleochroic dyes, furthermore nanoparticles, conductive salts, preferably ethyldimethyldodecylammonium 4-hexoxybenzoate, tetrabutylammonium tetraphenylborate or complex salts of crown ethers (cf., for example, Haller et al., Mol. Cryst. Liq. Cryst. 24, 249-258 (1973 )), for improving the conductivity, or substances for modifying the dielectric anisotropy, the viscosity and/or the alignment of the nematic phases. Substances of this type are described, for example, in DE-A 22 09 127 , 22 40 864 , 23 21 632 , 23 38 281 , 24 50 088 , 26 37 430 and 28 53 728 .
  • conductive salts preferably ethyldimethyldodecylammonium 4-hexoxybenz
  • the LC media which can be used in accordance with the invention are prepared in a manner conventional per se, for example by mixing one or more of the above-mentioned compounds with one or more polymerisable compounds as defined above, and optionally with further liquid-crystalline compounds and/or additives.
  • the desired amount of the components used in lesser amount is dissolved in the components making up the principal constituent, advantageously at elevated temperature. It is also possible to mix solutions of the components in an organic solvent, for example in acetone, chloroform or methanol, and to remove the solvent again, for example by distillation, after thorough mixing.
  • the invention furthermore relates to the process for the preparation of the LC media according to the invention.
  • the LC media according to the invention may also comprise compounds in which, for example, H, N, O, Cl, F have been replaced by the corresponding isotopes like deuterium etc.
  • the LC media according to the invention comprise one or more compounds selected from the group consisting of compounds from Table A.
  • Table B shows possible chiral dopants which can be added to the LC media according to the invention.
  • the LC media preferably comprise 0 to 10% by weight, in particular 0.01 to 5% by weight, particularly preferably 0.1 to 3% by weight, of dopants.
  • the LC media preferably comprise one or more dopants selected from the group consisting of compounds from Table B.
  • Table C Table C shows possible stabilisers which can be added to the LC media according to the invention. (n here denotes an integer from 1 to 12, preferably 1, 2, 3, 4, 5, 6, 7 or 8, terminal methyl groups are not shown).
  • the LC media preferably comprise 0 to 10% by weight, in particular 1 ppm to 5% by weight, particularly preferably 1 ppm to 1% by weight, of stabilisers.
  • the LC media preferably comprise one or more stabilisers selected from the group consisting of compounds from Table C.
  • Table D Table D shows illustrative compounds which can be used in the LC media in accordance with the present invention, preferably as reactive mesogenic compounds.
  • the mesogenic media comprise one or more compounds selected from the group of the compounds from Table D.
  • threshold voltage for the present invention relates to the capacitive threshold (V 0 ), also known as the Freedericks threshold, unless explicitly indicated otherwise.
  • the optical threshold may also, as generally usual, be quoted for 10% relative contrast (V 10 ).
  • the process of polymerising the polymerisable compounds in the PSA displays as described above and below is carried out at a temperature where the LC medium exhibits a liquid crystal phase, preferably a nematic phase, and most preferably is carried out at room temperature.
  • the display used for measurement of the capacitive threshold voltage consists of two plane-parallel glass outer plates at a separation of 25 ⁇ m, each of which has on the inside an electrode layer and an unrubbed polyimide alignment layer on top, which effect a homeotropic edge alignment of the liquid-crystal molecules.
  • the display or test cell used for measurement of the tilt angles consists of two plane-parallel glass outer plates at a separation of 4 ⁇ m, each of which has on the inside an electrode layer and a polyimide alignment layer on top, where the two polyimide layers are rubbed antiparallel to one another and effect a homeotropic edge alignment of the liquid-crystal molecules.
  • the polymerisable compounds are polymerised in the display or test cell by irradiation with UVA light of defined intensity for a prespecified time, with a voltage simultaneously being applied to the display (usually 10 V to 30 V alternating current, 1 kHz).
  • a metal halide lamp and an intensity of 100 mW/cm 2 is used for polymerisation. The intensity is measured using a standard UVA meter (Hoenle UV-meter high end with UVA sensor).
  • the tilt angle is determined by crystal rotation experiment (Autronic-Melchers TBA-105). A low value (i.e. a large deviation from the 90° angle) corresponds to a large tilt here.
  • the VHR value is measured as follows: 0.3% of a polymerisable monomeric compound is added to the LC host mixture, and the resultant mixture is introduced into VA-VHR test cells which comprise an unrubbed VA-polyimide alignment layer.
  • the LC-layer thickness d is approx. 6 ⁇ m, unless stated othewise.
  • the VHR value is determined after 5 min at 100°C before and after UV exposure at 1 V, 60 Hz, 64 ⁇ s pulse (measuring instrument: Autronic-Melchers VHRM-105).
  • Polymerisable mesogenic compound (RM) (1) is prepared as follows.
  • Methacrylic acid (1.79 g, 20.8 mmol) and 4-(dimethylamino)pyridine (0.045 g, 0.36 mmol) is added to a suspension of 2-(4'-hydroxy-biphenyl-4-yloxymethyl)-propane-1,3-diol (1.0 g, 3.6 mmol) in dichloromethane (40 ml).
  • the reaction mixture is treated dropwise at 0 °C with a solution of N-(3-dimethylaminopropyl)- N '-ethylcarbodiimide (3.23 g, 20.8 mmol) in dichloromethane (10 ml) and stirred for 20 h at room temperature.
  • Polymerisable mesogenic compound (RM) (2) is prepared as follows.
  • the obtained crude product is recrystallized with heptanes/ethylacetate solvent mixture to provide 4'-(2-benzyloxy-1-benzyloxymethyl-ethoxy)-biphenyl-4-ol as white solid (5.2 g).
  • Methacrylic acid (3.78 g, 43.8 mmol) and 4-(dimethylamino)pyridine (0.094 g, 0.77 mmol) is added to a suspension of 2-(4'-hydroxy-biphenyl-4-yloxy)-propane-1,3-diol (2.0 g, 7.7 mmol) in dichloromethane (60 ml).
  • the reaction mixture is treated dropwise at 0 °C with a solution of N -(3-dimethylaminopropyl)- N '-ethylcarbodiimide (6.80 g, 43.8 mmol) in dichloromethane (20 ml) and stirred for 20 h at room temperature.
  • Polymerisable mesogenic compound (RM) (3) is prepared as follows.
  • the reaction mixture is added into 600 ml water, and extracted with 2 x 150 ml ethylacetate. The organic phase is combined. After removing solvent in vacuo, the crude product is purified by silica gel chromatography with toluene/acetate 4:1 as eluent to provide 4'-(2,2-diethoxy-ethoxy)-biphenyl-4-ol as white solid (13.5 g).
  • Methacrylic acid (6.02 g, 69.8 mmol) and 4-(dimethylamino)pyridine (0.36 g, 2.91 mmol) is added to a suspension of 4'-(2,2-diethoxy-ethoxy)-biphenyl-4-ol (17.7 g, 58.2 mmol) in dichloromethane (130 ml).
  • the reaction mixture is treated dropwise at 0 °C with a solution of N -(3-dimethylaminopropyl)- N '-ethylcarbodiimide (11.3 g, 72.8 mmol) in dichloromethane (20 ml) and stirred overnight at room temperature.
  • the obtained product is recrystallized from heptane to afford white crystals of 2-methyl-acrylic acid 4'-[2,2-bis-(2-methyl-acryloyloxy)-ethoxy]-biphenyl-4-yl ester (0.6 g, m.p. 85°C).
  • Polymerisable mesogenic compound (RM) 4 is prepared as follows.
  • reaction mixture is heated to reflux and stirred overnight. After cooling to room temperature 800 ml dist. water and 400 ml ethylacetate are added, and the mixture is neutralized carefully with 6 M HCl acid under cooling to pH ⁇ 4. The aqueous phase is extracted with ethylacetate. The organic phase is combined and washed with sat. aq. NaCl solution, dried over sodium sulfate. After removing solvent in vacuo, the solid residue is purified by recrystallization with ethanol to provide 4a as white solid (16 g).
  • 4b To a solution of 4a (5.5 g, 12.0 mmol), 1,3-bis-benzyloxy-propan-2-ol (3.27 g, 12.0 mmol), and triphenylphosphine (3.57 g, 13.6 mmol) in 40 ml THF is added diisopropylazodicarboxylate (2.78 ml, 14.1 mmol) dropwise at room temperature. The resulted suspension is stirred at room temperature overnight. The solvent is then removed in vacuo. The oily residue is purified by silica gel chromatography with heptane/ethylacetate as eluent to provide 4b as colorless oil (6.5 g).
  • 4c A suspension of 4b (6.3 g, 9.0 mmol) in tetrahydrofuran (70 ml) is treated with palladium (5%) on activated charcoal (2.0 g) and submitted to hydrogenation for 18 hs. The catalyst is then filtered off. After removing solvent in vacuo, the solid residue is recrystallized with dichloromethane to provide 4c as white solid (2.5 g).
  • Polymerisable mesogenic compound (RM) 5 is prepared as follows.
  • reaction mixture After cooling to room temperature, the reaction mixture is neutralized carefully with 6 M HCl acid under cooling to pH ⁇ 7.
  • the aqueous phase is extracted with ethyl acetate.
  • the organic phase is combined and washed with sat. aq. NaCl solution, dried over sodium sulfate. After removing solvent in vacuo, the solid residue is purified by recrystallized from ethyl acetate to provide 5a as white solid (18.0 g).
  • 5c A solution of 5b (6.5 g, 12.3 mmol) and 0.4 ml conc. HCl acid in 150 ml methanol/20 ml THF solvent mixture is treated with palladium (5%) on activated charcoal (6.5 g) and submitted to hydrogenation under 2 bar at 30°C for 4hs. The catalyst is then filtered off, and the remaining solution is concentrated in vacuo. The oily residue is purified by silica gel chromatography with DCM/methanol solvent mixture as eluent to provide 5c as yellowish oil (2.4 g).
  • the nematic LC mixture N1 is formulated as follows. CCH-501 9.00% cl.p. + 70.0 °C CCH-35 14.00% ⁇ n 0.0825 PCH-53 8.00% ⁇ -3.5 PCH-304FF 14.00% ⁇ ll 3,5 PCH-504 13.00% K 3 /K 1 1.00 CCP-302FF 8.00% Y 1 141 mPa s CCP-503FF 8.00% V 0 2.6 V CCP-21 FF 9.00% CCP-31 FF 9.00% CPY-2-O2 8.00%
  • the nematic LC mixture N2 is formulated as follows. CY-3-O2 18.00% cl.p. + 74.5 °C CPY-2-O2 10.00% ⁇ n 0.1021 CPY-3-O2 10.00% ⁇ -3.1 CCY-3-O2 9.00% ⁇
  • the nematic LC mixture N3 is formulated as follows. CC-3-V 20.00% cl.p. + 74.5 °C CC-3-V1 10.00% ⁇ n 0.1084 CCH-34 8.00% ⁇ -3.2 CCH-35 4.00% ⁇
  • the nematic LC mixture N4 is formulated as follows. CC-3-V 27.50% cl.p. + 74.8 °C CC-3-V1 7.50% ⁇ n 0.0986 CCH-23 3.00% ⁇ -3.4 CCP-3-1 3.75% ⁇
  • the nematic LC mixture N5 is formulated as follows. CC-3-V 41.50% cl.p. + 74.6 °C CCP-3-1 2.00% ⁇ n 0.0983 CCY-3-01 5.25% ⁇ -3.1 CCY-3-02 12.50% ⁇
  • the nematic LC mixture N6 is formulated as follows. CC-3-V 27.50% cl.p. + 75.6 °C CC-3-V1 8.00% ⁇ n 0.0989 CCH-23 2.50% ⁇ -3.4 CCP-3-1 3.00% ⁇ ll CCY-3-02 12.00% K 3 /K 1 1.16 CCY-4-02 2.00% ⁇ 1 94 mPa s CPY-2-02 10.00% V 0 2.28 V CPY-3-02 10.50% CY-3-02 15.50% CY-3-04 1.00% PY-3-02 7.00% PYP-2-3 1.00%
  • the nematic LC mixture N7 is formulated as follows. CC-3-V 41.50% cl.p. + 74.5 °C CCY-3-01 2.50% ⁇ n 0.0984 CCY-3-02 11.50% ⁇ -3.3 CCY-3-03 5.00% ⁇
  • the nematic LC mixture N8 is formulated as follows. CC-3-V 28.00% cl.p. + 74.9 °C CC-3-V1 10.00% ⁇ n 0.1026 CCH-35 1.00% ⁇ -3.0 CCP-3-1 6.00% ⁇
  • the nematic LC mixture N9 is formulated as follows. CC-3-V 15.00% cl.p. + 74.4 °C CC-3-V1 9.00% ⁇ n 0.1086 CCH-23 8.00% ⁇ -3.2 CCH-34 7.50% ⁇
  • the nematic LC mixture N10 is formulated as follows. CC-3-V 42.00% cl.p. + 73.5 °C CCY-3-01 5.00% ⁇ n 0.1007 CCY-3-02 10.00% ⁇ -3.5 CCY-4-02 2.50% ⁇
  • the nematic LC mixture N11 is formulated as follows. CC-3-V 45.50% cl.p. + 73.0 °C CCY-3-01 3.00% ⁇ n 0.1011 CCY-3-02 11.00% ⁇ -3.5 CCY-4-02 3.50% ⁇
  • the nematic LC mixture N12 is formulated as follows. CC-3-V 34.50% cl.p. + 75.0 °C CC-3-V1 8.00% ⁇ n 0.1075 CCY-3-01 7.00% ⁇ -3.1 CCY-3-02 11.50% ⁇
  • the nematic LC mixture N13 is formulated as follows. CY-3-02 16.50% cl.p. + 74.0 °C CCY-4-02 10.50% ⁇ n 0.1069 CCY-5-02 6.00% ⁇ -3.2 CPY-2-02 9.00% ⁇
  • the nematic LC mixture N14 is formulated as follows. CY-3-02 12.00% cl.p. + 74.0 °C CY-3-04 10.00% ⁇ n 0.1064 CCY-3-02 6.00% ⁇ -3.2 CCY-4-02 6.50% ⁇
  • the nematic LC mixture N15 is formulated as follows. CC-3-V 28.50% cl.p. +74.5 °C CCP-31 12.50% ⁇ n 0.1077 CCOY-2-02 19.00% ⁇ -3.2 CCOY-3-02 11.50% ⁇ ll 3.6 PY-3-02 13.50% K 3 /K 1 0.91 PP-1-3 10.00% ⁇ 1 99 PYP-2-3 5.00% V 0 2.34 V
  • Polymerisable mixtures P1.1, P1.2, P1.3, P1.4, P1.5, P1.6, P1.7, P1.8, P1.9, P1.10, P1.11, P1.12, P1.13, P1.14 and P1.15 according to the invention are prepared by adding RM 1 of Example 1 to each of LC mixtures N1-N15, respectively, at a concentration of 0.3% by weight.
  • Polymerisable mixtures P2.1, P2.2, P2.3, P2.4, P2.5, P2.6, P2.7, P2.8, P2.9, P2.10, P2.11, P2.12, P2.13, P2.14 and P2.15 according to the invention are prepared by adding RM 2 of Example 2 to each of LC mixtures N1-N15, respectively, at a concentration of 0.3% by weight.
  • Polymerisable mixtures P3.1, P3.2, P3.3, P3.4, P3.5, P3.6, P3.7, P3.8, P3.9, P3.10, P3.11, P3.12, P3.13, P3.14 and P3.15 according to the invention are prepared by adding RM 3 of Example 3 to each of LC mixtures N1-N15, respectively, at a concentration of 0.3% by weight.
  • Polymerisable mixtures P4.1, P4.2 and P4.3 according to the invention are prepared by adding RM 4 of Example 4 to each of LC mixtures N1-N3, respectively, at a concentration of 0.3% by weight.
  • Polymerisable mixtures P5.1, P5.2 and P5.3 according to the invention are prepared by adding RM 5 of Example 5 to each of LC mixtures N1-N3, respectively, at a concentration of 0.3% by weight.
  • Table 1 Polymerisable Mixtures according to the invention No. P1.1 P1.2 P1.3 P1.4 P1.5 P1.6 P1.7 P1.8 RM 1 1 1 1 1 1 1 1 Host N1 N2 N3 N4 N5 N6 N7 N8 No. P1.9 P1.10 P1.11 P1.12 P1.13 P1.14 P1.15 RM 1 1 1 1 1 1 1 Host N9 N10 N11 N12 N13 N14 N15 No. P2.1 P2.2 P2.3 P2.4 P2.5 P2.6 P2.7 P2.8 RM 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 Host N1 N2 N3 N4 N5 N6 N7 N8 No.
  • polymerisable mixtures C1.1, C1.2 and C1.3 are prepared by adding RM C1 of prior art to each of LC mixtures N1, N2 and N3, respectively, at a concentration of 0.3% by weight
  • polymerisable mixtures C2.1, C2.2 and C2.3 are prepared by adding RM C2 of prior art to each of LC mixtures N1, N2 and N3, respectively, at a concentration of 0.3% by weight.
  • Table 2 Polymerisable Comparison Mixtures No. C1.1 C1.2 C1.3 C2.1 C2.2 C2.3 RM C1 C1 C1 C2 C2 C2 Host N1 N2 N3 N1 N2 N3
  • the polymerisable mixtures according to the invention and the polymerisable comparison mixtures are each inserted into a VA e/o test cell, respectively.
  • the test cells comprise a VA-polyimide alignment layer (JALS-2096-R1) which is rubbed antiparallel (for the test cells with host mixture N3 the polyimide AL64101was used).
  • the LC-layer thickness d is approx. 4 ⁇ m.
  • Each test cell is irradiated with UV light having an intensity of 100 mW/cm 2 for the time indicated with application of a voltage of 24 V rms (alternating current), which causes polymerisation of the RM.
  • VHR values of the polymerisable mixtures before and after UV exposure are measured as described above.
  • "Suntest” means a second irradiation step with lower UV intensity but longer exposure time than the first step.
  • the residual content of unpolymerised RM (in % by weight) in the test cells is measured by HPLC after various exposure times. For this purpose each mixture is polymerised in the test cell under the conditions stated above. The mixture is then rinsed out of the test cell using MEK (methyl ethyl ketone) and measured.
  • MEK methyl ethyl ketone
  • the tilt angle is measured before and after UV irradiation by a crystal rotation experiment (Autronic-Melchers TBA-105).
  • RMs 1-5 In the host mixture N1 without an alkenyl compound all RMs show high VHR values after suntest. In the host mixture N2 containing an alkenyl compound (CC-3-V) the RMs 1-5 according to the present invention show higher VHR values after suntest compared to the RM C1. Even the VHR values for RM1 and RM2 are kept on a high level, RMs 3-5 have the highest VHR after the UV load and similar or higher values than RM C2 of prior art. In the host mixture N3 containing an alkenyl compound (CC-3-V), the trireactive RMs 3-5 and RM C2 show higher VHR values after suntest than direactive RM C1.
  • the tilt angle measurements confirm the results of the residual RM content measurements.
  • the RMs 1-5 according to the present invention show faster generation of a higher tilt angle compared to the RMs C1 and C2 of prior art.
  • the tilt generation has been performed in a 2-step process (2 min UV light, 100 mW/cm 2 + 2 h suntest). Then the testcells are subjected to a voltage of 10 V RMS (1 kHz) for a time of 7 days at 40°C. After a relaxation time of 10-20 min the tilt angle after stress was measured.
  • Tilt stability Mixture C1.1 (N1 +RM C1) P1.3 (N3 + RM 1) P2.3 (N3 + RM 2) P3.3 (N3 + RM 3) Pretilt Angle / ° Before stress 83.6 84.4 84.2 84.7 After stress 83.2 84.2 84.0 84.5 Change after stress 0.4 0.2 0.2 0.2 Mixture C1.3 (N3 + RM C1) P4.3 (N3 + RM 4) Pretilt Angle / ° Before stress 84.7 83.8 After stress 84.3 83.4 Change after stress 0.4 0.4 0.4
  • the change of the pretilt after stress is smaller with the RMs 1-4 according to the invention, compared to the RM C1. Also RMs 1-4 according to the invention show a better tilt stability than RM C1.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Physics & Mathematics (AREA)
  • Nonlinear Science (AREA)
  • General Physics & Mathematics (AREA)
  • Mathematical Physics (AREA)
  • Optics & Photonics (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Liquid Crystal Substances (AREA)
  • Liquid Crystal (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Pyridine Compounds (AREA)

Abstract

The present invention relates to polymerisable compounds, to processes and intermediates for the preparation thereof, to liquid-crystal (LC) media comprising them, and to the use of the polymerisable compounds and LC media for optical, electro-optical and electronic purposes, in particular in LC displays, especially in LC displays of the PSA ("polymer sustained alignment") type.

Description

  • The present invention relates to polymerisable compounds, to processes and intermediates for the preparation thereof, to liquid-crystal (LC) media comprising them, and to the use of the polymerisable compounds and LC media for optical, electro-optical and electronic purposes, in particular in LC displays, especially in LC displays of the polymer sustained alignment type.
  • Background of the Invention
  • The liquid-crystal displays (LC displays) used at present are usually those of the TN ("twisted nematic") type. However, these have the disadvantage of a strong viewing-angle dependence of the contrast.
  • In addition, so-called VA ("vertically aligned") displays are known which have a broader viewing angle. The LC cell of a VA display contains a layer of an LC medium between two transparent electrodes, where the LC medium usually has a negative dielectric anisotropy. In the switched-off state, the molecules of the LC layer are aligned perpendicular to the electrode surfaces (homeotropically) or have a tilted homeotropic alignment. On application of an electrical voltage to the two electrodes, a realignment of the LC molecules parallel to the electrode surfaces takes place.
  • Furthermore, OCB ("optically compensated bend") displays are known which are based on a birefringence effect and have an LC layer with a so-called "bend" alignment and usually positive dielectric anisotropy. On application of an electrical voltage, a realignment of the LC molecules perpendicular to the electrode surfaces takes place. In addition, OCB displays normally contain one or more birefringent optical retardation films in order to prevent undesired transparency to light of the bend cell in the dark state. OCB displays have a broader viewing angle and shorter response times compared with TN displays.
  • Also known are so-called IPS ("in-plane switching") displays, which contain an LC layer between two substrates, where the two electrodes are arranged on only one of the two substrates and preferably have intermeshed, comb-shaped structures. On application of a voltage to the electrodes, an electric field which has a significant component parallel to the LC layer is thereby generated between them. This causes realignment of the LC molecules in the layer plane.
  • Furthermore, so-called FFS ("fringe-field switching") displays have been reported (see, inter alia, S.H. Jung et al., Jpn. J. Appl. Phys., Volume 43, No. 3, 2004, 1028), which contain two electrodes on the same substrate, one of which structured in a comb-shaped manner and the other is unstructured. A strong, so-called "fringe field" is thereby generated, i.e. a strong electric field close to the edge of the electrodes, and, throughout the cell, an electric field which has both a strong vertical component and also a strong horizontal component. FFS displays have a low viewing-angle dependence of the contrast. FFS displays usually contain an LC medium with positive dielectric anisotropy, and an alignment layer, usually of polyimide, which provides planar alignment to the molecules of the LC medium.
  • FFS displays can be operated as active-matrix or passive-matrix displays. In the case of active-matrix displays, individual pixels are usually addressed by integrated, non-linear active elements, such as, for example, transistors (for example thin-film transistors ("TFTs")), while in the case of passive-matrix displays, individual pixels are usually addressed by the multiplex method, as known from the prior art.
  • Furthermore, FFS displays have been disclosed (see S.H. Lee et al., Appl. Phys. Lett. 73(20), 1998, 2882-2883 and S.H. Lee et al., Liquid Crystals 39(9), 2012, 1141-1148), which have similar electrode design and layer thickness as FFS displays, but comprise a layer of an LC medium with negative dielectric anisotropy instead of an LC medium with positive dielectric anisotropy. The LC medium with negative dielectric ansiotropy shows a more favourable director orientation that has less tilt and more twist orientation compared to the LC medium with positive dielectric anisotropy, as a result of which these displays have a higher transmission. The displays further comprise an alignment layer, preferably of polyimide provided on at least one of the substrates that is in contact with the LC medium and induces planar alignment of the LC molecules of the LC medium. These displays are also known as "Ultra Brightness FFS (UB-FFS)" mode displays. These displays require an LC medium with high reliability.
  • The term "reliability" as used hereinafter means the quality of the performance of the display during time and with different stress loads, such as light load, temperature, humidity, voltage, and comprises display effects such as image sticking (area and line image sticking), mura, yogore etc. which are known to the skilled person in the field of LC displays. As a standard parameter for categorising the reliability usually the voltage holding ration (VHR) value is used, which is a measure for maintaining a constant electrical voltage in a test display. The higher the VHR value, the better the reliability of the LC medium.
  • In VA displays of the more recent type, uniform alignment of the LC molecules is restricted to a plurality of relatively small domains within the LC cell. Disclinations may exist between these domains, also known as tilt domains. VA displays having tilt domains have, compared with conventional VA displays, a greater viewing-angle independence of the contrast and the grey shades. In addition, displays of this type are simpler to produce since additional treatment of the electrode surface for uniform alignment of the molecules in the switched-on state, such as, for example, by rubbing, is no longer necessary. Instead, the preferential direction of the tilt or pretilt angle is controlled by a special design of the electrodes.
  • In so-called MVA ("multidomain vertical alignment") displays, this is usually achieved by the electrodes having protrusions which cause a local pretilt. As a consequence, the LC molecules are aligned parallel to the electrode surfaces in different directions in different, defined regions of the cell on application of a voltage. "Controlled" switching is thereby achieved, and the formation of interfering disclination lines is prevented. Although this arrangement improves the viewing angle of the display, it results, however, in a reduction in its transparency to light. A further development of MVA uses protrusions on only one electrode side, while the opposite electrode has slits, which improves the transparency to light. The slitted electrodes generate an inhomogeneous electric field in the LC cell on application of a voltage, meaning that controlled switching is still achieved. For further improvement of the transparency to light, the separations between the slits and protrusions can be increased, but this in turn results in a lengthening of the response times. In so-called PVA ("patterned VA") displays, protrusions are rendered completely superfluous in that both electrodes are structured by means of slits on the opposite sides, which results in increased contrast and improved transparency to light, but is technologically difficult and makes the display more sensitive to mechanical influences ("tapping", etc.). For many applications, such as, for example, monitors and especially TV screens, however, a shortening of the response times and an improvement in the contrast and luminance (transmission) of the display are demanded.
  • A further development are displays of the so-called PS ("polymer sustained") or PSA ("polymer sustained alignment") type, for which the term "polymer stabilised" is also occasionally used. In these, a small amount (for example 0.3% by weight, typically < 1% by weight) of one or more polymerisable, compound(s), preferably polymerisable monomeric compound(s), is added to the LC medium and, after filling the LC medium into the display, is polymerised or crosslinked in situ, usually by UV photopolymerisation, optionally while a voltage is applied to the electrodes of the display. The polymerisation is carried out at a temperature where the LC medium exhibits a liquid crystal phase, usually at room temperature. The addition of polymerisable mesogenic or liquid-crystalline compounds, also known as reactive mesogens or "RMs", to the LC mixture has proven particularly suitable.
  • Unless indicated otherwise, the term "PSA" is used hereinafter when referring to displays of the polymer sustained alignment type in general, and the term "PS" is used when referring to specific display modes, like PS-VA, PS-TN and the like.
  • Also, unless indicated otherwise, the term "RM" is used hereinafter when referring to a polymerisable mesogenic or liquid-crystalline compound.
  • In the meantime, the PS(A) principle is being used in various conventional LC display modes. Thus, for example, PS-VA, PS-OCB, PS-IPS, PS-FFS, PS-UB-FFS and PS-TN displays are known. The polymerisation of the RMs preferably takes place with an applied voltage in the case of PS-VA and PS-OCB displays, and with or without, preferably without, an applied voltage in the case of PS-IPS displays. As can be demonstrated in test cells, the PS(A) method results in a pretilt in the cell. In the case of PS-OCB displays, for example, it is possible for the bend structure to be stabilised so that an offset voltage is unnecessary or can be reduced. In the case of PS-VA displays, the pretilt has a positive effect on response times. For PS-VA displays, a standard MVA or PVA pixel and electrode layout can be used. In addition, however, it is also possible, for example, to manage with only one structured electrode side and no protrusions, which significantly simplifies production and at the same time results in very good contrast at the same time as very good transparency to light.
  • Furthermore, the so-called posi-VA displays ("positive VA") have proven to be a particularly suitable mode. Like in classical VA displays, the initial orientation of the LC molecules in posi-VA displays is homeotropic, i.e. substantially perpendicular to the substrates, in the initial state when no voltage is applied. However, in contrast to classical VA displays, in posi-VA displays LC media with positive dielectric anisotropy are used. Like in the usually used IPS displays, the two electrodes in posi-VA displays are arranged on only one of the two substrates, and preferably exhibit intermeshed and comb-shaped (interdigital) structures. By application of a voltage to the interdigital electrodes, which create an electrical field that is substantially parallel to the layer of the LC medium, the LC molecules are transferred into an orientation that is substantially parallel to the substrates. In posi-VA displays polymer stabilisation, by addition of RMs to the LC medium which are polymerised in the display, has also proven to be advantageous, as a significant reduction of the switching times could thereb< be realised.
  • PS-VA displays are described, for example, in EP 1 170 626 A2 , US 6,861,107 , US 7,169,449 , US 2004/0191428 A1 , US 2006/0066793 A1 and US 2006/0103804 A1 . PS-OCB displays are described, for example, in T.-J-Chen et al., Jpn. J. Appl. Phys. 45, 2006, 2702-2704 and S. H. Kim, L.-C-Chien, Jpn. J. Appl. Phys. 43, 2004, 7643-7647. PS-IPS displays are described, for example, in US 6,177,972 and Appl. Phys. Lett. 1999, 75(21), 3264. PS-TN displays are described, for example, in Optics Express 2004, 12(7), 1221.
  • Like the conventional LC displays described above, PSA displays can be operated as active-matrix or passive-matrix displays. In the case of active-matrix displays, individual pixels are usually addressed by integrated, non-linear active elements, such as, for example, transistors (for example thin-film transistors ("TFTs")), while in the case of passive-matrix displays, individual pixels are usually addressed by the multiplex method, as known from the prior art.
  • The PSA display may also comprise an alignment layer on one or both of the substrates forming the display cell. The alignment layer is usually applied on the electrodes (where such electrodes are present) such that it is in contact with the LC medium and induces initial alignment of the LC molecules. The alignment layer may comprise or consist of, for example, a polyimide, which may also be rubbed, or may be prepared by a photoalignment method.
  • In particular for monitor and especially TV applications, optimisation of the response times, but also of the contrast and luminance (thus also transmission) of the LC display continues to be demanded. The PSA method can provide significant advantages here. In particular in the case of PS-VA, PS-IPS, PS-FFS and PS-posi-VA displays, a shortening of the response times, which correlate with a measurable pretilt in test cells, can be achieved without significant adverse effects on other parameters.
  • Prior art has suggested biphenyl diacrylates or dimethacrylates, which are optionally fluorinated as RMs for use in PSA displays
  • However, the problem arises that not all combinations consisting of an LC mixture and one or more RMs are suitable for use in PSA displays because, for example, an inadequate tilt or none at all becomes established or since, for example, the so-called "voltage holding ratio" (VHR or HR) is inadequate for TFT display applications. In addition, it has been found that, on use in PSA displays, the LC mixtures and RMs known from the prior art do still have some disadvantages. Thus, not every known RM which is soluble in LC mixtures is suitable for use in PSA displays. In addition, it is often difficult to find a suitable selection criterion for the RM besides direct measurement of the pretilt in the PSA display. The choice of suitable RMs becomes even smaller if polymerisation by means of UV light without the addition of photoinitiators is desired, which may be advantageous for certain applications.
  • In addition, the selected combination of LC host mixture/RM should have the lowest possible rotational viscosity and the best possible electrical properties. In particular, it should have the highest possible VHR. In PSA displays, a high VHR after irradiation with UV light is particularly necessary since UV exposure is a requisite part of the display production process, but also occurs as normal exposure during operation of the finished display.
  • In particular, it would be desirable to have available novel materials for PSA displays which produce a particularly small pretilt angle. Preferred materials here are those which produce a lower pretilt angle during polymerisation for the same exposure time than the materials known to date, and/or through the use of which the (higher) pretilt angle that can be achieved with known materials can already be achieved after a shorter exposure time. The production time ("tact time") of the display could thus be shortened and the costs of the production process reduced.
  • A further problem in the production of PSA displays is the presence or removal of residual amounts of unpolymerised RMs, in particular after the polymerisation step for production of the pretilt angle in the display. For example, unreacted RMs of this type may adversely affect the properties of the display by, for example, polymerising in an uncontrolled manner during operation after finishing of the display.
  • Thus, the PSA displays known from the prior art often exhibit the undesired effect of so-called "image sticking" or "image burn", i.e. the image produced in the LC display by temporary addressing of individual pixels still remains visible even after the electric field in these pixels has been switched off or after other pixels have been addressed.
  • This "image sticking" can occur on the one hand if LC host mixtures having a low VHR are used. The UV component of daylight or the backlighting can cause undesired decomposition reactions of the LC molecules therein and thus initiate the production of ionic or free-radical impurities. These may accumulate, in particular, at the electrodes or the alignment layers, where they may reduce the effective applied voltage. This effect can also be observed in conventional LC displays without a polymer component.
  • In addition, an additional "image sticking" effect caused by the presence of unpolymerised RMs is often observed in PSA displays. Uncontrolled polymerisation of the residual RMs is initiated here by UV light from the environment or by the backlighting. In the switched display areas, this changes the tilt angle after a number of addressing cycles. As a result, a change in transmission in the switched areas may occur, while it remains unchanged in the unswitched areas.
  • It is therefore desirable for the polymerisation of the RMs to proceed as completely as possible during production of the PSA display and for the presence of unpolymerised RMs in the display to be excluded as far as possible or reduced to a minimum. Thus, RMs and LC mixtures are required which enable or support highly effective and complete polymerisation of the RMs. In addition, controlled reaction of the residual RM amounts would be desirable. This would be simpler if the RM polymerised more rapidly and effectively than the compounds known to date.
  • A further problem that has been observed in the operation of PSA displays is the stability of the pretilt angle. Thus, it was observed that the pretilt angle, which was generated during display manufacture by polymerising the RM as described above, does not remain constant but can deteriorate after the display was subjected to voltage stress during its operation. This can negatively affect the display performance, e.g. by increasing the black state transmission and hence lowering the contrast.
  • Another problem to be solved is that the RMs of prior art do often have high melting points, and do only show limited solubility in many currently common LC mixtures, and therefore frequently tend to spontaneously crystallise out of the mixture. In addition, the risk of spontaneous polymerisation prevents the LC host mixture being warmed in order to dissolve the polymerisable component, meaning that the best possible solubility even at room temperature is necessary. In addition, there is a risk of separation, for example on introduction of the LC medium into the LC display (chromatography effect), which may greatly impair the homogeneity of the display. This is further increased by the fact that the LC media are usually introduced at low temperatures in order to reduce the risk of spontaneous polymerisation (see above), which in turn has an adverse effect on the solubility.
  • Another problem observed in prior art is that LC media for use in PSA displays, including but not limited to displays of the PSA type, do often exhibit high viscosities and, as a consequence, high switching times. In order to reduce the viscosity and switching time of the LC medium, it has been suggested in prior art to add LC compounds with an alkenyl group. However, it was observed that LC media containing alkenyl compounds often show a decrease of the reliability and stability, and a decrease of the VHR especially after exposure to UV radiation. Especially for use in PSA displays this is a considerable disadvantage, because the photo-polymerisation of the RMs in the PSA display is usually carried out by exposure to UV radiation, which may cause a VHR drop in the LC medium.
  • There is thus still a great demand for PSA displays and LC media and polymerisable compounds for use in such displays, which do not show the drawbacks as described above, or only do so to a small extent, and have improved properties. In particular, there is a great demand for PSA displays, and LC media and polymerisable compounds for use in such PSA displays, which enable a high specific resistance at the same time as a large working-temperature range, short response times, even at low temperatures, and a low threshold voltage, a low pretilt angle, a multiplicity of grey shades, high contrast and a broad viewing angle, have high reliability and high values for the "voltage holding ratio" (VHR) after UV exposure, and, in case of the polymerisable compounds, have low melting points and a high solubility in the LC host mixtures.
  • The invention is based on the object of providing novel suitable materials, in particular RMs and LC media comprising same, for use in PSA displays, which do not have the disadvantages indicated above or do so to a reduced extent, polymerise as rapidly and completely as possible, enable a low pretilt angle to be established as quickly as possible, reduce or prevent the occurrence of "image sticking" in the display, and preferably at the same time enable very high specific resistance values, high VHR values, low threshold voltages and short response times, and have a high solubility in the LC media which are typically used as host mixtures in PSA displays.
  • A further object of the invention is the provision of novel RMs, in particular for optical, electro-optical and electronic applications, and of suitable processes and intermediates for the preparation thereof.
  • In particular, the invention is based on the object of providing polymerisable compounds like RMs which produce a lower pretilt after photopolymerisation, which results in the desired pretilt being achieved more quickly and thus in significantly shortened times for production of the LC display, and which are easily processable in an LC mixture.
  • This object has been achieved in accordance with the present invention by compounds, mixtures and processes as described in the present application. In particular, it has been found, surprisingly, that the use of multireactive polymerisable compounds of formula I as described hereinafter, which contain at least three polymerisable groups, and contain at least one branched polymerisable group, in PSA displays facilitates particularly low pretilt angles and fast establishment of the desired tilt angles.
  • This has been demonstrated in connection with an LC medium by means of pretilt measurements. In particular, a pretilt has been achieved without the addition of photoinitiator. In addition, the polymerisable compounds according to the present invention exhibit significantly faster generation of the pretilt angle compared with the compounds known from prior art, as demonstrated by exposure time-dependent measurements of the pretilt angle.
  • It has also been demonstrated that the polymerisable compounds according to the present invention are especially suitable for use in LC host mixtures containing mesogenic or LC compounds with an alkenyl group. The use of the polymerisable compounds according to the present invention in such LC host mixtures enables LC media with high VHR values and high reliability.
  • In addition, the polymerisable compounds according to the invention exhibit a high polymerisation rate, causing smaller unreacted residual amounts to remain in the cell. The electro-optical properties of the cell are thus improved, and in addition controlled reaction of these residual amounts becomes simpler. The polymerisable compounds are therefore suitable for creating a high pretilt in PSA type displays.
  • Also, the polymerisable compounds according to the invention show a low tendency towards crystallisation and high solubility in typical commercially available LC host mixtures.
  • US 7,060,200 B1 and US 2006/0172090 A1 disclose multireactive compounds with branched polymerisable groups for use in polymerisable LC materials and LC polymers, but do not disclose polymerisable compounds as disclosed or claimed hereinafter, or their use in LC media for PSA type LC displays.
  • Summay of the Invention
  • The invention relates to compounds of formula I

            P1-Sp1-(A1-Z1)n-A2-O-Sp4-CH(Sp2-P2)(Sp3-P3)     I

    in which the individual radicals have the following meanings:
  • P1, P2, P3
    independently of each other denote a polymerisable group,
    Sp1-4
    independently of each other denote a spacer group or a single bond,
    A1, A2
    independently of each other, and on each occurrence identically or differently, denote an aromatic, heteroaromatic, alicyclic or heterocyclic group having 4 to 25 C atoms, which may also contain fused rings, and which is optionally mono- or polysubstituted by L,
    Z1
    denotes, on each occurrence identically or differently, -O-, -S-, -CO-, -CO-O-, -O-CO-, -O-CO-O-, -OCH2-, -CH2O-, -SCH2-, -CH2S-, -CF2O-, -OCF2-, -CF2S-, -SCF2-, -(CH2)n-, -CF2CH2-, -CH2CF2-, -(CF2)n-, -CH=CH-, -CF=CF-, -CH=CF-, -CF=CH-, -C≡C-, -CH=CH-CO-O-, -O-CO-CH=CH-, -CH2-CH2-CO-O-, -O-CO-CH2-CH2-, -CR00R000-, or a single bond,
    L
    denotes P1-, P1-Sp1-, F, Cl, Br, I, -CN, -NO2, -NCO, -NCS, - OCN, -SCN, -C(=O)N(Rx)2, -C(=O)Y1, -C(=O)Rx, -N(Rx)2, optionally substituted silyl, optionally substituted aryl or heteroaryl having 5 to 20 ring atoms, or straight-chain or branched alkyl having 1 to 25, particularly preferably 1 to 10, C atoms, in which, in addition, one or more non-adjacent CH2 groups may each be replaced, independently of one another, by -C(R00)=C(R000)-, -C≡C-, -N(R00)-, -O-, -S-, -CO-, -CO-O-, -O-CO-, -O-CO-O- in such a way that O and/or S atoms are not linked directly to one another, and in which, in addition, one or more H atoms may be replaced by F, Cl, CN, P1 or P1-Sp1-,
    R00 and R000
    each, independently of one another, denote H or alkyl having 1 to 12 C atoms,
    Y1
    is halogen,
    Rx
    denotes P1, P1-Sp1-, H, halogen, straight chain, branched or cyclic alkyl having 1 to 25 C atoms, wherein one or more non-adjacent CH2-groups are optionally replaced by -O-, -S-, -CO-, - CO-O-, -O-CO-, -O-CO-O- in such a manner that O- and/or S-atoms are not directly connected with each other, and wherein one or more H atoms are optionally replaced by F, Cl, P1- or P1-Sp1-, optionally substituted aryl, aryloxy, heteroaryl or heteroaryloxy having 5 to 20 ring atoms,
    n
    is 1, 2, 3 or 4.
  • The invention further relates to the use of compounds of formula I as polymerisable compounds in LC media and LC displays, especially in the LC medium, active layer or alignment layer of an LC display, wherein the LC displays are preferably PSA displays.
  • The invention further relates to methods for preparing compounds of formula I, and to novel intermediates used or obtained in these methods.
  • The invention furthermore relates to an LC medium comprising one or more compounds of formula I.
  • The invention furthermore relates to an LC medium comprising one or more polymerisable compounds, at least one of which is a compound of formula I.
  • The invention furthermore relates to an LC medium comprising
    • a polymerisable component A) comprising, preferably consisting of, one or more polymerisable compounds, at least one of which is a compound of formula I, and
    • a liquid-crystalline component B), hereinafter also referred to as "LC host mixture", comprising, preferably consisting of, one or more mesogenic or liquid-crystalline compounds.
  • The liquid-crystalline component B) of an LC medium according to the present invention is hereinafter also referred to as "LC host mixture", and preferably comprises, or consists of, one or more, preferably at least two mesogenic or LC compounds selected from low-molecular-weight compounds which are unpolymerisable.
  • The invention furthermore relates to an LC medium as described above and below, wherein the LC host mixture or component B comprise at least one mesogenic or LC compound comprising an alkenyl group.
  • The invention furthermore relates to an LC medium or LC display as described above, wherein the compounds of formula I are polymerised.
  • The invention furthermore relates to a process for preparing an LC medium as described above and below, comprising the steps of mixing one or more mesogenic or LC compounds, or an LC host mixture or LC component B) as described above and below, with one or more compounds of formula I, and optionally with further LC compounds and/or additives.
  • The invention furthermore relates to the use of compounds of formula I and LC media according to the invention in PSA displays, in particular the use in PSA displays containing an LC medium, for the production of a tilt angle in the LC medium by in-situ polymerisation of the compound(s) of the formula I in the PSA display, preferably in an electric or magnetic field.
  • The invention furthermore relates to an LC display comprising one or more compounds of formula I or an LC medium according to the invention, in particular a PSA display, particularly preferably a PS-VA, PS-OCB, PS-IPS, PS-FFS, PS-UB-FFS, PS-posi-VA or PS-TN display.
  • The invention furthermore relates to an LC display comprising a polymer obtainable by polymerisation of one or more compounds of formula I or of a polymerisable component A) as described above, or comprising an LC medium according to the invention, which is preferably a PSA display, very preferably a PS-VA, PS-OCB, PS-IPS, PS-FFS, PS-UB-FFS, PS-posi-VA or PS-TN display.
  • The invention furthermore relates to an LC display of the PSA type comprising two substrates, at least one which is transparent to light, an electrode provided on each substrate or two electrodes provided on only one of the substrates, and located between the substrates a layer of an LC medium that comprises one or more polymerisable compounds and an LC component as described above and below, wherein the polymerisable compounds are polymerised between the substrates of the display.
  • The invention furthermore relates to a process for manufacturing an LC display as described above and below, comprising the steps of filling or otherwise providing an LC medium, which comprises one or more polymerisable compounds as described above and below, between the substrates of the display, and polymerising the polymerisable compounds.
  • The PSA displays according to the invention have two electrodes, preferably in the form of transparent layers, which are applied to one or both of the substrates. In some displays, for example in PS-VA, PS-OCB or PS-TN displays, one electrode is applied to each of the two substrates. In other displays, for example in PS-posi-VA, PS-IPS or PS-FFS or PS-UB-FFS displays, both electrodes are applied to only one of the two substrates.
  • In a preferred embodiment the polymerisable component is polymerised in the LC display while a voltage is applied to the electrodes of the display.
  • The polymerisable compounds of the polymerisable compoment are preferably polymerised by photo-polymerisation, very preferably by UV photo-polymerisation.
  • Detailed Description of the Invention
  • As used herein, the terms "active layer" and "switchable layer" mean a layer in an electrooptical display, for example an LC display, that comprises one or more molecules having structural and optical anisotropy, like for example LC molecules, which change their orientation upon an external stimulus like an electric or magnetic field, resulting in a change of the transmission of the layer for polarized or unpolarized light.
  • As used herein, the terms "tilt" and "tilt angle" will be understood to mean a tilted alignment of the LC molecules of an LC medium relative to the surfaces of the cell in an LC display (here preferably a PSA display). The tilt angle here denotes the average angle (< 90°) between the longitudinal molecular axes of the LC molecules (LC director) and the surface of the plane-parallel outer plates which form the LC cell. A low value for the tilt angle (i.e. a large deviation from the 90° angle) corresponds to a large tilt here. A suitable method for measurement of the tilt angle is given in the examples. Unless indicated otherwise, tilt angle values disclosed above and below relate to this measurement method.
  • As used herein, the terms "reactive mesogen" and "RM" will be understood to mean a compound containing a mesogenic or liquid crystalline skeleton, and one or more functional groups attached thereto which are suitable for polymerisation and are also referred to as "polymerisable group" or "P".
  • Unless stated otherwise, the term "polymerisable compound" as used herein will be understood to mean a polymerisable monomeric compound.
  • As used herein, the term "low-molecular-weight compound" will be understood to mean to a compound that is monomeric and/or is not prepared by a polymerisation reaction, as opposed to a "polymeric compound" or a "polymer".
  • As used herein, the term "unpolymerisable compound" will be understood to mean a compound that does not contain a functional group that is suitable for polymerisation under the conditions usually applied for the polymerisation of the RMs.
  • The term "mesogenic group" as used herein is known to the person skilled in the art and described in the literature, and means a group which, due to the anisotropy of its attracting and repelling interactions, essentially contributes to causing a liquid-crystal (LC) phase in low-molecular-weight or polymeric substances. Compounds containing mesogenic groups (mesogenic compounds) do not necessarily have to have an LC phase themselves. It is also possible for mesogenic compounds to exhibit LC phase behaviour only after mixing with other compounds and/or after polymerisation. Typical mesogenic groups are, for example, rigid rod- or disc-shaped units. An overview of the terms and definitions used in connection with mesogenic or LC compounds is given in Pure Appl. Chem. 73(5), 888 (2001) and C. Tschierske, G. Pelzl, S. Diele, Angew. Chem. 2004, 116, 6340-6368.
  • The term "spacer group", hereinafter also referred to as "Sp", as used herein is known to the person skilled in the art and is described in the literature, see, for example, Pure Appl. Chem. 73(5), 888 (2001) and C. Tschierske, G. Pelzl, S. Diele, Angew. Chem. 2004, 116, 6340-6368. As used herein, the terms "spacer group" or "spacer" mean a flexible group, for example an alkylene group, which connects the mesogenic group and the polymerisable group(s) in a polymerisable mesogenic compound.
  • Above and below,
    Figure imgb0001
    denotes a trans-1,4-cyclohexylene ring, and
    Figure imgb0002
    denotes a 1,4-phenylene ring.
  • Above and below "organic group" denotes a carbon or hydrocarbon group.
  • "Carbon group" denotes a mono- or polyvalent organic group containing at least one carbon atom, where this either contains no further atoms (such as, for example, -C≡C-) or optionally contains one or more further atoms, such as, for example, N, O, S, B, P, Si, Se, As, Te or Ge (for example carbonyl, etc.). The term "hydrocarbon group" denotes a carbon group which additionally contains one or more H atoms and optionally one or more heteroatoms, such as, for example, N, O, S, B, P, Si, Se, As, Te or Ge.
  • "Halogen" denotes F, Cl, Br or I.
  • -CO-, -C(=O)- and -C(O)- denote a carbonyl group, i.e.
    Figure imgb0003
  • A carbon or hydrocarbon group can be a saturated or unsaturated group. Unsaturated groups are, for example, aryl, alkenyl or alkynyl groups. A carbon or hydrocarbon radical having more than 3 C atoms can be straight-chain, branched and/or cyclic and may also contain spiro links or condensed rings.
  • The terms "alkyl", "aryl", "heteroaryl", etc., also encompass polyvalent groups, for example alkylene, arylene, heteroarylene, etc.
  • The term "aryl" denotes an aromatic carbon group or a group derived therefrom. The term "heteroaryl" denotes "aryl" as defined above, containing one or more heteroatoms, preferably selected from N, O, S, Se, Te, Si and Ge.
  • Preferred carbon and hydrocarbon groups are optionally substituted, straight-chain, branched or cyclic, alkyl, alkenyl, alkynyl, alkoxy, alkylcarbonyl, alkoxycarbonyl, alkylcarbonyloxy and alkoxycarbonyloxy having 1 to 40, preferably 1 to 20, very preferably 1 to 12, C atoms, optionally substituted aryl or aryloxy having 5 to 30, preferably 6 to 25, C atoms, or optionally substituted alkylaryl, arylalkyl, alkylaryloxy, arylalkyloxy, arylcarbonyl, aryloxycarbonyl, arylcarbonyloxy and aryloxycarbonyloxy having 5 to 30, preferably 6 to 25, C atoms, wherein one or more C atoms may also be replaced by hetero atoms, preferably selected from N, O, S, Se, Te, Si and Ge.
  • Further preferred carbon and hydrocarbon groups are C1-C20 alkyl, C2-C20 alkenyl, C2-C20 alkynyl, C3-C20 allyl, C4-C20 alkyldienyl, C4-C20 polyenyl, C6-C20 cycloalkyl, C4-C15 cycloalkenyl, C6-C30 aryl, C6-C30 alkylaryl, C6-C30 arylalkyl, C6-C30 alkylaryloxy, C6-C30 arylalkyloxy, C2-C30 heteroaryl, C2-C30 heteroaryloxy.
  • Particular preference is given to C1-C12 alkyl, C2-C12 alkenyl, C2-C12 alkynyl, C6-C25 aryl and C2-C25 heteroaryl.
  • Further preferred carbon and hydrocarbon groups are straight-chain, branched or cyclic alkyl having 1 to 20, preferably 1 to 12, C atoms, which are unsubstituted or mono- or polysubstituted by F, Cl, Br, I or CN and in which one or more non-adjacent CH2 groups may each be replaced, independently of one another, by -C(Rx)=C(Rx)-, -C≡C-, -N(Rx)-, -O-, -S-, -CO-, -CO-O-, -O-CO-, -O-CO-O- in such a way that O and/or S atoms are not linked directly to one another.
  • Rx preferably denotes H, halogen, a straight-chain, branched or cyclic alkyl chain having 1 to 15 C atoms, in which, in addition, one or more non-adjacent C atoms may be replaced by -O-, -S-, -CO-, -CO-O-, -O-CO-, -O-CO-O- and in which one or more H atoms may be replaced by fluorine, an optionally substituted aryl or aryloxy group having 6 to 30 C atoms, or an optionally substituted heteroaryl or heteroaryloxy group having 2 to 30 C atoms.
  • Preferred alkoxy groups are, for example, methoxy, ethoxy, 2-methoxy-ethoxy, n-propoxy, i-propoxy, n-butoxy, i-butoxy, s-butoxy, t-butoxy, 2-methylbutoxy, n-pentoxy, n-hexoxy, n-heptoxy, n-octoxy, n-nonoxy, n-decoxy, n-undecoxy, n-dodecoxy, etc.
  • Preferred alkyl groups are, for example, methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, s-butyl, t-butyl, 2-methylbutyl, n-pentyl, s-pentyl, cyclopentyl, n-hexyl, cyclohexyl, 2-ethylhexyl, n-heptyl, cycloheptyl, n-octyl, cyclooctyl, n-nonyl, n-decyl, n-undecyl, n-dodecyl, dodecanyl, trifluoromethyl, perfluoro-n-butyl, 2,2,2-trifluoroethyl, perfluorooctyl, perfluorohexyl, etc.
  • Preferred alkenyl groups are, for example, ethenyl, propenyl, butenyl, pentenyl, cyclopentenyl, hexenyl, cyclohexenyl, heptenyl, cycloheptenyl, octenyl, cyclooctenyl, etc.
  • Preferred alkynyl groups are, for example, ethynyl, propynyl, butynyl, pentynyl, hexynyl, octynyl, etc.
  • Preferred alkoxy groups are, for example, methoxy, ethoxy, 2-methoxy-ethoxy, n-propoxy, i-propoxy, n-butoxy, i-butoxy, s-butoxy, t-butoxy, 2-methylbutoxy, n-pentoxy, n-hexoxy, n-heptoxy, n-octoxy, n-nonoxy, n-decoxy, n-undecoxy, n-dodecoxy, etc.
  • Preferred amino groups are, for example, dimethylamino, methylamino, methylphenylamino, phenylamino, etc.
  • Aryl and heteroaryl groups can be monocyclic or polycyclic, i.e. they can contain one ring (such as, for example, phenyl) or two or more rings, which may also be fused (such as, for example, naphthyl) or covalently bonded (such as, for example, biphenyl), or contain a combination of fused and linked rings. Heteroaryl groups contain one or more heteroatoms, preferably selected from O, N, S and Se.
  • Particular preference is given to mono-, bi- or tricyclic aryl groups having 6 to 25 C atoms and mono-, bi- or tricyclic heteroaryl groups having 5 to 25 ring atoms, which optionally contain fused rings and are optionally substituted. Preference is furthermore given to 5-, 6- or 7-membered aryl and heteroaryl groups, in which, in addition, one or more CH groups may be replaced by N, S or O in such a way that O atoms and/or S atoms are not linked directly to one another.
  • Preferred aryl groups are, for example, phenyl, biphenyl, terphenyl, [1,1':3',1"]terphenyl-2'-yl, naphthyl, anthracene, binaphthyl, phenanthrene, 9,10-dihydro-phenanthrene, pyrene, dihydropyrene, chrysene, perylene, tetracene, pentacene, benzopyrene, fluorene, indene, indenofluorene, spirobifluorene, etc.
  • Preferred heteroaryl groups are, for example, 5-membered rings, such as pyrrole, pyrazole, imidazole, 1,2,3-triazole, 1,2,4-triazole, tetrazole, furan, thiophene, selenophene, oxazole, isoxazole, 1,2-thiazole, 1,3-thiazole, 1,2,3-oxadiazole, 1,2,4-oxadiazole, 1,2,5-oxadiazole, 1,3,4-oxadiazole, 1,2,3-thiadiazole, 1,2,4-thiadiazole, 1,2,5-thiadiazole, 1,3,4-thiadiazole, 6-membered rings, such as pyridine, pyridazine, pyrimidine, pyrazine, 1,3,5-triazine, 1,2,4-triazine, 1,2,3-triazine, 1,2,4,5-tetrazine, 1,2,3,4-tetrazine, 1,2,3,5-tetrazine, or condensed groups, such as indole, isoindole, indolizine, indazole, benzimidazole, benzotriazole, purine, naphthimidazole, phenanthrimidazole, pyridimidazole, pyrazinimidazole, quinoxalinimidazole, benzoxazole, naphthoxazole, anthroxazole, phenanthroxazole, isoxazole, benzothiazole, benzofuran, isobenzofuran, dibenzofuran, quinoline, isoquinoline, pteridine, benzo-5,6-quinoline, benzo-6,7-quinoline, benzo-7,8-quinoline, benzoisoquin-oline, acridine, phenothiazine, phenoxazine, benzopyridazine, benzopyrimidine, quinoxaline, phenazine, naphthyridine, azacarbazole, benzocarboline, phenanthridine, phenanthroline, thieno[2,3b]thiophene, thieno[3,2b]thiophene, dithienothiophene, isobenzothiophene, dibenzothiophene, benzothiadiazo-thiophene, or combinations of these groups.
  • The aryl and heteroaryl groups mentioned above and below may also be substituted by alkyl, alkoxy, thioalkyl, fluorine, fluoroalkyl or further aryl or heteroaryl groups.
  • The (non-aromatic) alicyclic and heterocyclic groups encompass both saturated rings, i.e. those containing exclusively single bonds, and also partially unsaturated rings, i.e. those which may also contain multiple bonds. Heterocyclic rings contain one or more heteroatoms, preferably selected from Si, O, N, S and Se.
  • The (non-aromatic) alicyclic and heterocyclic groups can be monocyclic, i.e. contain only one ring (such as, for example, cyclohexane), or polycyclic, i.e. contain a plurality of rings (such as, for example, decahydronaphthalene or bicyclooctane). Particular preference is given to saturated groups. Preference is furthermore given to mono-, bi- or tricyclic groups having 5 to 25 ring atoms, which optionally contain fused rings and are optionally substituted. Preference is furthermore given to 5-, 6-, 7- or 8-membered carbocyclic groups, in which, in addition, one or more C atoms may be replaced by Si and/or one or more CH groups may be replaced by N and/or one or more non-adjacent CH2 groups may be replaced by -O- and/or -S-.
  • Preferred alicyclic and heterocyclic groups are, for example, 5-membered groups, such as cyclopentane, tetrahydrofuran, tetrahydrothiofuran, pyrrolidine, 6-membered groups, such as cyclohexane, silinane, cyclohexene, tetrahydropyran, tetrahydrothiopyran, 1,3-dioxane, 1,3-dithiane, piperidine, 7-membered groups, such as cycloheptane, and fused groups, such as tetrahydronaphthalene, decahydronaphthalene, indane, bicyclo[1.1.1]-pentane-1,3-diyl, bicyclo[2.2.2]octane-1,4-diyl, spiro[3.3]heptane-2,6-diyl, octahydro-4,7-methanoindane-2,5-diyl.
  • Preferred substituents are, for example, solubility-promoting groups, such as alkyl or alkoxy, electron-withdrawing groups, such as fluorine, nitro or nitrile, or substituents for increasing the glass transition temperature (Tg) in the polymer, in particular bulky groups, such as, for example, t-butyl or optionally substituted aryl groups.
  • Preferred substituents, hereinafter also referred to as "L", are, for example, F, Cl, Br, I, -CN, -NO2, -NCO, -NCS, -OCN, -SCN, -C(=O)N(Rx)2, -C(=O)Y1, -C(=O)Rx, -N(Rx)2, straight-chain or branched alkyl, alkoxy, alkylcarbonyl, alkoxycarbonyl, alkylcarbonyloxy or alkoxycarbonyloxy each having 1 to 25 C atoms, in which one or more H atoms may optionally be replaced by F or Cl, optionally substituted silyl having 1 to 20 Si atoms, or optionally substituted aryl having 6 to 25, preferably 6 to 15, C atoms,
  • wherein Rx denotes H, F, Cl, CN, or straight chain, branched or cyclic alkyl having 1 to 25 C atoms, wherein one or more non-adjacent CH2-groups are optionally replaced by -O-, -S-, -CO-, -CO-O-, -O-CO-, -O-CO-O- in such a manner that O- and/or S-atoms are not directly connected with each other, and wherein one or more H atoms are each optionally replaced by F, Cl, P-or P-Sp-, and
  • Y1 denotes halogen.
  • "Substituted silyl or aryl" preferably means substituted by halogen, -CN, R0, -OR0, -CO-R0, -CO-O-R0, -O-CO-R0 or -O-CO-O-R0, wherein R0 denotes H or alkyl with 1 to 20 C atoms.
  • Particularly preferred substituents L are, for example, F, Cl, CN, NO2, CH3, C2H5, OCH3, OC2H5, COCH3, COC2H5, COOCH3, COOC2H5, CF3, OCF3, OCHF2, OC2F5, furthermore phenyl.
    Figure imgb0004
    is preferably
    Figure imgb0005
    in which L has one of the meanings indicated above.
  • The polymerisable group P1-3 is a group which is suitable for a polymerisation reaction, such as, for example, free-radical or ionic chain polymerisation, polyaddition or polycondensation, or for a polymer-analogous reaction, for example addition or condensation onto a main polymer chain. Particular preference is given to groups for chain polymerisation, in particular those containing a C=C double bond or -C=C- triple bond, and groups which are suitable for polymerisation with ring opening, such as, for example, oxetane or epoxide groups.
  • Preferred groups P1-3 are selected from the group consisting of CH2=CW1-CO-O-, CH2=CW1-CO-,
    Figure imgb0006
    Figure imgb0007
    CH2=CW2-(O)k3-, CW1=CH-CO-(O)k3-, CW1=CH-CO-NH-, CH2=CW1-CO-NH-, CH3-CH=CH-O-, (CH2=CH)2CH-OCO-, (CH2=CH-CH2)2CH-OCO-, (CH2=CH)2CH-O-, (CH2=CH-CH2)2N-, (CH2=CH-CH2)2N-CO-, HO-CW2W3-, HS-CW2W3-, HW2N-, HO-CW2W3-NH-, CH2=CW1-CO-NH-, CH2=CH-(COO)k1-Phe-(O)k2-, CH2=CH-(CO)k1-Phe-(O)k2-, Phe-CH=CH-, HOOC-, OCN- and W4W5W6Si-, in which W1 denotes H, F, Cl, CN, CF3, phenyl or alkyl having 1 to 5 C atoms, in particular H, F, Cl or CH3, W2 and W3 each, independently of one another, denote H or alkyl having 1 to 5 C atoms, in particular H, methyl, ethyl or n-propyl, W4, W5 and W6 each, independently of one another, denote Cl, oxaalkyl or oxacarbonylalkyl having 1 to 5 C atoms, W7 and W8 each, independently of one another, denote H, Cl or alkyl having 1 to 5 C atoms, Phe denotes 1,4-phenylene, which is optionally substituted by one or more radicals L as defined above which are other than P-Sp-, k1, k2 and k3 each, independently of one another, denote 0 or 1, k3 preferably denotes 1, and k4 denotes an integer from 1 to 10.
  • Particularly preferred groups P1-3 are selected from the group consisting of CH2=CW1-CO-O-, CH2=CW1-CO-,
    Figure imgb0008
    Figure imgb0009
    CH2=CW2-O-, CH2=CW2-, CW1=CH-CO-(O)k3-, CW1=CH-CO-NH-, CH2=CW1-CO-NH-, (CH2=CH)2CH-OCO-, (CH2=CH-CH2)2CH-OCO-, (CH2=CH)2CH-O-, (CH2=CH-CH2)2N-, (CH2=CH-CH2)2N-CO-, CH2=CW1-CO-NH-, CH2=CH-(COO)k1-Phe-(O)k2-, CH2=CH-(CO)k1-Phe-(O)k2-, Phe-CH=CH- and W4W5W6Si-, in which W1 denotes H, F, Cl, CN, CF3, phenyl or alkyl having 1 to 5 C atoms, in particular H, F, Cl or CH3, W2 and W3 each, independently of one another, denote H or alkyl having 1 to 5 C atoms, in particular H, methyl, ethyl or n-propyl, W4, W5 and W6 each, independently of one another, denote Cl, oxaalkyl or oxacarbonylalkyl having 1 to 5 C atoms, W7 and W8 each, independently of one another, denote H, Cl or alkyl having 1 to 5 C atoms, Phe denotes 1,4-phenylene, k1, k2 and k3 each, independently of one another, denote 0 or 1, k3 preferably denotes 1, and k4 denotes an integer from 1 to 10.
  • Very particularly preferred groups P1-3 are selected from the group consisting of CH2=CW1-CO-O-, in particular CH2=CH-CO-O-, CH2=C(CH3)-CO-O- and CH2=CF-CO-O-, furthermore CH2=CH-O-, (CH2=CH)2CH-O-CO-, (CH2=CH)2CH-O-,
    Figure imgb0010
  • Further preferred polymerisable groups P1-3 are selected from the group consisting of vinyl, vinyloxy, acrylate, methacrylate, fluoroacrylate, chloroacrylate, oxetane and epoxide groups, very preferably from acrylate and methacrylate groups.
  • If the spacer groups Sp1-3 are different from a single bond, they are preferably of the formula Sp"-X", so that the respective radical Pi-Spi-, like for example P1-Sp1-, conforms to the formula P-Sp"-X"-, where Sp" and X" have the meanings given below.
  • If the spacer group Sp4 is different from a single bond, it is preferably of the formula X"-Sp", so that the respective radical -A2-Sp4- conforms to the formula -A2-X"-Sp"-, where Sp" and X" have the meanings given below.
  • Sp"
    denotes alkylene having 1 to 20, preferably 1 to 12, C atoms, which is optionally mono- or polysubstituted by F, Cl, Br, I or CN and in which, in addition, one or more non-adjacent CH2 groups may each be replaced, independently of one another, by -O-, -S-, -NH-, -N(R0)-, -Si(R00R000)-, - CO-, -CO-O-, -O-CO-, -O-CO-O-, -S-CO-, -CO-S-, -N(R00)-CO-O-, -O-CO-N(R00)-, -N(R00)-CO-N(R00)-, -CH=CH- or -C≡C- in such a way that O and/or S atoms are not linked directly to one another,
    X"
    denotes -O-, -S-, -CO-, -CO-O-, -O-CO-, -O-CO-O-, -CO-N(R00)-, -N(R00)-CO-, -N(R00)-CO-N(R00)-, -OCH2-, -CH2O-, -SCH2-, -CH2S-, -CF2O-, -OCF2-, -CF2S-, -SCF2-, -CF2CH2-, -CH2CF2-, -CF2CF2-, -CH=N-, -N=CH-, -N=N-, -CH=CR0-, -CY2=CY3-, -C≡C-, -CH=CH-CO-O-, -O-CO-CH=CH- or a single bond,
    R00 and R000
    each, independently of one another, denote H or alkyl having 1 to 12 C atoms, and
    Y2 and Y3
    each, independently of one another, denote H, F, Cl or CN.
  • X" is preferably -O-, -S-, -CO-, -COO-, -OCO-, -O-COO-, -CO-NR0-, -NR0-CO-, -NR0-CO-NR0- or a single bond.
  • Typical spacer groups -Sp"-X"- are, for example, -(CH2)p1-, -(CH2CH2O)q1-CH2CH2-, -CH2CH2-S-CH2CH2-, -CH2CH2-NH-CH2CH2- or -(SiR00R000-O)p1-, in which p1 is an integer from 1 to 12, q1 is an integer from 1 to 3, and R00 and R000 have the meanings indicated above.
  • Particularly preferred groups -Sp"-X"- are -(CH2)p1-, -(CH2)p1-O-, -(CH2)p1-O-CO-, -(CH2)p1-O-CO-O-, in which p1 and q1 have the meanings indicated above.
  • Particularly preferred groups -X"-Sp"- are -(CH2)p1, -O-(CH2)p1-, -CO-O-(CH2)p1-, -O-CO-O-(CH2)p1-, in which p1 and q1 have the meanings indicated above.
  • Particularly preferred groups Sp" are, for example, in each case straight-chain ethylene, propylene, butylene, pentylene, hexylene, heptylene, octylene, nonylene, decylene, undecylene, dodecylene, octadecylene, ethyleneoxyethylene, methyleneoxybutylene, ethylenethioethylene, ethylene-N-methyliminoethylene, 1-methylalkylene, ethenylene, propenylene and butenylene.
  • Preferred compounds of formula I are those in which A1, A2 each, independently of one another, denote 1,4-phenylene, naphthalene-1,4-diyl or naphthalene-2,6-diyl, where one or more CH groups in these groups are optionally replaced by N, cyclohexane-1,4-diyl, in which, in addition, one or more non-adjacent CH2 groups are optionally replaced by O and/or S, 1,4-cyclohexenylene, bicyclo[1.1.1]pentane-1,3-diyl, bicyclo[2.2.2]octane-1,4-diyl, spiro[3.3]heptane-2,6-diyl, piperidine-1,4-diyl, decahydronaphthalene-2,6-diyl, 1,2,3,4-tetrahydronaphthalene-2,6-diyl, indane-2,5-diyl, octahydro-4,7-methanoindane-2,5-diyl, anthracene-2,7-diyl, fluorene-2,7-diyl, phenanthrene-2,7-diyl or 9,10-dihydro-phenanthrene-2,7-diyl,where all these groups are unsubstituted or mono- or polysubstituted by L.
  • Further preferred compounds of formula I are those in which
    • P1, P2 and P3 are selected from the group consisting of acrylate, methacrylate and oxetane,
    • Sp1 is a single bond,
    • Sp1 is -(CH2)p2- or -(CH2)p1-O-, in which p1 is an integer from 1 to 6, preferably 1, 2 or 3,
    • Sp2 and Sp3 denote -(CH2)p2-, in which p2 is an integer from 1 to 6, preferably 1, 2 or 3, very preferably methylene,
    • Sp4 is -(CH2)p4-, in which p4 is an integer from 1 to 6, preferably 1, 2 or 3, very preferably methylene,
    • Sp1 is a single bond, and Sp2, Sp3 and Sp4 are methylene,
    • Sp1 and Sp4 are a single bond, and Sp2 and Sp3 are methylene,
    • Sp1, Sp2 and Sp3 are a single bond, and Sp4 is ethylene,
    • L does not denote or contain a polymerisable group,
    • A1 and A2 are selected from the group consisting of 1,4-phenylene, naphthalene-2,6-diyl, phenanthrene-2,7-diyl and 9,10-dihydro-phenanthrene-2,7-diyl, where, in addition, one or two CH groups in these rings are optionally replaced by N, and where these rings are optionally mono- or polysubstituted by L, as described above and below,
    • Z1 is selected from the group consisting of -O-, -CO-O-, -OCO-, -OCH2-, -CH2O-, -CF2O-, -OCF2-, -CH2CH2-, -CH=CH-, -CF=CF-, -CH=CF-, -CF=CH-, -C≡C-, and a single bond,
    • Z1 is a single bond,
    • n is 1 or 2, - L is an unpolymerisable group, preferably selected from F, Cl, -CN and straight-chain or branched alkyl having 1 to 25, particularly preferably 1 to 10, C atoms, in which, in addition, one or more non-adjacent CH2 groups may each be replaced, independently of one another, by -C(R00)=C(R000)-, -C≡C-, -N(R00)-, -O-, -S-, -CO-, -CO-O-, -O-CO-, -O-CO-O- in such a way that O and/or S atoms are not linked directly to one another, and in which, in addition, one or more H atoms may be replaced by F, Cl, Br, I or CN.
  • Very preferred compounds of formula I are selected from the following subformulae
    Figure imgb0011
    Figure imgb0012
    Figure imgb0013
    Figure imgb0014
    Figure imgb0015
    Figure imgb0016
    Figure imgb0017
    wherein P1, P2, P3 and L are as defined in formula I and r is 0, 1, 2, 3 or 4.
  • The invention furthermore relates to compounds of formula II

            Pg1-Sp1-(A1-Z1)n-A2-O-Sp4-CH(Sp2-Pg2)(Sp3-Pg3)     II

    in which Sp1, Sp2, Sp3, Sp4, A1, A2, Z1 and n have the meaning indicated in formula I or above and below, and Pg1, Pg2 and Pg3 denote independently of each other OH, a protected hydroxyl group or a masked hydroxyl group.
  • The compounds of formula II are suitable as intermediates for the preparation of compounds of the formula I and its subformulae.
  • The invention further relates to the use of the compounds of formula II as intermediates for the preparation of compounds of the formula I and its subformulae.
  • Suitable protected hydroxyl groups Pg1-3 are known to the person skilled in the art. Preferred protecting groups for hydroxyl groups are alkyl, alkoxyalkyl, acyl, alkylsilyl, arylsilyl and arylmethyl groups, especially 2-tetrahydropyranyl, methoxymethyl, methoxyethoxymethyl, acetyl, triisopropylsilyl, tert-butyl-dimethylsilyl or benzyl.
  • The term "masked hydroxyl group" is understood to mean any functional group that can be chemically converted into a hydroxyl group. Suitable masked hydroxyl groups Pg1-3 are known to the person skilled in the art. A preferred masking group for CH(CH2-Pg2)(CH2-Pg3) is a malonate group - CH(CO2Et)2.
  • Preferred compounds of formula II are selected from the following subformulae:
    Figure imgb0018
    Figure imgb0019
    Figure imgb0020
    Figure imgb0021
    Figure imgb0022
    Figure imgb0023
    Figure imgb0024
    wherein Pg1, Pg2 and Pg3 are as defined in formula II or have one of the preferred meanings given above, and L and r are as defined in formula I1.
  • The compounds and intermediates of the formulae I and II and sub-formulae thereof can be prepared analogously to processes known to the person skilled in the art and described in standard works of organic chemistry, such as, for example, in Houben-Weyl, Methoden der organischen Chemie [Methods of Organic Chemistry], Thieme-Verlag, Stuttgart.
  • Particularly suitable and preferred processes for the preparation of compounds and intermediates of the formulae I and II are depicted by way of example in the following schemes and preferably comprise one or more of the steps described below.
  • For example, compounds of formula I can be synthesised by esterification or etherification of the intermediates of formula II, wherein Pg1-3 denote OH, using corresponding acids, acid derivatives, or halogenated compounds containing a polymerisable group P1.
  • As exemplarily shown in Scheme 1, acrylic or methacrylic esters (wherein Sp1-4, A1-2, Z1 and n have the meanings given above, and "Acr" denotes an acrylate or methacrylate group) can be prepared by esterification of the corresponding alcohols with acid derivatives like, for example, (meth)acryloyl chloride or (meth)acrylic anhydride in the presence of a base like pyridine or triethyl amine, and 4-(N,N-dimethylamino)pyridine (DMAP). Alternatively the esters can be prepared by esterification of the alcohols with (meth)acrylic acid in the presence of a dehydrating reagent, for example according to Steglich with dicyclohexylcarbodiimide (DCC), N-(3-dimethylaminopropyl)-N'-ethylcarbodiimide (EDC) or N-(3-dimethylaminopropyl)-N'-ethylcarbodiimide hydrochloride and DMAP.
    Figure imgb0025
  • Suitable reaction schemes for the synthesis of compounds of formula I are exemplarily illustrated below. Other compounds of formula I with different mesogenic cores and/or different spacer groups can be prepared by the person skilled in the art in analogy thereto without inventive contribution.
    Figure imgb0026
    Figure imgb0027
    Figure imgb0028
    Figure imgb0029
  • For the production of PSA displays, the polymerisable compounds cointained in the LC medium are polymerised or crosslinked (if one compound contains two or more polymerisable groups) by in-situ polymerisation in the LC medium between the substrates of the LC display, optionally while a voltage is applied to the electrodes.
  • The structure of the PSA displays according to the invention corresponds to the usual geometry for PSA displays, as described in the prior art cited at the outset. Geometries without protrusions are preferred, in particular those in which, in addition, the electrode on the colour filter side is unstructured and only the electrode on the TFT side has slots. Particularly suitable and preferred electrode structures for PS-VA displays are described, for example, in US 2006/0066793 A1 .
  • A preferred PSA type LC display of the present invention comprises:
    • a first substrate including a pixel electrode defining pixel areas, the pixel electrode being connected to a switching element disposed in each pixel area and optionally including a micro-slit pattern, and optionally a first alignment layer disposed on the pixel electrode,
    • a second substrate including a common electrode layer, which may be disposed on the entire portion of the second substrate facing the first substrate, and optionally a second alignment layer,
    • an LC layer disposed between the first and second substrates and including an LC medium comprising a polymerisable component A and a liquid crystal component B as described above and below, wherein the polymerisable component A may also be polymerised.
  • The first and/or second alignment layer controls the alignment direction of the LC molecules of the LC layer. For example, in PS-VA displays the alignment layer is selected such that it imparts to the LC molecules homeotropic (or vertical) alignment (i.e. perpendicular to the surface) or tilted alignment. Such an alignment layer may for example comprise a polyimide, which may also be rubbed, or may be prepared by a photoalignment method.
  • The LC layer with the LC medium can be deposited between the substrates of the display by methods that are conventionally used by display manufacturers, for example the so-called one-drop-filling (ODF) method. The polymerisable component of the LC medium is then polymerised for example by UV photopolymerisation. The polymerisation can be carried out in one step or in two or more steps.
  • The PSA display may comprise further elements, like a colour filter, a black matrix, a passivation layer, optical retardation layers, transistor elements for addressing the individual pixels, etc., all of which are well known to the person skilled in the art and can be employed without inventive skill.
  • The electrode structure can be designed by the skilled person depending on the individual display type. For example for PS-VA displays a multi-domain orientation of the LC molecules can be induced by providing electrodes having slits and/or bumps or protrusions in order to create two, four or more different tilt alignment directions.
  • Upon polymerisation the polymerisable compounds form a crosslinked polymer, which causes a certain pretilt of the LC molecules in the LC medium. Without wishing to be bound to a specific theory, it is believed that at least a part of the crosslinked polymer, which is formed by the polymerisable compounds, will phase-separate or precipitate from the LC medium and form a polymer layer on the substrates or electrodes, or the alignment layer provided thereon. Microscopic measurement data (like SEM and AFM) have confirmed that at least a part of the formed polymer accumulates at the LC/substrate interface.
  • The polymerisation can be carried out in one step. It is also possible firstly to carry out the polymerisation, optionally while applying a voltage, in a first step in order to produce a pretilt angle, and subsequently, in a second polymerisation step without an applied voltage, to polymerise or crosslink the compounds which have not reacted in the first step ("end curing").
  • Suitable and preferred polymerisation methods are, for example, thermal or photopolymerisation, preferably photopolymerisation, in particular UV induced photopolymerisation, which can be achieved by exposure of the polymerisable compounds to UV radiation.
  • Optionally one or more polymerisation initiators are added to the polymerisable compounds. Suitable conditions for the polymerisation and suitable types and amounts of initiators are known to the person skilled in the art and are described in the literature. Suitable for free-radical polymerisation are, for example, the commercially available photoinitiators Irgacure651®, Irgacure184®, Irgacure907®, Irgacure369® or Darocure1173® (Ciba AG). If a polymerisation initiator is employed, its proportion is preferably 0.001 to 5% by weight, particularly preferably 0.001 to 1% by weight.
  • The polymerisable compounds according to the invention are also suitable for polymerisation without an initiator, which is accompanied by considerable advantages, such, for example, lower material costs and in particular less contamination of the LC medium by possible residual amounts of the initiator or degradation products thereof. The polymerisation can thus also be carried out without the addition of an initiator. In a preferred embodiment, the LC medium thus does not contain a polymerisation initiator.
  • The polymerisable component (component A) or the LC medium may also comprise one or more stabilisers in order to prevent undesired spontaneous polymerisation of the RMs, for example during storage or transport. Suitable types and amounts of stabilisers are known to the person skilled in the art and are described in the literature. Particularly suitable are, for example, the commercially available stabilisers from the Irganox® series (Ciba AG), such as, for example, Irganox® 1076. If stabilisers are employed, their proportion, based on the total amount of RMs or the polymerisable component (component A), is preferably 10-500,000 ppm, particularly preferably 50-50,000 ppm.
  • The polymerisable compounds of formula I do in particular show good UV absorption in, and are therefore especially suitable for, a process of preparing a PSA display including one or more of the following features:
    • the polymerisable medium is exposed to UV light in the display in a 2-step process, including a first UV exposure step ("UV-1 step") to generate the tilt angle, and a second UV exposure step ("UV-2 step") to finish polymerization,
    • the polymerisable medium is exposed to UV light in the display generated by an energy-saving UV lamp (also known as "green UV lamps"). These lamps are characterized by a relative low intensity (1/100-1/10 of a conventional UV1 lamp) in their absorption spectra from 300-380nm, and are preferably used in the UV2 step, but are optionally also used in the UV1 step when avoiding high intensity is necessary for the process.
    • the polymerisable medium is exposed to UV light in the display generated by a UV lamp with a radiation spectrum that is shifted to longer wavelengths, preferably 340nm or more, to avoid short UV light exposure in the PS-VA process.
  • Both using lower intensity and a UV shift to longer wavelengths protect the organic layer against damage that may be caused by the UV light.
  • A preferred embodiment of the present invention relates to a process for preparing a PSA display as described above and below, comprising one or more of the following features:
    • the polymerisable LC medium is exposed to UV light in a 2-step process, including a first UV exposure step ("UV-1 step") to generate the tilt angle, and a second UV exposure step ("UV-2 step") to finish polymerization,
    • the polymerisable LC medium is exposed to UV light generated by a UV lamp having an intensity of from 0.5 mW/cm2 to 10 mW/cm2 in the wavelength range from 300-380nm, preferably used in the UV2 step, and optionally also in the UV1 step,
    • the polymerisable LC medium is exposed to UV light having a wavelength of 340 nm or more, and preferably 400 nm or less.
  • This preferred process can be carried out for example by using the desired UV lamps or by using a band pass filter and/or a cut-off filter, which are substantially transmissive for UV light with the respective desired wavelength(s) and are substantially blocking light with the respective undesired wavelengths. For example, when irradiation with UV light of wavelengths λ of 300-400nm is desired, UV exposure can be carried out using a wide band pass filter being substantially transmissive for wavelengths 300nm < λ < 400nm. When irradiation with UV light of wavelength λ of more than 340 nm is desired, UV exposure can be carried out using a cut-off filter being substantially transmissive for wavelengths λ > 340 nm.
  • "Substantially transmissive" means that the filter transmits a substantial part, preferably at least 50% of the intensity, of incident light of the desired wavelength(s). "Substantially blocking" means that the filter does not transmit a substantial part, preferably at least 50% of the intensity, of incident light of the undesired wavelengths. "Desired (undesired) wavelength" e.g. in case of a band pass filter means the wavelengths inside (outside) the given range of λ, and in case of a cut-off filter means the wavelengths above (below) the given value of λ.
  • This preferred process enables the manufacture of displays by using longer UV wavelengths, thereby reducing or even avoiding the hazardous and damaging effects of short UV light components.
  • UV radiation energy is in general from 6 to 100 J, depending on the production process conditions.
  • Preferably the LC medium according to the present invention does essentially consist of one or more polymerisable compounds of formula I and an LC host mixture as described above and below. However, the LC medium or LC host mixture may additionally comprise one or more further components or additives, preferably selected from the list including but not limited to co-monomers, chiral dopants, polymerisation initiators, inhibitors, stabilizers, surfactants, wetting agents, lubricating agents, dispersing agents, hydrophobing agents, adhesive agents, flow improvers, defoaming agents, deaerators, diluents, reactive diluents, auxiliaries, colourants, dyes, pigments and nanoparticles.
  • Particular preference is given to LC media comprising one, two or three polymerisable compounds of formula I.
  • Preference is furthermore given to LC media in which the polymerisable component (component A) comprises exclusively polymerisable compounds of formula I.
  • Preference is furthermore given to LC media in which the liquid-crystalline component (component B) or the LC host mixture has a nematic LC phase, and preferably has no chiral liquid crystal phase.
  • Preference is furthermore given to achiral compounds of formula I, and to LC media in which the compounds of component A and/or B are selected exclusively from the group consisting of achiral compounds.
  • Preferably the proportion of the polymerisable component or component A) in the LC medium is from > 0 to < 5%, very preferably from > 0 to < 1%, most preferably from 0.01 to 0.5%.
  • Preferably the proportion of compounds of formula I in the LC medium is from >0 to < 5%, very preferably from >0 to < 1%, most preferably from 0.01 to 0.5%.
  • Preferably the proportion of the liquid-crystalline component or component B) in the LC medium is from 95 to < 100%, very preferably from 99 to <100%.
  • In a preferred embodiment the polymerisable compounds of the polymerisable component (component B) are exclusively selected from formula I.
  • In another preferred embodiment the polymerisable component (component B) comprises, in addition to the compounds of formula I, one or more further polymerisable compounds ("co-monomers"), preferably selected from RMs.
  • Suitable and preferred mesogenic comonomers are selected from the following formulae:
    Figure imgb0030
    Figure imgb0031
    Figure imgb0032
    Figure imgb0033
    Figure imgb0034
    Figure imgb0035
    Figure imgb0036
    Figure imgb0037
    Figure imgb0038
    Figure imgb0039
    Figure imgb0040
    Figure imgb0041
    Figure imgb0042
    Figure imgb0043
    Figure imgb0044
    Figure imgb0045
    Figure imgb0046
    Figure imgb0047
    Figure imgb0048
    Figure imgb0049
    Figure imgb0050
    Figure imgb0051
    Figure imgb0052
    Figure imgb0053
    Figure imgb0054
    Figure imgb0055
    Figure imgb0056
    Figure imgb0057
    Figure imgb0058
    Figure imgb0059
    in which the individual radicals have the following meanings:
  • P1, P2 and P3
    each, independently of one another, denote an acrylate or methacrylate group,
    Sp1, Sp2 and Sp3
    each, independently of one another, denote a single bond or a spacer group having one of the meanings indicated above and below for Sp1, and particularly preferably denote -(CH2)p1-, -(CH2)p1-O-, -(CH2)p1-CO-O- -, -(CH2)p1-O-CO- or -(CH2)p1-O-CO-O-, in which p1 is an integer from 1 to 12, where, in addition, one or more of the radicals P1-Sp1-, P1-Sp2- and P3-Sp3- may denote Raa, with the proviso that at least one of the radicals P1-Sp1-, P2-Sp2 and P3-Sp3- present is different from Raa,
    Raa
    denotes H, F, Cl, CN or straight-chain or branched alkyl having 1 to 25 C atoms, in which, in addition, one or more non-adjacent CH2 groups may each be replaced, independently of one another, by C(R0)=C(R00)-, -C≡C-, -N(R0)-, -O-, -S-, -CO-, -CO-O-, -O-CO-, -O-CO-O- in such a way that O and/or S atoms are not linked directly to one another, and in which, in addition, one or more H atoms may be replaced by F, Cl, CN or P1-Sp1-, particularly preferably straight-chain or branched, optionally mono- or polyfluorinated alkyl, alkoxy, alkenyl, alkynyl, alkylcarbonyl, alkoxycarbonyl, alkylcarbonyloxy or alkoxycarbonyloxy having 1 to 12 C atoms (where the alkenyl and alkynyl radicals have at least two C atoms and the branched radicals have at least three C atoms),
    R0, R00
    each, independently of one another and identically or differently on each occurrence, denote H or alkyl having 1 to 12 C atoms,
    Ry and Rz
    each, independently of one another, denote H, F, CH3 or CF3,
    X1, X2 and X3
    each, independently of one another, denote -CO-O-, -O-CO- or a single bond,
    Z1
    denotes -O-, -CO-, -C(RyRz)- or -CF2CF2-,
    Z2 and Z3
    each, independently of one another, denote -CO-O-, -O-CO-, -CH2O-, -OCH2-, -CF2O-, -OCF2- or -(CH2)n-, where n is 2, 3 or 4,
    L
    on each occurrence, identically or differently, denotes F, Cl, CN or straight-chain or branched, optionally mono- or polyfluorinated alkyl, alkoxy, alkenyl, alkynyl, alkylcarbonyl, alkoxycarbonyl, alkylcarbonyloxy or alkoxycarbonyloxy having 1 to 12 C atoms, preferably F,
    L' and L"
    each, independently of one another, denote H, F or Cl,
    r
    denotes 0, 1, 2, 3 or 4,
    s
    denotes 0, 1, 2 or 3,
    t
    denotes 0, 1 or 2,
    x
    denotes 0 or 1.
  • Especially preferred are compounds of formulae M2, M13, M17, M23 and M29.
  • Further preferred are trireactive compounds M15 to M30, in particular M17, M18, M19, M23, M24, M25, M29 and M30.
  • In the compounds of formulae M1 to M30 the group
    Figure imgb0060
    is preferably
    Figure imgb0061
    Figure imgb0062
    wherein L on each occurrence, identically or differently, has one of the meanings given above or below, and is preferably F, Cl, CN, NO2, CH3, C2H5, C(CH3)3, CH(CH3)2, CH2CH(CH3)C2H5, OCH3, OC2H5, COCH3, COC2H5, COOCH3, COOC2H5, CF3, OCF3, OCHF2, OC2F5 or P-Sp-, very preferably F, Cl, CN, CH3, C2H5, OCH3, COCH3, OCF3 or P-Sp-, more preferably F, Cl, CH3, OCH3, COCH3 oder OCF3, especially F or CH3.
  • Besides the polymerisable compounds described above, the LC media for use in the LC displays according to the invention comprise an LC mixture ("host mixture") comprising one or more, preferably two or more LC compounds which are selected from low-molecular-weight compounds that are unpolymerisable. These LC compounds are selected such that they stable and/or unreactive to a polymerisation reaction under the conditions applied to the polymerisation of the polymerisable compounds.
  • In principle, any LC mixture which is suitable for use in conventional displays is suitable as host mixture. Suitable LC mixtures are known to the person skilled in the art and are described in the literature, for example mixtures in VA displays in EP 1 378 557 A1 and mixtures for OCB displays in EP 1 306 418 A1 and DE 102 24 046 A1 .
  • In addition to the polymerisable compounds the LC medium according to the present invention comprises one or more mesogenic or liquid crystalline compounds comprising an alkenyl group, ("alkenyl compound"), where this alkenyl group is preferably stable to a polymerisation reaction under the conditions used for the polymerisation of the polymerisable compounds of formula I or of the other polymerisable compounds contained in the LC medium.
  • The polymerisable compounds of formula I are especially suitable for use in an LC host mixture that comprises one or more mesogenic or LC compounds comprising an alkenyl group (hereinafter also referred to as "alkenyl compounds"), wherin said alkenyl group is stable to a polymerisation reaction under the conditions used for polymerisation of the compounds of formula I and of the other polymerisable compounds contained in the LC medium. Compared to RMs known from prior art the compounds of formula I do in such an LC host mixture exhibit improved properties, like solubility, reactivity or capability of generating a tilt angle.
  • The LC host mixture is preferably a nematic LC mixture.
  • The alkenyl groups in the alkenyl compounds are preferably selected from straight-chain, branched or cyclic alkenyl, in particular having 2 to 25 C atoms, particularly preferably having 2 to 12 C atoms, in which, in addition, one or more non-adjacent CH2 groups may be replaced by -O-, -S-, -CO-, -CO-O-, -O-CO-, -O-CO-O- in such a way that O and/or S atoms are not linked directly to one another, and in which, in addition, one or more H atoms may be replaced by F and/or Cl.
  • Preferred alkenyl groups are straight-chain alkenyl having 2 to 7 C atoms and cyclohexenyl, in particular ethenyl, propenyl, butenyl, pentenyl, hexenyl, heptenyl, 1,4-cyclohexen-1-yl and 1,4-cyclohexen-3-yl.
  • The concentration of compounds containing an alkenyl group in the LC host mixture (i.e. without any polymerisable compounds) is preferably from 5% to 100%, very preferably from 20% to 60%.
  • Especially preferred are LC mixtures containing 1 to 5, preferably 1, 2 or 3 compounds having an alkenyl group.
  • The mesogenic and LC compounds containing an alkenyl group are preferably selected from the following formulae:
    Figure imgb0063
    Figure imgb0064
    in which the individual radicals, on each occurrence identically or differently, each, independently of one another, have the following meaning:
    Figure imgb0065
    Figure imgb0066
    Figure imgb0067
    Figure imgb0068
    Figure imgb0069
    Figure imgb0070
  • RA1
    alkenyl having 2 to 9 C atoms or, if at least one of the rings X, Y and Z denotes cyclohexenyl, also one of the meanings of RA2,
    RA2
    alkyl having 1 to 12 C atoms, in which, in addition, one or two non-adjacent CH2 groups may be replaced by -O-, -CH=CH-, -CO-, -OCO- or -COO- in such a way that O atoms are not linked directly to one another,
    Zx
    -CH2CH2-, -CH=CH-, -CF2O-, -OCF2-, -CH2O-, -OCH2-, -CO-O-, -O-CO-, -C2F4-, -CF=CF-, -CH=CH-CH2O-, or a single bond, preferably a single bond,
    L1-4
    each, independently of one another, H, F, Cl, OCF3, CF3, CH3, CH2F or CHF2H, preferably H, F or Cl,
    x
    1 or 2,
    z
    0 or 1.
  • RA2 is preferably straight-chain alkyl or alkoxy having 1 to 8 C atoms or straight-chain alkenyl having 2 to 7 C atoms.
  • The LC medium preferably comprises no compounds containing a terminal vinyloxy group (-O-CH=CH2), in particular no compounds of the formula AN or AY in which RA1 or RA2 denotes or contains a terminal vinyloxy group (-O-CH=CH2).
  • Preferably, L1 and L2 denote F, or one of L1 and L2 denotes F and the other denotes Cl, and L3 and L4 denote F, or one of L3 and L4 denotes F and the other denotes Cl.
  • The compounds of the formula AN are preferably selected from the following sub-formulae:
    Figure imgb0071
    Figure imgb0072
    Figure imgb0073
    Figure imgb0074
    Figure imgb0075
    Figure imgb0076
    Figure imgb0077
    Figure imgb0078
    Figure imgb0079
    Figure imgb0080
    Figure imgb0081
    Figure imgb0082
    in which alkyl and alkyl* each, independently of one another, denote a straight-chain alkyl radical having 1-6 C atoms, and alkenyl and alkenyl* each, independently of one another, denote a straight-chain alkenyl radical having 2-7 C atoms. Alkenyl and alkenyl* preferably denote CH2=CH-, CH2=CHCH2CH2-, CH3-CH=CH-, CH3-CH2-CH=CH-, CH3-(CH2)2-CH=CH-, CH3-(CH2)3-CH=CH- or CH3-CH=CH-(CH2)2-.
  • The compounds of the formula AY are preferably selected from the following sub-formulae:
    Figure imgb0083
    Figure imgb0084
    Figure imgb0085
    Figure imgb0086
    Figure imgb0087
    Figure imgb0088
    Figure imgb0089
    Figure imgb0090
    Figure imgb0091
    Figure imgb0092
    Figure imgb0093
    Figure imgb0094
    Figure imgb0095
    Figure imgb0096
    Figure imgb0097
    Figure imgb0098
    Figure imgb0099
    Figure imgb0100
    Figure imgb0101
    Figure imgb0102
    Figure imgb0103
    Figure imgb0104
    Figure imgb0105
    Figure imgb0106
    Figure imgb0107
    Figure imgb0108
    Figure imgb0109
    Figure imgb0110
    Figure imgb0111
    Figure imgb0112
    Figure imgb0113
    in which alkyl and alkyl* each, independently of one another, denote a straight-chain alkyl radical having 1-6 C atoms, and alkenyl and alkenyl* each, independently of one another, denote a straight-chain alkenyl radical having 2-7 C atoms. Alkenyl and alkenyl* preferably denote CH2=CH-, CH2=CHCH2CH2-, CH3-CH=CH-, CH3-CH2-CH=CH-, CH3-(CH2)2-CH=CH-, CH3-(CH2)3-CH=CH- or CH3-CH=CH-(CH2)2-.
  • Very preferred compounds of the formula AN are selected from the following sub-formulae:
    Figure imgb0114
    Figure imgb0115
    Figure imgb0116
    in which m denotes 1, 2, 3, 4, 5 or 6, i denotes 0, 1, 2 or 3, and Rb1 denotes H, CH3 or C2H5.
  • Very particularly preferred compounds of the formula AN are selected from the following sub-formulae:
    Figure imgb0117
    Figure imgb0118
    Figure imgb0119
    Figure imgb0120
    Figure imgb0121
  • Most preferred are compounds of formula AN1a2 and AN1a5.
  • Very particularly preferred compounds of the formula AY are selected from the following sub-formulae:
    Figure imgb0122
    Figure imgb0123
    Figure imgb0124
    Figure imgb0125
    Figure imgb0126
    Figure imgb0127
    in which m and n each, independently of one another, denote 1, 2, 3, 4, 5 or 6, and alkenyl denotes CH2=CH-, CH2=CHCH2CH2-, CH3-CH=CH-, CH3-CH2-CH=CH-, CH3-(CH2)2-CH=CH-, CH3-(CH2)3-CH=CH- or CH3-CH=CH-(CH2)2-.
  • In a first preferred embodiment the LC medium contains an LC host mixture based on compounds with negative dielectric anisotropy. Such LC media are especially suitable for use in PS-VA and PS-UB-FFS displays. Particularly preferred embodiments of such an LC medium are those of sections a)-z) below:
    • a) LC medium which comprises one or more compounds of the formulae CY and/or PY:
      Figure imgb0128
      Figure imgb0129
      wherein
      a
      denotes 1 or 2,
      b
      denotes 0 or 1,
      Figure imgb0130
      denotes
      Figure imgb0131
      R1 and R2
      each, independently of one another, denote alkyl having 1 to 12 C atoms, where, in addition, one or two non-adjacent CH2 groups may be replaced by -O-, -CH=CH-, -CO-, -OCO- or -COO- in such a way that O atoms are not linked directly to one another, preferably alkyl or alkoxy having 1 to 6 C atoms,
      Zx and Zy
      each, independently of one another, denote -CH2CH2-, -CH=CH-, -CF2O-, -OCF2-, -CH2O-, -OCH2-, -CO-O-, -O-CO-, -C2F4-, -CF=CF-, -CH=CH-CH2O- or a single bond, preferably a single bond,
      L1-4
      each, independently of one another, denote F, Cl, OCF3, CF3, CH3, CH2F, CHF2.
      Preferably, both L1 and L2 denote F or one of L1 and L2 denotes F and the other denotes Cl, or both L3 and L4 denote F or one of L3 and L4 denotes F and the other denotes Cl.
      The compounds of the formula CY are preferably selected from the group consisting of the following sub-formulae:
      Figure imgb0132
      Figure imgb0133
      Figure imgb0134
      Figure imgb0135
      Figure imgb0136
      Figure imgb0137
      Figure imgb0138
      Figure imgb0139
      Figure imgb0140
      Figure imgb0141
      Figure imgb0142
      Figure imgb0143
      Figure imgb0144
      Figure imgb0145
      Figure imgb0146
      Figure imgb0147
      Figure imgb0148
      Figure imgb0149
      Figure imgb0150
      Figure imgb0151
      Figure imgb0152
      Figure imgb0153
      Figure imgb0154
      Figure imgb0155
      Figure imgb0156
      Figure imgb0157
      Figure imgb0158
      Figure imgb0159
      Figure imgb0160
      Figure imgb0161
      Figure imgb0162
      Figure imgb0163
      Figure imgb0164
      in which a denotes 1 or 2, alkyl and alkyl* each, independently of one another, denote a straight-chain alkyl radical having 1-6 C atoms, and alkenyl denotes a straight-chain alkenyl radical having 2-6 C atoms, and (O) denotes an oxygen atom or a single bond. Alkenyl preferably denotes CH2=CH-, CH2=CHCH2CH2-, CH3-CH=CH-, CH3-CH2-CH=CH-, CH3-(CH2)2-CH=CH-, CH3-(CH2)3-CH=CH- or CH3-CH=CH-(CH2)2-.
      The compounds of the formula PY are preferably selected from the group consisting of the following sub-formulae:
      Figure imgb0165
      Figure imgb0166
      Figure imgb0167
      Figure imgb0168
      Figure imgb0169
      Figure imgb0170
      Figure imgb0171
      Figure imgb0172
      Figure imgb0173
      Figure imgb0174
      Figure imgb0175
      Figure imgb0176
      Figure imgb0177
      Figure imgb0178
      Figure imgb0179
      Figure imgb0180
      Figure imgb0181
      Figure imgb0182
      Figure imgb0183
      Figure imgb0184
      in which alkyl and alkyl* each, independently of one another, denote a straight-chain alkyl radical having 1-6 C atoms, and alkenyl denotes a straight-chain alkenyl radical having 2-6 C atoms, and (O) denotes an oxygen atom or a single bond. Alkenyl preferably denotes CH2=CH-, CH2=CHCH2CH2-, CH3-CH=CH-, CH3-CH2-CH=CH-, CH3-(CH2)2-CH=CH-, CH3-(CH2)3-CH=CH- or CH3-CH=CH-(CH2)2-.
    • b) LC medium which additionally comprises one or more compounds of the following formula:
      Figure imgb0185
      in which the individual radicals have the following meanings:
      Figure imgb0186
      denotes
      Figure imgb0187
      Figure imgb0188
      Figure imgb0189
      denotes
      Figure imgb0190
      R3 and R4
      each, independently of one another, denote alkyl having 1 to 12 C atoms, in which, in addition, one or two non-adjacent CH2 groups may be replaced by -O-, -CH=CH-, -CO-, -O-CO- or -CO-O- in such a way that O atoms are not linked directly to one another,
      ZY
      denotes -CH2CH2-, -CH=CH-, -CF2O-, -OCF2-, -CH2O-, -OCH2-, -CO-O-, -O-CO-, -C2F4-, -CF=CF-, -CH=CH-CH2O- or a single bond, preferably a single bond.
      The compounds of the formula ZK are preferably selected from the group consisting of the following sub-formulae:
      Figure imgb0191
      Figure imgb0192
      Figure imgb0193
      Figure imgb0194
      Figure imgb0195
      Figure imgb0196
      Figure imgb0197
      Figure imgb0198
      Figure imgb0199
      Figure imgb0200
      in which alkyl and alkyl* each, independently of one another, denote a straight-chain alkyl radical having 1-6 C atoms, and alkenyl denotes a straight-chain alkenyl radical having 2-6 C atoms. Alkenyl preferably denotes CH2=CH-, CH2=CHCH2CH2-, CH3-CH=CH-, CH3-CH2-CH=CH-, CH3-(CH2)2-CH=CH-, CH3-(CH2)3-CH=CH- or CH3-CH=CH-(CH2)2-.
      Especially preferred are compounds of formula ZK1.
      Particularly preferred compounds of formula ZK are selected from the following sub-formulae:
      Figure imgb0201
      Figure imgb0202
      Figure imgb0203
      wherein the propyl, butyl and pentyl groups are straight-chain groups.
      Most preferred are compounds of formula ZK1 a.
    • c) LC medium which additionally comprises one or more compounds of the following formula:
      Figure imgb0204
      in which the individual radicals on each occurrence, identically or differently, have the following meanings:
      R5 and R6
      each, independently of one another, denote alkyl having 1 to 12 C atoms, where, in addition, one or two non-adjacent CH2 groups may be replaced by -O-, -CH=CH-, -CO-, -OCO- or -COO- in such a way that O atoms are not linked directly to one another, preferably alkyl or alkoxy having 1 to 6 C atoms,
      Figure imgb0205
      denotes
      Figure imgb0206
      Figure imgb0207
      denotes
      Figure imgb0208
      and
      e
      denotes 1 or 2.
      The compounds of the formula DK are preferably selected from the group consisting of the following sub-formulae:
      Figure imgb0209
      Figure imgb0210
      Figure imgb0211
      Figure imgb0212
      Figure imgb0213
      Figure imgb0214
      Figure imgb0215
      Figure imgb0216
      Figure imgb0217
      Figure imgb0218
      Figure imgb0219
      Figure imgb0220
      in which alkyl and alkyl* each, independently of one another, denote a straight-chain alkyl radical having 1-6 C atoms, and alkenyl denotes a straight-chain alkenyl radical having 2-6 C atoms. Alkenyl preferably denotes CH2=CH-, CH2=CHCH2CH2-, CH3-CH=CH-, CH3-CH2-CH=CH-, CH3-(CH2)2-CH=CH-, CH3-(CH2)3-CH=CH- or CH3-CH=CH-(CH2)2-.
    • d) LC medium which additionally comprises one or more compounds of the following formula:
      Figure imgb0221
      in which the individual radicals have the following meanings:
      Figure imgb0222
      denotes
      Figure imgb0223
      Figure imgb0224
      with at least one ring F being different from cyclohexylene,
      f
      denotes 1 or 2,
      R1 and R2
      each, independently of one another, denote alkyl having 1 to 12 C atoms, where, in addition, one or two non-adjacent CH2 groups may be replaced by -O-, -CH=CH-, -CO-, -OCO- or -COO- in such a way that O atoms are not linked directly to one another,
      Zx
      denotes -CH2CH2-, -CH=CH-, -CF2O-, -OCF2-, -CH2O-, -OCH2-, -CO-O-, -O-CO-, -C2F4-, -CF=CF-, -CH=CH-CH2O- or a single bond, preferably a single bond,
      L1 and L2
      each, independently of one another, denote F, Cl, OCF3, CF3, CH3, CH2F, CHF2.
      Preferably, both radicals L1 and L2 denote F or one of the radicals L1 and L2 denotes F and the other denotes Cl.
      The compounds of the formula LY are preferably selected from the group consisting of the following sub-formulae:
      Figure imgb0225
      Figure imgb0226
      Figure imgb0227
      Figure imgb0228
      Figure imgb0229
      Figure imgb0230
      Figure imgb0231
      Figure imgb0232
      Figure imgb0233
      Figure imgb0234
      Figure imgb0235
      Figure imgb0236
      Figure imgb0237
      Figure imgb0238
      Figure imgb0239
      Figure imgb0240
      Figure imgb0241
      Figure imgb0242
      Figure imgb0243
      Figure imgb0244
      Figure imgb0245
      Figure imgb0246
      Figure imgb0247
      Figure imgb0248
      in which R1 has the meaning indicated above, alkyl denotes a straight-chain alkyl radical having 1-6 C atoms, (O) denotes an oxygen atom or a single bond, and v denotes an integer from 1 to 6. R1 preferably denotes straight-chain alkyl having 1 to 6 C atoms or straight-chain alkenyl having 2 to 6 C atoms, in particular CH3, C2H5, n-C3H7, n-C4H9, n-C5H11, CH2=CH-, CH2=CHCH2CH2-, CH3-CH=CH-, CH3-CH2-CH=CH-, CH3-(CH2)2-CH=CH-, CH3-(CH2)3-CH=CH- or CH3-CH=CH-(CH2)2-.
    • e) LC medium which additionally comprises one or more compounds selected from the group consisting of the following formulae:
      Figure imgb0249
      Figure imgb0250
      Figure imgb0251
      Figure imgb0252
      in which alkyl denotes C1-6-alkyl, Lx denotes H or F, and X denotes F, Cl, OCF3, OCHF2 or OCH=CF2. Particular preference is given to compounds of the formula G1 in which X denotes F.
    • f) LC medium which additionally comprises one or more compounds selected from the group consisting of the following formulae:
      Figure imgb0253
      Figure imgb0254
      Figure imgb0255
      Figure imgb0256
      Figure imgb0257
      Figure imgb0258
      Figure imgb0259
      Figure imgb0260
      Figure imgb0261
      Figure imgb0262
      Figure imgb0263
      Figure imgb0264
      Figure imgb0265
      Figure imgb0266
      Figure imgb0267
      Figure imgb0268
      in which R5 has one of the meanings indicated above for R1, alkyl denotes C1-6-alkyl, d denotes 0 or 1, and z and m each, independently of one another, denote an integer from 1 to 6. R5 in these compounds is particularly preferably C1-6-alkyl or -alkoxy or C2-6-alkenyl, d is preferably 1. The LC medium according to the invention preferably comprises one or more compounds of the above-mentioned formulae in amounts of ≥ 5% by weight.
    • g) LC medium which additionally comprises one or more biphenyl compounds selected from the group consisting of the following formulae:
      Figure imgb0269
      Figure imgb0270
      Figure imgb0271
      in which alkyl and alkyl* each, independently of one another, denote a straight-chain alkyl radical having 1-6 C atoms, and alkenyl and alkenyl* each, independently of one another, denote a straight-chain alkenyl radical having 2-6 C atoms. Alkenyl and alkenyl* preferably denote CH2=CH-, CH2=CHCH2CH2-, CH3-CH=CH-, CH3-CH2-CH=CH-, CH3-(CH2)2-CH=CH-, CH3-(CH2)3-CH=CH- or CH3-CH=CH-(CH2)2-.
      The proportion of the biphenyls of the formulae B1 to B3 in the LC mixture is preferably at least 3% by weight, in particular ≥ 5% by weight.
      The compounds of the formula B2 are particularly preferred.
      The compounds of the formulae B1 to B3 are preferably selected from the group consisting of the following sub-formulae:
      Figure imgb0272
      Figure imgb0273
      Figure imgb0274
      Figure imgb0275
      in which alkyl* denotes an alkyl radical having 1-6 C atoms. The medium according to the invention particularly preferably comprises one or more compounds of the formulae B1a and/or B2c.
    • h) LC medium which additionally comprises one or more terphenyl compounds of the following formula:
      Figure imgb0276
      in which R5 and R6 each, independently of one another, have one of the meanings indicated above, and
      Figure imgb0277
      each, independently of one another, denote
      Figure imgb0278
      in which L5 denotes F or Cl, preferably F, and L6 denotes F, Cl, OCF3, CF3, CH3, CH2F or CHF2, preferably F.
      The compounds of the formula T are preferably selected from the group consisting of the following sub-formulae:
      Figure imgb0279
      Figure imgb0280
      Figure imgb0281
      Figure imgb0282
      Figure imgb0283
      Figure imgb0284
      Figure imgb0285
      Figure imgb0286
      Figure imgb0287
      Figure imgb0288
      Figure imgb0289
      Figure imgb0290
      Figure imgb0291
      Figure imgb0292
      Figure imgb0293
      Figure imgb0294
      Figure imgb0295
      Figure imgb0296
      Figure imgb0297
      Figure imgb0298
      Figure imgb0299
      Figure imgb0300
      Figure imgb0301
      Figure imgb0302
      in which R denotes a straight-chain alkyl or alkoxy radical having 1-7 C atoms, R* denotes a straight-chain alkenyl radical having 2-7 C atoms, (O) denotes an oxygen atom or a single bond, and m denotes an integer from 1 to 6. R* preferably denotes CH2=CH-, CH2=CHCH2CH2-, CH3-CH=CH-, CH3-CH2-CH=CH-, CH3-(CH2)2-CH=CH-, CH3-(CH2)3-CH=CH- or CH3-CH=CH-(CH2)2-.
      R preferably denotes methyl, ethyl, propyl, butyl, pentyl, hexyl, methoxy, ethoxy, propoxy, butoxy or pentoxy.
      The LC medium according to the invention preferably comprises the terphenyls of the formula T and the preferred sub-formulae thereof in an amount of 0.5-30% by weight, in particular 1-20% by weight.
      Particular preference is given to compounds of the formulae T1, T2, T3 and T21. In these compounds, R preferably denotes alkyl, furthermore alkoxy, each having 1-5 C atoms.
      The terphenyls are preferably employed in mixtures according to the invention if the Δn value of the mixture is to be ≥ 0.1. Preferred mixtures comprise 2-20% by weight of one or more terphenyl compounds of the formula T, preferably selected from the group of compounds T1 to T22.
    • i) LC medium which additionally comprises one or more compounds selected from the group consisting of the following formulae:
      Figure imgb0303
      Figure imgb0304
      Figure imgb0305
      Figure imgb0306
      Figure imgb0307
      Figure imgb0308
      Figure imgb0309
      Figure imgb0310
      Figure imgb0311
      Figure imgb0312
      Figure imgb0313
      in which R1 and R2 have the meanings indicated above and preferably each, independently of one another, denote straight-chain alkyl having 1 to 6 C atoms or straight-chain alkenyl having 2 to 6 C atoms.
      Preferred media comprise one or more compounds selected from the formulae O1, 03 and 04.
    • k) LC medium which additionally comprises one or more compounds of the following formula:
      Figure imgb0314
      in which
      Figure imgb0315
      denotes
      Figure imgb0316
      Figure imgb0317
      Figure imgb0318
      R9 denotes H, CH3, C2H5 or n-C3H7, (F) denotes an optional fluorine substituent, and q denotes 1, 2 or 3, and R7 has one of the meanings indicated for R1, preferably in amounts of > 3% by weight, in particular ≥ 5% by weight and very particularly preferably 5-30% by weight.
      Particularly preferred compounds of the formula FI are selected from the group consisting of the following sub-formulae:
      Figure imgb0319
      Figure imgb0320
      Figure imgb0321
      Figure imgb0322
      Figure imgb0323
      Figure imgb0324
      Figure imgb0325
      Figure imgb0326
      in which R7 preferably denotes straight-chain alkyl, and R9 denotes CH3, C2H5 or n-C3H7. Particular preference is given to the compounds of the formulae FI1, FI2 and FI3.
    • l) LC medium which additionally comprises one or more compounds selected from the group consisting of the following formulae:
      Figure imgb0327
      Figure imgb0328
      Figure imgb0329
      Figure imgb0330
      in which R8 has the meaning indicated for R1, and alkyl denotes a straight-chain alkyl radical having 1-6 C atoms.
    • m) LC medium which additionally comprises one or more compounds which contain a tetrahydronaphthyl or naphthyl unit, such as, for example, the compounds selected from the group consisting of the following formulae:
      Figure imgb0331
      Figure imgb0332
      Figure imgb0333
      Figure imgb0334
      Figure imgb0335
      Figure imgb0336
      Figure imgb0337
      Figure imgb0338
      Figure imgb0339
      Figure imgb0340
      in which
      R10 and R11
      each, independently of one another, denote alkyl having 1 to 12 C atoms, where, in addition, one or two non-adjacent CH2 groups may be replaced by -O-, -CH=CH-, -CO-, -OCO- or -COO- in such a way that O atoms are not linked directly to one another, preferably alkyl or alkoxy having 1 to 6 C atoms,
      and R10 and R11 preferably denote straight-chain alkyl or alkoxy having 1 to 6 C atoms or straight-chain alkenyl having 2 to 6 C atoms, and
      Z1 and Z2
      each, independently of one another, denote -C2H4-, -CH=CH-, -(CH2)4-, -(CH2)3O-, -O(CH2)3-, -CH=CH-CH2CH2-, -CH2CH2CH=CH-, -CH2O-, -OCH2-, -CO-O-, -O-CO-, -C2F4-, -CF=CF-, -CF=CH-, -CH=CF-, -CH2- or a single bond.
    • n) LC medium which additionally comprises one or more difluorodibenzochromans and/or chromans of the following formulae:
      Figure imgb0341
      Figure imgb0342
      Figure imgb0343
      in which
      R11 and R12
      each, independently of one another, have one of the meanings indicated above for R11,
      ring M
      is trans-1,4-cyclohexylene or 1,4-phenylene,
      Zm
      -C2H4-, -CH2O-, -OCH2-, -CO-O- or -O-CO-,
      c
      is 0, 1 or 2,
      preferably in amounts of 3 to 20% by weight, in particular in amounts of 3 to 15% by weight.
      Particularly preferred compounds of the formulae BC, CR and RC are selected from the group consisting of the following sub-formulae:
      Figure imgb0344
      Figure imgb0345
      Figure imgb0346
      Figure imgb0347
      Figure imgb0348
      Figure imgb0349
      Figure imgb0350
      Figure imgb0351
      Figure imgb0352
      Figure imgb0353
      Figure imgb0354
      Figure imgb0355
      Figure imgb0356
      Figure imgb0357
      Figure imgb0358
      Figure imgb0359
      Figure imgb0360
      Figure imgb0361
      Figure imgb0362
      in which alkyl and alkyl* each, independently of one another, denote a straight-chain alkyl radical having 1-6 C atoms, (O) denotes an oxygen atom or a single bond, c is 1 or 2, and alkenyl and alkenyl* each,
      independently of one another, denote a straight-chain alkenyl radical having 2-6 C atoms. Alkenyl and alkenyl* preferably denote CH2=CH-, CH2=CHCH2CH2-, CH3-CH=CH-, CH3-CH2-CH=CH-, CH3-(CH2)2-CH=CH-, CH3-(CH2)3-CH=CH- or CH3-CH=CH-(CH2)2-.
      Very particular preference is given to mixtures comprising one, two or three compounds of the formula BC-2.
    • o) LC medium which additionally comprises one or more fluorinated phenanthrenes and/or dibenzofurans of the following formulae:
      Figure imgb0363
      Figure imgb0364
      in which R11 and R12 each, independently of one another, have one of the meanings indicated above for R11, b denotes 0 or 1, L denotes F, and r denotes 1, 2 or 3.
      Particularly preferred compounds of the formulae PH and BF are selected from the group consisting of the following sub-formulae:
      Figure imgb0365
      Figure imgb0366
      Figure imgb0367
      Figure imgb0368
      in which R and R' each, independently of one another, denote a straight-chain alkyl or alkoxy radical having 1-7 C atoms.
    • p) LC medium which additionally comprises one or more monocyclic compounds of the following formula
      Figure imgb0369
      wherein
      R1 and R2
      each, independently of one another, denote alkyl having 1 to 12 C atoms, where, in addition, one or two non-adjacent CH2 groups may be replaced by -O-, -CH=CH-, -CO-, -OCO- or -COO- in such a way that O atoms are not linked directly to one another, preferably alkyl or alkoxy having 1 to 6 C atoms,
      L1 and L2
      each, independently of one another, denote F, Cl, OCF3, CF3, CH3, CH2F, CHF2.
      Preferably, both L1 and L2 denote F or one of L1 and L2 denotes F and the other denotes Cl,
      The compounds of the formula Y are preferably selected from the group consisting of the following sub-formulae:
      Figure imgb0370
      Figure imgb0371
      Figure imgb0372
      Figure imgb0373
      Figure imgb0374
      Figure imgb0375
      Figure imgb0376
      Figure imgb0377
      Figure imgb0378
      Figure imgb0379
      in which, Alkyl and Alkyl* each, independently of one another, denote a straight-chain alkyl radical having 1-6 C atoms, Alkoxy denotes a straight-chain alkoxy radical having 1-6 C atoms, Alkenyl and Alkenyl* each, independently of one another, denote a straight-chain alkenyl radical having 2-6 C atoms, and O denotes an oxygen atom or a single bond. Alkenyl and Alkenyl* preferably denote CH2=CH-, CH2=CHCH2CH2-, CH3-CH=CH-, CH3-CH2-CH=CH-, CH3-(CH2)2-CH=CH-, CH3-(CH2)3-CH=CH- or CH3-CH=CH-(CH2)2-.
      Particularly preferred compounds of the formula Y are selected from the group consisting of the following sub-formulae:
      Figure imgb0380
      Figure imgb0381
      wherein Alkoxy preferably denotes straight-chain alkoxy with 3, 4, or 5 C atoms.
    • q) LC medium which, apart from the polymerisable compounds according to the invention, in particular of the formula I or sub-formulae thereof and the comonomers, comprises no compounds which contain a terminal vinyloxy group (-O-CH=CH2).
    • r) LC medium which comprises 1 to 5, preferably 1, 2 or 3, polymerisable compounds, preferably selected from polymerisable compounds according to the invention, in particular of the formula I or sub-formulae thereof.
    • s) LC medium in which the proportion of polymerisable compounds, in particular of the formula I or sub-formulae thereof, in the mixture as a whole is 0.05 to 5%, preferably 0.1 to 1%.
    • t) LC medium which comprises 1 to 8, preferably 1 to 5, compounds of the formulae CY1, CY2, PY1 and/or PY2. The proportion of these compounds in the mixture as a whole is preferably 5 to 60%, particularly preferably 10 to 35%. The content of these individual compounds is preferably in each case 2 to 20%.
    • u) LC medium which comprises 1 to 8, preferably 1 to 5, compounds of the formulae CY9, CY10, PY9 and/or PY10. The proportion of these compounds in the mixture as a whole is preferably 5 to 60%, particularly preferably 10 to 35%. The content of these individual compounds is preferably in each case 2 to 20%.
    • v) LC medium which comprises 1 to 10, preferably 1 to 8, compounds of the formula ZK, in particular compounds of the formulae ZK1, ZK2 and/or ZK6. The proportion of these compounds in the mixture as a whole is preferably 3 to 25%, particularly preferably 5 to 45%. The content of these individual compounds is preferably in each case 2 to 20%.
    • w) LC medium in which the proportion of compounds of the formulae CY, PY and ZK in the mixture as a whole is greater than 70%, preferably greater than 80%.
    • x) LC medium in which the LC host mixture contains one or more compounds containing an alkenyl group, preferably selected from the group consisting of formula CY, PY and LY, wherein one or both of R1 and R2 denote straight-chain alkenyl having 2-6 C atoms, formula ZK and DK, wherein one or both of R3 and R4 or one or both of R5 and R6 denote straight-chain alkenyl having 2-6 C atoms, and formula B2 and B3, very preferably selected from formulae CY15, CY16, CY24, CY32, PY15, PY16, ZK3, ZK4, DK3, DK6, B2 and B3, most preferably selected from formulae ZK3, ZK4, B2 and B3. The concentration of these compounds in the LC host mixture is preferably from 2 to 70%, very preferably from 3 to 55%.
    • y) LC medium which contains one or more, preferably 1 to 5, compounds selected of formula PY1-PY8, very preferably of formula PY2. The proportion of these compounds in the mixture as a whole is preferably 1 to 30%, particularly preferably 2 to 20%. The content of these individual compounds is preferably in each case 1 to 20%.
    • z) LC medium which contains one or more, preferably 1, 2 or 3, compounds of formula T2. The content of these compounds in the mixture as a whole is preferably 1 to 20%.
  • In a second preferred embodiment the LC medium contains an LC host mixture based on compounds with positive dielectric anisotropy. Such LC media are especially suitable for use in PS-OCB-, PS-TN-, PS-Posi-VA-, PS-IPS- or PS-FFS-displays.
  • Particularly preferred is an LC medium of this second preferred embodiment, which contains one or more compounds selected from the group consisting of compounds of formula AA and BB
    Figure imgb0382
    Figure imgb0383
    and optionally contains, in addition to the compounds of formula AA and/or BB, one or more compounds of formula CC
    Figure imgb0384
    in which the individual radicals have the following meanings:
    Figure imgb0385
    each, independently of one another, and on each occurrence, identically or differently
    Figure imgb0386
    Figure imgb0387
    Figure imgb0388
    each, independently of one another, and on each occurrence, identically or differently
    Figure imgb0389
    Figure imgb0390
  • R21, R31, R41, R42
    each, independently of one another, alkyl, alkoxy, oxaalkyl or alkoxyalkyl having 1 to 9 C atoms or alkenyl or alkenyloxy having 2 to 9 C atoms, all of which are optionally fluorinated,
    X0
    F, Cl, halogenated alkyl or alkoxy having 1 to 6 C atoms or halogenated alkenyl or alkenyloxy having 2 to 6 C atoms,
    Z31
    -CH2CH2-, -CF2CF2-, -COO-, trans-CH=CH-, trans-CF=CF-, -CH2O- or a single bond, preferably -CH2CH2-,-COO-, trans-CH=CH- or a single bond, particularly preferably -COO-, trans-CH=CH- or a single bond,
    Z41, Z42
    -CH2CH2-, -COO-, trans-CH=CH-, trans-CF=CF-, -CH2O-, -CF2O-, -C=C- or a single bond, preferably a single bond,
    L21, L22, L31, L32
    H or F,
    g
    0, 1, 2 or 3,
    h
    0, 1, 2 or 3.
  • X0 is preferably F, Cl, CF3, CHF2, OCF3, OCHF2, OCFHCF3, OCFHCHF2, OCFHCHF2, OCF2CH3, OCF2CHF2, OCF2CHF2, OCF2CF2CHF2, OCF2CF2CHF2, OCFHCF2CF3, OCFHCF2CHF2, OCF2CF2CF3, OCF2CF2CClF2, OCClFCF2CF3 or CH=CF2, very preferably F or OCF3
  • The compounds of formula AA are preferably selected from the group consisting of the following formulae:
    Figure imgb0391
    Figure imgb0392
    Figure imgb0393
    Figure imgb0394
    in which A21, R21, X0, L21 and L22 have the meanings given in formula AA, L23 and L24 each, independently of one another, are H or F, and X0 is preferably F. Particularly preferred are compounds of formulae AA1 and AA2.
  • Particularly preferred compounds of formula AA1 are selected from the group consisting of the following subformulae:
    Figure imgb0395
    Figure imgb0396
    Figure imgb0397
    Figure imgb0398
    Figure imgb0399
    in which R21, X0, L21 and L22 have the meaning given in formula AA1, L23, L24, L25 and L26 are each, independently of one another, H or F, and X0 is preferably F.
  • Very particularly preferred compounds of formula AA1 are selected from the group consisting of the following subformulae:
    Figure imgb0400
    Figure imgb0401
    Figure imgb0402
    Figure imgb0403
    Figure imgb0404
    In which R21 is as defined in formula AA1.
  • Very preferred compounds of formula AA2 are selected from the group consisting of the following subformulae:
    Figure imgb0405
    Figure imgb0406
    Figure imgb0407
    Figure imgb0408
    Figure imgb0409
    Figure imgb0410
    Figure imgb0411
    Figure imgb0412
    Figure imgb0413
    Figure imgb0414
    in which R21, X0, L21 and L22 have the meaning given in formula AA2, L23, L24, L25 and L26 each, independently of one another, are H or F, and X0 is preferably F.
  • Very particularly preferred compounds of formula AA2 are selected from the group consisting of the following subformulae:
    Figure imgb0415
    Figure imgb0416
    Figure imgb0417
    Figure imgb0418
    Figure imgb0419
    Figure imgb0420
    Figure imgb0421
    Figure imgb0422
    Figure imgb0423
    Figure imgb0424
    in which R21 and X0 are as defined in formula AA2.
  • Particularly preferred compounds of formula AA3 are selected from the group consisting of the following subformulae:
    Figure imgb0425
    Figure imgb0426
    Figure imgb0427
    in which R21, X0, L21 and L22 have the meaning given in formula AA3, and X0 is preferably F.
  • Particularly preferred compounds of formula AA4 are selected from the group consisting of the following subformulae:
    Figure imgb0428
    in which R21 is as defined in formula AA4.
  • The compounds of formula BB are preferably selected from the group consisting of the following formulae:
    Figure imgb0429
    Figure imgb0430
    Figure imgb0431
    in which g, A31, A32, R31, X0, L31 and L32 have the meanings given in formula BB, and X0 is preferably F. Particularly preferred are compounds of formulae BB1 and BB2.
  • Particularly preferred compounds of formula BB1 are selected from the group consisting of the following subformulae:
    Figure imgb0432
    Figure imgb0433
    in which R31, X0, L31 and L32 have the meaning given in formula BB1, and X0 is preferably F.
  • Very particularly preferred compounds of formula BB1a are selected from the group consisting of the following subformulae:
    Figure imgb0434
    Figure imgb0435
    Figure imgb0436
    Figure imgb0437
    Figure imgb0438
    Figure imgb0439
    in which R31 is as defined in formula BB1.
  • Very particularly preferred compounds of formula BB1 b are selected from the group consisting of the following subformulae:
    Figure imgb0440
    Figure imgb0441
    Figure imgb0442
    Figure imgb0443
    in which R31 is as defined in formula BB1.
  • Particularly preferred compounds of formula BB2 are selected from the group consisting of the following subformulae:
    Figure imgb0444
    Figure imgb0445
    Figure imgb0446
    Figure imgb0447
    Figure imgb0448
    Figure imgb0449
    Figure imgb0450
    Figure imgb0451
    Figure imgb0452
    Figure imgb0453
    in which R31, X0, L31 and L32 have the meaning given in formula BB2, L33, L34, L35 and L36 are each, independently of one another, H or F, and X0 is preferably F.
  • Very particularly preferred compounds of formula BB2 are selected from the group consisting of the following subformulae:
    Figure imgb0454
    Figure imgb0455
    Figure imgb0456
    Figure imgb0457
    Figure imgb0458
    in which R31 is as defined in formula BB2.
  • Very particularly preferred compounds of formula BB2b are selected from the group consisting of the following subformulae
    Figure imgb0459
    Figure imgb0460
    Figure imgb0461
    Figure imgb0462
    in which R31 is as defined in formula BB2.
  • Very particularly preferred compounds of formula BB2c are selected from the group consisting of the following subformulae:
    Figure imgb0463
    Figure imgb0464
    Figure imgb0465
    Figure imgb0466
    Figure imgb0467
    in which R31 is as defined in formula BB2.
  • Very particularly preferred compounds of formula BB2d and BB2e are selected from the group consisting of the following subformulae:
    Figure imgb0468
    Figure imgb0469
    in which R31 is as defined in formula BB2.
  • Very particularly preferred compounds of formula BB2f are selected from the group consisting of the following subformulae:
    Figure imgb0470
    Figure imgb0471
    Figure imgb0472
    Figure imgb0473
    Figure imgb0474
    in which R31 is as defined in formula BB2.
  • Very particularly preferred compounds of formula BB2g are selected from the group consisting of the following subformulae:
    Figure imgb0475
    Figure imgb0476
    Figure imgb0477
    Figure imgb0478
    Figure imgb0479
    in which R31 is as defined in formula BB2.
  • Very particularly preferred compounds of formula BB2h are selected from the group consisting of the following subformulae:
    Figure imgb0480
    Figure imgb0481
    Figure imgb0482
    in which R31 and X0 are as defined in formula BB2.
  • Very particularly preferred compounds of formula BB2i are selected from the group consisting of the following subformulae:
    Figure imgb0483
    Figure imgb0484
    in which R31 and X0 are as defined in formula BB2.
  • Very particularly preferred compounds of formula BB2k are selected from the group consisting of the following subformulae:
    Figure imgb0485
    Figure imgb0486
    in which R31 and X0 are as defined in formula BB2.
  • Alternatively to, or in addition to, the compounds of formula BB1 and/or BB2 the LC media may also comprise one or more compounds of formula BB3 as defined above.
  • Particularly preferred compounds of formula BB3 are selected from the group consisting of the following subformulae:
    Figure imgb0487
    Figure imgb0488
    in which R31 is as defined in formula BB3.
  • Preferably the LC media according to this second preferred embodiment comprise, in addition to the compounds of formula AA and/or BB, one or more dielectrically neutral compounds having a dielectric anisotropy in the range from -1.5 to +3, preferably selected from the group of compounds of formula CC as defined above.
  • Particularly preferred compounds of formula CC are selected from the group consisting of the following subformulae:
    Figure imgb0489
    Figure imgb0490
    Figure imgb0491
    Figure imgb0492
    Figure imgb0493
    Figure imgb0494
    Figure imgb0495
    Figure imgb0496
    Figure imgb0497
    Figure imgb0498
    Figure imgb0499
    Figure imgb0500
    Figure imgb0501
    Figure imgb0502
  • In which R41 and R42 have the meanings given in formula CC, and preferably denote each, independently of one another, alkyl, alkoxy, fluorinated alkyl or fluorinated alkoxy with 1 to 7 C atoms, or alkenyl, alkenyloxy, alkoxyalkyl or fluorinated alkenyl with 2 to 7 C atoms, and L4 is H or F.
  • Preferably the LC media according to this second preferred embodiment comprise, in addition or alternatively to the dielectrically neutral compounds of formula CC, one or more dielectrically neutral compounds having a dielectric anisotropy in the range from -1.5 to +3, selected from the group of compounds of formula DD.
    Figure imgb0503
    In which A41, A42, Z41, Z42, R41, R42 and h have the meanings given in formula CC.
  • Particularly preferred compounds of formula DD are selected from the group consisting of the following subformulae:
    Figure imgb0504
    Figure imgb0505
    in which R41 and R42 have the meanings given in formula DD and R41 preferably denotes alkyl bedeutet, and in formula DD1 R42 preferably denotes alkenyl, particularly preferably -(CH2)2-CH=CH-CH3, and in formula DD2 R42 preferably denotes alkyl, -(CH2)2-CH=CH2 or -(CH2)2-CH=CH-CH3.
  • The compounds of formula AA and BB are preferably used in the LC medium according to the invention in a concentration from 2% to 60%, more preferably from 3% to 35%, and very particularly preferably from 4% to 30% in the mixture as a whole.
  • The compounds of formula CC and DD are preferably used in the LC medium according to the invention in a concentration from 2% to 70%, more preferably from 5% to 65%, even more preferably from 10% to 60%, and very particularly preferably from 10%, preferably 15%, to 55% in the mixture as a whole.
  • The combination of compounds of the preferred embodiments mentioned above with the polymerised compounds described above causes low threshold voltages, low rotational viscosities and very good low-temperature stabilities in the LC media according to the invention at the same time as constantly high clearing points and high HR values, and allows the rapid establishment of a particularly low pretilt angle in PSA displays. In particular, the LC media exhibit significantly shortened response times, in particular also the grey-shade response times, in PSA displays compared with the media from the prior art.
  • The LC media and LC host mixtures of the present invention preferably have a nematic phase range of at least 80 K, particularly preferably at least 100 K, and a rotational viscosity ≤ 250 mPa·s, preferably ≤ 200 mPa·s, at 20°C.
  • In the VA-type displays according to the invention, the molecules in the layer of the LC medium in the switched-off state are aligned perpendicular to the electrode surfaces (homeotropically) or have a a tilted homeotropic alignment. On application of an electrical voltage to the electrodes, a realignment of the LC molecules takes place with the longitudinal molecular axes parallel to the electrode surfaces.
  • LC media according to the invention based on compounds with negative dielectric anisotropy according to the first preferred embodiment, in particular for use in displays of the PS-VA and PS-UB-FFS type, have a negative dielectric anisotropy Δε, preferably from -0.5 to -10, in particular from -2.5 to -7.5, at 20°C and 1 kHz.
  • The birefringence Δn in LC media according to the invention for use in displays of the PS-VA and PS-UB-FFS type is preferably below 0.16, particularly preferably from 0.06 to 0.14, very particularly preferably from 0.07 to 0,12.
  • In the OCB-type displays according to the invention, the molecules in the layer of the LC medium have a "bend" alignment. On application of an electrical voltage, a realignment of the LC molecules takes place with the longitudinal molecular axes perpendicular to the electrode surfaces.
  • LC media according to the invention for use in displays of the PS-OCB, PS-TN, PS-IPS, PS-posi-VA and PS-FFS type are preferably those based on compounds with positive dielectric anisotropy according to the second preferred embodiment, and preferably have a positive dielectric anisotropy Δε from +4 to +17 at 20°C and 1 kHz.
  • The birefringence Δn in LC media according to the invention for use in displays of the PS-OCB type is preferably from 0.14 to 0.22, particularly preferably from 0.16 to 0.22.
  • The birefringence Δn in LC media according to the invention for use in displays of the PS-TN-, PS-posi-VA-, PS-IPS- oder PS-FFS-type is preferably from 0.07 to 0.15, particularly preferably from 0.08 to 0.13.
  • LC media according to the invention, based on compounds with positive dielectric anisotropy according to the second preferred embodiment, for use in displays of the PS-TN-, PS-posi-VA-, PS-IPS- oder PS-FFS-type, preferably have a positive dielectric anisotropy Δε from +2 to +30, particularly preferably from +3 to +20, at 20°C and 1 kHz.
  • The LC media according to the invention may also comprise further additives which are known to the person skilled in the art and are described in the literature, such as, for example, polymerisation initiators, inhibitors, stabilisers, surface-active substances or chiral dopants. These may be polymerisable or non-polymerisable. Polymerisable additives are accordingly ascribed to the polymerisable component or component A). Non-polymerisable additives are accordingly ascribed to the non-polymerisable component or component B).
  • In a preferred embodiment the LC media contain one or more chiral dopants, preferably in a concentration from 0.01 to 1%, very preferably from 0.05 to 0.5%. The chiral dopants are preferably selected from the group consisting of compounds from Table B below, very preferably from the group consisting of R- or S-1011, R- or S-2011, R- or S-3011, R- or S-4011, and R- or S-5011.
  • In another preferred embodiment the LC media contain a racemate of one or more chiral dopants, which are preferably selected from the chiral dopants mentioned in the previous paragraph.
  • Furthermore, it is possible to add to the LC media, for example, 0 to 15% by weight of pleochroic dyes, furthermore nanoparticles, conductive salts, preferably ethyldimethyldodecylammonium 4-hexoxybenzoate, tetrabutylammonium tetraphenylborate or complex salts of crown ethers (cf., for example, Haller et al., Mol. Cryst. Liq. Cryst. 24, 249-258 (1973)), for improving the conductivity, or substances for modifying the dielectric anisotropy, the viscosity and/or the alignment of the nematic phases. Substances of this type are described, for example, in DE-A 22 09 127 , 22 40 864 , 23 21 632 , 23 38 281 , 24 50 088 , 26 37 430 and 28 53 728 .
  • The individual components of the preferred embodiments a)-z) of the LC media according to the invention are either known or methods for the preparation thereof can readily be derived from the prior art by the person skilled in the relevant art, since they are based on standard methods described in the literature. Corresponding compounds of the formula CY are described, for example, in EP-A-0 364 538 . Corresponding compounds of the formula ZK are described, for example, in DE-A-26 36 684 and DE-A-33 21 373 .
  • The LC media which can be used in accordance with the invention are prepared in a manner conventional per se, for example by mixing one or more of the above-mentioned compounds with one or more polymerisable compounds as defined above, and optionally with further liquid-crystalline compounds and/or additives. In general, the desired amount of the components used in lesser amount is dissolved in the components making up the principal constituent, advantageously at elevated temperature. It is also possible to mix solutions of the components in an organic solvent, for example in acetone, chloroform or methanol, and to remove the solvent again, for example by distillation, after thorough mixing. The invention furthermore relates to the process for the preparation of the LC media according to the invention.
  • It goes without saying to the person skilled in the art that the LC media according to the invention may also comprise compounds in which, for example, H, N, O, Cl, F have been replaced by the corresponding isotopes like deuterium etc.
  • The following examples explain the present invention without restricting it. However, they show the person skilled in the art preferred mixture concepts with compounds preferably to be employed and the respective concentrations thereof and combinations thereof with one another. In addition, the examples illustrate which properties and property combinations are accessible.
  • The following abbreviations are used:
    • (n, m, z: in each case, independently of one another, 1, 2, 3, 4, 5 or 6)
      Figure imgb0506
      Figure imgb0507
      Figure imgb0508
      Figure imgb0509
      Figure imgb0510
      Figure imgb0511
  • In a preferred embodiment of the present invention, the LC media according to the invention comprise one or more compounds selected from the group consisting of compounds from Table A. Table B
    Table B shows possible chiral dopants which can be added to the LC media according to the invention.
    Figure imgb0512
    Figure imgb0513
    C 15 CB 15
    Figure imgb0514
    Figure imgb0515
    CM 21 R/S-811
    Figure imgb0516
    Figure imgb0517
    CM 44 CM 45
    Figure imgb0518
    Figure imgb0519
    CM 47 CN
    Figure imgb0520
    Figure imgb0521
    R/S-2011 R/S-3011
    Figure imgb0522
    Figure imgb0523
    R/S-4011 R/S-5011
    Figure imgb0524
    RIS-1011
  • The LC media preferably comprise 0 to 10% by weight, in particular 0.01 to 5% by weight, particularly preferably 0.1 to 3% by weight, of dopants. The LC media preferably comprise one or more dopants selected from the group consisting of compounds from Table B. Table C
    Table C shows possible stabilisers which can be added to the LC media according to the invention.
    (n here denotes an integer from 1 to 12, preferably 1, 2, 3, 4, 5, 6, 7 or 8, terminal methyl groups are not shown).
    Figure imgb0525
    Figure imgb0526
    Figure imgb0527
    Figure imgb0528
    Figure imgb0529
    Figure imgb0530
    Figure imgb0531
    Figure imgb0532
    Figure imgb0533
    Figure imgb0534
    Figure imgb0535
    Figure imgb0536
    Figure imgb0537
    Figure imgb0538
    Figure imgb0539
    Figure imgb0540
    Figure imgb0541
    Figure imgb0542
    Figure imgb0543
    Figure imgb0544
    Figure imgb0545
    Figure imgb0546
    Figure imgb0547
    Figure imgb0548
    Figure imgb0549
    Figure imgb0550
    Figure imgb0551
    Figure imgb0552
    Figure imgb0553
    Figure imgb0554
    Figure imgb0555
    Figure imgb0556
    Figure imgb0557
    Figure imgb0558
  • The LC media preferably comprise 0 to 10% by weight, in particular 1 ppm to 5% by weight, particularly preferably 1 ppm to 1% by weight, of stabilisers. The LC media preferably comprise one or more stabilisers selected from the group consisting of compounds from Table C. Table D
    Table D shows illustrative compounds which can be used in the LC media in accordance with the present invention, preferably as reactive mesogenic compounds.
    Figure imgb0559
    RM-1
    Figure imgb0560
    RM-2
    Figure imgb0561
    RM-3
    Figure imgb0562
    RM-4
    Figure imgb0563
    RM-5
    Figure imgb0564
    RM-6
    Figure imgb0565
    RM-7
    Figure imgb0566
    RM-8
    Figure imgb0567
    RM-9
    Figure imgb0568
    RM-10
    Figure imgb0569
    RM-11
    Figure imgb0570
    RM-12
    Figure imgb0571
    RM-13
    Figure imgb0572
    RM-14
    Figure imgb0573
    RM-15
    Figure imgb0574
    RM-16
    Figure imgb0575
    RM-17
    Figure imgb0576
    RM-18
    Figure imgb0577
    RM-19
    Figure imgb0578
    RM-20
    Figure imgb0579
    RM-21
    Figure imgb0580
    RM-22
    Figure imgb0581
    RM-23
    Figure imgb0582
    RM-24
    Figure imgb0583
    RM-25
    Figure imgb0584
    RM-26
    Figure imgb0585
    RM-27
    Figure imgb0586
    RM-28
    Figure imgb0587
    RM-29
    Figure imgb0588
    RM-30
    Figure imgb0589
    RM-31
    Figure imgb0590
    RM-32
    Figure imgb0591
    RM-33
    Figure imgb0592
    RM-34
    Figure imgb0593
    RM-35
    Figure imgb0594
    RM-36
    Figure imgb0595
    RM-37
    Figure imgb0596
    RM-38
    Figure imgb0597
    RM-39
    Figure imgb0598
    RM-40
    Figure imgb0599
    RM-41
    Figure imgb0600
    RM-42
    Figure imgb0601
    RM-43
    Figure imgb0602
    RM-44
    Figure imgb0603
    RM-45
    Figure imgb0604
    RM-46
    Figure imgb0605
    RM-47
    Figure imgb0606
    RM-48
    Figure imgb0607
    RM-49
    Figure imgb0608
    RM-50
    Figure imgb0609
    RM-51
    Figure imgb0610
    RM-52
    Figure imgb0611
    RM-53
    Figure imgb0612
    RM-54
    Figure imgb0613
    RM-55
    Figure imgb0614
    RM-56
    Figure imgb0615
    RM-57
    Figure imgb0616
    RM-58
    Figure imgb0617
    RM-59
    Figure imgb0618
    RM-60
    Figure imgb0619
    RM-61
    Figure imgb0620
    RM-62
    Figure imgb0621
    RM-63
    Figure imgb0622
    RM-64
    Figure imgb0623
    RM-65
    Figure imgb0624
    RM-66
    Figure imgb0625
    RM-67
    Figure imgb0626
    RM-68
    Figure imgb0627
    RM-69
    Figure imgb0628
    RM-70
    Figure imgb0629
    RM-71
  • In a preferred embodiment of the present invention, the mesogenic media comprise one or more compounds selected from the group of the compounds from Table D.
  • In addition, the following abbreviations and symbols are used:
  • V0
    threshold voltage, capacitive [V] at 20°C,
    ne
    extraordinary refractive index at 20°C and 589 nm,
    no
    ordinary refractive index at 20°C and 589 nm,
    Δn
    optical anisotropy at 20°C and 589 nm,
    ε
    dielectric permittivity perpendicular to the director at 20°C and 1 kHz,
    ε||
    dielectric permittivity parallel to the director at 20°C and 1 kHz,
    Δε
    dielectric anisotropy at 20°C and 1 kHz,
    cl.p., T(N,I)
    clearing point [°C],
    γ1
    rotational viscosity at 20°C [mPa·s],
    K1
    elastic constant, "splay" deformation at 20°C [pN],
    K2
    elastic constant, "twist" deformation at 20°C [pN],
    K3
    elastic constant, "bend" deformation at 20°C [pN].
  • Unless explicitly noted otherwise, all concentrations in the present application are quoted in per cent by weight and relate to the corresponding mixture as a whole, comprising all solid or liquid-crystalline components, without solvents.
  • Unless explicitly noted otherwise, all temperature values indicated in the present application, such as, for example, for the melting point T(C,N), the transition from the smectic (S) to the nematic (N) phase T(S,N) and the clearing point T(N,I), are quoted in degrees Celsius (°C). M.p. denotes melting point, cl.p. = clearing point. Furthermore, C = crystalline state, N = nematic phase, S = smectic phase and I = isotropic phase. The data between these symbols represent the transition temperatures.
  • All physical properties are and have been determined in accordance with "Merck Liquid Crystals, Physical Properties of Liquid Crystals", Status Nov. 1997, Merck KGaA, Germany, and apply for a temperature of 20°C, and Δn is determined at 589 nm and Δε at 1 kHz, unless explicitly indicated otherwise in each case.
  • The term "threshold voltage" for the present invention relates to the capacitive threshold (V0), also known as the Freedericks threshold, unless explicitly indicated otherwise. In the examples, the optical threshold may also, as generally usual, be quoted for 10% relative contrast (V10).
  • Unless stated otherwise, the process of polymerising the polymerisable compounds in the PSA displays as described above and below is carried out at a temperature where the LC medium exhibits a liquid crystal phase, preferably a nematic phase, and most preferably is carried out at room temperature.
  • Unless stated otherwise, methods of preparing test cells and measuring their electrooptical and other properties are carried out by the methods as described hereinafter or in analogy thereto.
  • The display used for measurement of the capacitive threshold voltage consists of two plane-parallel glass outer plates at a separation of 25 µm, each of which has on the inside an electrode layer and an unrubbed polyimide alignment layer on top, which effect a homeotropic edge alignment of the liquid-crystal molecules.
  • The display or test cell used for measurement of the tilt angles consists of two plane-parallel glass outer plates at a separation of 4 µm, each of which has on the inside an electrode layer and a polyimide alignment layer on top, where the two polyimide layers are rubbed antiparallel to one another and effect a homeotropic edge alignment of the liquid-crystal molecules.
  • The polymerisable compounds are polymerised in the display or test cell by irradiation with UVA light of defined intensity for a prespecified time, with a voltage simultaneously being applied to the display (usually 10 V to 30 V alternating current, 1 kHz). In the examples, unless indicated otherwise, a metal halide lamp and an intensity of 100 mW/cm2 is used for polymerisation. The intensity is measured using a standard UVA meter (Hoenle UV-meter high end with UVA sensor).
  • The tilt angle is determined by crystal rotation experiment (Autronic-Melchers TBA-105). A low value (i.e. a large deviation from the 90° angle) corresponds to a large tilt here.
  • The VHR value is measured as follows: 0.3% of a polymerisable monomeric compound is added to the LC host mixture, and the resultant mixture is introduced into VA-VHR test cells which comprise an unrubbed VA-polyimide alignment layer. The LC-layer thickness d is approx. 6 µm, unless stated othewise. The VHR value is determined after 5 min at 100°C before and after UV exposure at 1 V, 60 Hz, 64 µs pulse (measuring instrument: Autronic-Melchers VHRM-105).
  • Example 1
  • Polymerisable mesogenic compound (RM) (1) is prepared as follows.
    Figure imgb0630
  • 1.1 2-(4'-Hydroxy-biphenyl-4-yloxymethyl)-propane-1,3-diol
  • To a solution of biphenyl-4,4'-diol (7.02 g, 37.7 mmol), 2-hydroxylpropane-1,3-diol (4.00 g, 37.7 mmol) and triphenylphosphine (11.22 g, 42.8 mmol) in THF (100 ml) is added diisopropylazodicarboxylate (8.72 ml, 44.4 mmol) dropwise at room temperature. The resulted suspension is stirred at room temperature for 2 hs. The solvent is then removed in vacuo. The oily residue is purified by silica gel chromatography with dichloromethane/methyl-t-butylether as eluent. The obtained crude product is recrystallized with acetonitrile to provide 2-(4'-hydroxy-biphenyl-4-yloxymethyl)-propane-1,3-diol as white solid (1.0 g).
  • 1.2 2-Methyl-acrylic acid 4'-[3-(2-methyl-acryloyloxy)-2-(2-methyl-acryloy )oxymethyl)-propoxy]-biphenyl-4-yl ester
  • Methacrylic acid (1.79 g, 20.8 mmol) and 4-(dimethylamino)pyridine (0.045 g, 0.36 mmol) is added to a suspension of 2-(4'-hydroxy-biphenyl-4-yloxymethyl)-propane-1,3-diol (1.0 g, 3.6 mmol) in dichloromethane (40 ml). The reaction mixture is treated dropwise at 0 °C with a solution of N-(3-dimethylaminopropyl)-N'-ethylcarbodiimide (3.23 g, 20.8 mmol) in dichloromethane (10 ml) and stirred for 20 h at room temperature. After removing solvent in vacuo, the oily residue is purified by silica gel chromatography with dichloromethane. The obtained product is recrystallized from acetonitrile to afford white crystals of 2-methyl-acrylic acid 4'-[3-(2-methyl-acryloyloxy)-2-(2-methyl-acryloyloxymethyl)-propoxy]-biphenyl-4-yl ester (0.38 g, m.p. 104 °C).
  • 1H-NMR (DMSO-d6, 500 MHz): δ (ppm) = 7.66 (d, J = 8.5 Hz, 2 H, Ar-H), 7.61 (d, J = 8.5 Hz, 2 H, Ar-H), 7.22 (d, J = 8.5 Hz, 2 H, Ar-H), 7.05 (d, J = 8.5 Hz, 2 H, Ar-H), 6.330 (m, 1 H, Holefin), 6.07 (m, 2 H, Holefin), 5.91 (m, 1 H, Holefin), 5.69 (m, 2 H, Holefin), 4.31 (d, J = 6 Hz, 4 H, OCH2), 4.17 (d, J = 6 Hz, 2 H, OCH2), 2.63 (m, 1 H, OCH2 CH), 2.02 (br. s, 3 H, CH3), 1.89 (m, 6H, 2 x CH3).
  • Example 2
  • Polymerisable mesogenic compound (RM) (2) is prepared as follows.
    Figure imgb0631
  • 2.1 4'-(2-Benzyloxy-1-benzyloxymethyl-ethoxy)-biphenyl-4-ol
  • To a solution of 4'-benzoyloxy-biphenyl-4-ol (5.00 g, 18.1 mmol), 1,3-bis-benzyloxy-propan-2-ol (4.93 g, 18.1 mmol), and triphenylphosphine (5.39 g, 20.5 mmol) in THF (50 ml) is added diisopropylazodicarboxylate (4.19 ml, 21.3 mmol) dropwise at room temperature. The resulted suspension is stirred at room temperature overnight. The solvent is then removed in vacuo. The oily residue is purified by silica gel chromatography with toluene as eluent. The obtained crude product is recrystallized with heptanes/ethylacetate solvent mixture to provide 4'-(2-benzyloxy-1-benzyloxymethyl-ethoxy)-biphenyl-4-ol as white solid (5.2 g).
  • 2.2 2-(4'-hydroxy-biphenyl-4-yloxy)-propane-1,3-diol
  • A solution of 4'-(2-benzyloxy-1-benzyloxymethyl-ethoxy)-biphenyl-4-ol (5.2 g, 9.8 mmol) in tetrahydrofuran (50 ml) is treated with palladium (5%) on activated charcoal (1.0 g) and submitted to hydrogenation for 22 hs. The catalyst is then filtered off, and the remaining solution is concentrated in vacuo. The residue is recrystallized from acetonitrile to give white crystals of 2-(4'-hydroxy-biphenyl-4-yloxy)-propane-1,3-diol (2.0 g).
  • 2.3 2-Methyl-acrylic acid 4'[2-(2-methyl-acryloyloxy)-1-(2-methyl-acryloy loxymethyl)-ethoxy]-biphenyl-4-yl ester
  • Methacrylic acid (3.78 g, 43.8 mmol) and 4-(dimethylamino)pyridine (0.094 g, 0.77 mmol) is added to a suspension of 2-(4'-hydroxy-biphenyl-4-yloxy)-propane-1,3-diol (2.0 g, 7.7 mmol) in dichloromethane (60 ml). The reaction mixture is treated dropwise at 0 °C with a solution of N-(3-dimethylaminopropyl)-N'-ethylcarbodiimide (6.80 g, 43.8 mmol) in dichloromethane (20 ml) and stirred for 20 h at room temperature. After removing solvent in vacuo, the oily residue is purified by silica gel chromatography with heptanes/ethylacetate as eluent. The obtained product is recrystallized from ethanol to afford white crystals of 2-methyl-acrylic acid 4'-[3-(2-methyl-acryloyloxy)-2-(2-methyl-acryloyloxymethyl)-propoxy]-biphenyl-4-yl ester (0.60 g, m.p. 50 °C).
  • 1H-NMR (DMSO-d6, 500 MHz): δ (ppm) = 7.66 (d, J = 8.5 Hz, 2 H, Ar-H), 7.61 (d, J = 8.5 Hz, 2 H, Ar-H), 7.23 (d, J = 8.5 Hz, 2 H, Ar-H), 7.13 (d, J = 8.5 Hz, 2 H, Ar-H), 6.30 (m, 1 H, Holefin), 6.00 (m, 2 H, Holefin), 5.91 (m, 1 H, Holefin), 5.68 (m, 2 H, Holefin), 5.00 (m, 1 H, OCH), 4.42 (m, 4 H, 2 x OCH2), 2.02 (br. s, 3 H, CH3), 1.86 (m, 6H, 2 x CH3).
  • Example 3
  • Polymerisable mesogenic compound (RM) (3) is prepared as follows.
    Figure imgb0632
  • 3.1 4-(2,2-Diethoxy-ethoxy)-biphenyl-4-ol
  • Sodium hydride (60% suspension in paraffin oil, 5.08 g, 127.0 mmol) is added in several portions to a solution of biphenyl-4,4'-diol (21.5 g, 115.5 mmol) in dry DMF (270 ml) at 10°C. The resulted suspension is stirred at room temperature for one hour, and then heated to 60°C. The solution of 2-bromo-1,1-diethoxy-ethane (26.2 g, 132.8 mmol) in 30 ml dry DMF is added dropwise at 60°C. The reaction mixture is then heated to 95°C and stirred for 4 hours. After cooling to room temperature, the reaction mixture is added into 600 ml water, and extracted with 2 x 150 ml ethylacetate. The organic phase is combined. After removing solvent in vacuo, the crude product is purified by silica gel chromatography with toluene/acetate 4:1 as eluent to provide 4'-(2,2-diethoxy-ethoxy)-biphenyl-4-ol as white solid (13.5 g).
  • 3.2 2-Methyl-acrylic acid 4'-(2,2-diethoxy-ethoxy)-biphenyl-4-yl ester
  • Methacrylic acid (6.02 g, 69.8 mmol) and 4-(dimethylamino)pyridine (0.36 g, 2.91 mmol) is added to a suspension of 4'-(2,2-diethoxy-ethoxy)-biphenyl-4-ol (17.7 g, 58.2 mmol) in dichloromethane (130 ml). The reaction mixture is treated dropwise at 0 °C with a solution of N-(3-dimethylaminopropyl)-N'-ethylcarbodiimide (11.3 g, 72.8 mmol) in dichloromethane (20 ml) and stirred overnight at room temperature. After removing solvent in vacuo, the oily residue is purified by silica gel chromatography with dichloromethane as eluent. The obtained product is recrystallized from heptanes/ethanol solvent mixture to afford white crystals of 2-methyl-acrylic acid 4'-(2,2-diethoxy-ethoxy)-biphenyl-4-yl ester (19.4 g).
  • 3.3 2-Methyl-acrylic acid 4'-(2-oxo-ethoxy)-biphenyl-4-yl ester
  • To a solution of 2-methyl-acrylic acid 4'-(2,2-diethoxy-ethoxy)-biphenyl-4-yl ester (9.0 g, 24.3 mmol) in 60 ml aceton/120 ml THF solvent mixture is added 180 ml 2 M HCl dropwise at 5°C. The reaction mixture is stirred at room temperature overnight. After removing organic solvent in vacuo, the resulted suspension is cooled to 5°C. The precipitated crude product is recrystallized from acetonitrile to provide 2-methyl-acrylic acid 4'-(2-oxo-ethoxy)-biphenyl-4-yl ester as white crystals (7.1 g).
  • 3.4 2-Methyl-acrylic acid 4'-[2,2-bis-(2-methyl-acryloyloxy)-ethoxy]-biphe nyl-4-yl ester
  • To a suspension of methacrylic acid anhydride (3.12 g, 20.2 mmol) in 20 ml dichloromethane is added dropwise 0.1 ml conc. HCl at 0°C. The solution of of 2-methyl-acrylic acid 4'-(2-oxo-ethoxy)-biphenyl-4-yl ester (3.0 g, 10.1 mmol) in 20 ml dichloromethane is then added dropwise. The reaction mixture is stirred at room temperature 48 hours. After removing solvent in vacuo, the oily residue is purified by silica gel chromatography with heptanes/ethylacetate as eluent. The obtained product is recrystallized from heptane to afford white crystals of 2-methyl-acrylic acid 4'-[2,2-bis-(2-methyl-acryloyloxy)-ethoxy]-biphenyl-4-yl ester (0.6 g, m.p. 85°C).
  • 1H-NMR (CDCl3, 500 MHz): δ (ppm) = 7.54 (d, J = 8.5 Hz, 2 H, Ar-H), 7.50 (d, J = 8.5 Hz, 2 H, Ar-H), 7.24 (tr., J = 5 Hz, 1 H, OCHO), 7.16 (d, J = 8.5 Hz, 2 H, Ar-H), 7.02 (d, J = 8.5 Hz, 2 H, Ar-H), 6.37 (m, 1 H, Holefin), 6.20 (m, 2 H, Holefin), 5.77 (m, 1 H, Holefin), 5.67 (m, 2 H, Holefin), 4.31 (d, J = 5 Hz, 2 H, OCH2), 2.08 (br. s, 3 H, CH3), 1.97 (m, 6H, 2 x CH3).
  • Example 4
  • Polymerisable mesogenic compound (RM) 4 is prepared as follows.
    Figure imgb0633
    Figure imgb0634
  • 4a: To a solution of 4-benzyloxyl-phenylboronic acid (20.42 g, 89.5 mol) and 3-Benzyloxy-propionic acid 4-bromo-phenyl ester (29.00 g; 86.5 mmo) in 600 ml 1,4-dioxane was added 65.7 g (447.0 mmol) potassium phosphate. The resulted suspension is degassed carefully with argon. Tris(dibenzylidene acetone)dipalladium(0) (1.64 g; 1.8 mmol) and 2-dicyclohexylphosphine-2',6'-dimethoxylbiphenyl (SPhos) (3.03 g, 7.2 mmol) is then added. The reaction mixture is heated to reflux and stirred overnight. After cooling to room temperature 800 ml dist. water and 400 ml ethylacetate are added, and the mixture is neutralized carefully with 6 M HCl acid under cooling to pH∼4. The aqueous phase is extracted with ethylacetate. The organic phase is combined and washed with sat. aq. NaCl solution, dried over sodium sulfate. After removing solvent in vacuo, the solid residue is purified by recrystallization with ethanol to provide 4a as white solid (16 g).
  • 4b: To a solution of 4a (5.5 g, 12.0 mmol), 1,3-bis-benzyloxy-propan-2-ol (3.27 g, 12.0 mmol), and triphenylphosphine (3.57 g, 13.6 mmol) in 40 ml THF is added diisopropylazodicarboxylate (2.78 ml, 14.1 mmol) dropwise at room temperature. The resulted suspension is stirred at room temperature overnight. The solvent is then removed in vacuo. The oily residue is purified by silica gel chromatography with heptane/ethylacetate as eluent to provide 4b as colorless oil (6.5 g).
  • 4c: A suspension of 4b (6.3 g, 9.0 mmol) in tetrahydrofuran (70 ml) is treated with palladium (5%) on activated charcoal (2.0 g) and submitted to hydrogenation for 18 hs. The catalyst is then filtered off. After removing solvent in vacuo, the solid residue is recrystallized with dichloromethane to provide 4c as white solid (2.5 g).
  • 4: Methacrylic acid (2.75 g, 32.0 mmol) and 4-(dimethylamino)pyridine (0.087 g, 32.0 mmol) is added to a suspension of 4c (2.5 g, 7.1 mmol) in 100 ml dichloromethane. The reaction mixture is treated dropwise at 0 °C with a solution of N-(3-dimethylaminopropyl)-N'-ethylcarbodiimide (4.96 g, 32.0 mmol) in 25 ml dichloromethane and stirred for 20 h at room temperature. After removing solvent in vacuo, the oily residue is purified by silica gel chromatography with heptane/ethyl acetate as eluent. The obtained product is recrystallized from ethanol to afford white crystals of 4 (2.5 g, m.p. 79 °C).
  • Example 5
  • Polymerisable mesogenic compound (RM) 5 is prepared as follows.
    Figure imgb0635
  • 5a: To a solution of 4-benzyloxyl-phenylboronic acid (22.67 g, 99.4 mmol) and 5-bromo-2-chloropyridine (19.13 g, 99.4 mmol) in 200 ml toluene was added 100 ml dist. water and 100 ml ethanol. Sodium carbonate (35.00 g, 330.0 mmol) is added. The resulted suspension is degassed carefully with argon. Tetrakis(triphenylphosphine)palladium(0) (1.10 g, 0.95 mmol) is then added. The reaction mixture is heated to reflux and stirred for 4hs. After cooling to room temperature, the reaction mixture is neutralized carefully with 6 M HCl acid under cooling to pH~7. The aqueous phase is extracted with ethyl acetate. The organic phase is combined and washed with sat. aq. NaCl solution, dried over sodium sulfate. After removing solvent in vacuo, the solid residue is purified by recrystallized from ethyl acetate to provide 5a as white solid (18.0 g).
  • 5b: To a suspension of sodium hydrid (2.22 g, 55.4 mmol, 60% suspension in paraffin oil) in 40 ml dry THF was added dropwise the solution of 1,3-bis-benzyloxy-propan-2-ol (14.01 g, 51.4 mmol) under cooling. The reaction mixture was allowed to warm up slowly to RT and stirred further for 30 min. The solution of 5a (13.7 g, 46.3 mmol) in 40 ml dry THF is then added at RT. The reaction mixture is stirred at RT for 1 h, then poured into 300 ml ice-water mixture. The aqueous phase is extracted with ethyl acetate. The organic phase is combined and washed with sat. aq. NaCl solution, dried over sodium sulfate. After removing solvent in vacuo, the oily residue is purified by silica gel chromatography with heptane/ethylacetate as eluent to provide 5b as colorless oil (6.5 g).
  • 5c: A solution of 5b (6.5 g, 12.3 mmol) and 0.4 ml conc. HCl acid in 150 ml methanol/20 ml THF solvent mixture is treated with palladium (5%) on activated charcoal (6.5 g) and submitted to hydrogenation under 2 bar at 30°C for 4hs. The catalyst is then filtered off, and the remaining solution is concentrated in vacuo. The oily residue is purified by silica gel chromatography with DCM/methanol solvent mixture as eluent to provide 5c as yellowish oil (2.4 g).
  • 5: Methacrylic acid (1.13 g, 13.0 mmol) and 4-(dimethylamino)pyridine (0.028 g, 0.23 mmol) is added to a suspension of 5c (0.6 g, 2.3 mmol) in 50 ml dichloromethane. The reaction mixture is treated dropwise at 0 °C with a solution of N-(3-dimethylaminopropyl)-N'-ethylcarbodiimide (2.03 g, 13.1 mmol) in 10 ml dichloromethane and stirred for 20 h at room temperature. After removing solvent in vacuo, the oily residue is purified by silica gel chromatography with heptanes/ethylacetate as eluent. The obtained product is recrystallized from ethanol to afford 5 as white crystals (0.15 g, m.p. 68 °C).
  • Mixture Examples A) Host Mixtures Example 1
  • The nematic LC mixture N1 is formulated as follows.
    CCH-501 9.00% cl.p. + 70.0 °C
    CCH-35 14.00% Δn 0.0825
    PCH-53 8.00% Δε -3.5
    PCH-304FF 14.00% εll 3,5
    PCH-504 13.00% K3/K1 1.00
    CCP-302FF 8.00% Y1 141 mPa s
    CCP-503FF 8.00% V0 2.6 V
    CCP-21 FF 9.00%
    CCP-31 FF 9.00%
    CPY-2-O2 8.00%
  • Example 2
  • The nematic LC mixture N2 is formulated as follows.
    CY-3-O2 18.00% cl.p. + 74.5 °C
    CPY-2-O2 10.00% Δn 0.1021
    CPY-3-O2 10.00% Δε -3.1
    CCY-3-O2 9.00% ε|| 3.5
    CCY-4-O2 4.00% K3/K1 1.16
    CC-3-V 40.00% γ1 86 mPa s
    PYP-2-3 9.00% V0 2.29 V
  • Example 3
  • The nematic LC mixture N3 is formulated as follows.
    CC-3-V 20.00% cl.p. + 74.5 °C
    CC-3-V1 10.00% Δn 0.1084
    CCH-34 8.00% Δε -3.2
    CCH-35 4.00% ε|| 3.5
    CCY-3-O1 5.50% K3/K1 1.04
    CCY-3-O2 12.00% γ1 94 mPa s
    CPY-2-O2 2.00% V0 2.33 V
    CPY-3-O2 12.00%
    PY-3-O2 15.00%
    PY-4-O2 8.50%
    PYP-2-3 3.00%
  • Example 4
  • The nematic LC mixture N4 is formulated as follows.
    CC-3-V 27.50% cl.p. + 74.8 °C
    CC-3-V1 7.50% Δn 0.0986
    CCH-23 3.00% Δε -3.4
    CCP-3-1 3.75% ε||
    CCY-3-02 12.50% K3/K1 1.16
    CPY-2-02 11.50% γ1 95 mPa s
    CPY-3-02 10.50% V0 2.26 V
    CY-3-02 15.50%
    PY-3-02 3.00%
    PY-4-02 5.25%
  • Example 5
  • The nematic LC mixture N5 is formulated as follows.
    CC-3-V 41.50% cl.p. + 74.6 °C
    CCP-3-1 2.00% Δn 0.0983
    CCY-3-01 5.25% Δε -3.1
    CCY-3-02 12.50% ε||
    CPY-2-02 12.25% K3/K1 1.11
    CPY-3-02 7.50% γ1 85 mPa s
    CY-3-02 5.50% V0 2.29 V
    PY-3-02 3.50%
    PY-4-02 10.00%
  • Example 6
  • The nematic LC mixture N6 is formulated as follows.
    CC-3-V 27.50% cl.p. + 75.6 °C
    CC-3-V1 8.00% Δn 0.0989
    CCH-23 2.50% Δε -3.4
    CCP-3-1 3.00% εll
    CCY-3-02 12.00% K3/K1 1.16
    CCY-4-02 2.00% γ1 94 mPa s
    CPY-2-02 10.00% V0 2.28 V
    CPY-3-02 10.50%
    CY-3-02 15.50%
    CY-3-04 1.00%
    PY-3-02 7.00%
    PYP-2-3 1.00%
  • Example 7
  • The nematic LC mixture N7 is formulated as follows.
    CC-3-V 41.50% cl.p. + 74.5 °C
    CCY-3-01 2.50% Δn 0.0984
    CCY-3-02 11.50% Δε -3.3
    CCY-3-03 5.00% ε||
    CPY-2-02 5.00% K3/K1 1.15
    CPY-3-02 12.00% γ1 89 mPa s
    CY-3-02 9.50% V0 2.29 V
    PY-3-02 7.00%
    PY-4-02 3.00%
    PYP-2-3 3.00%
  • Example 8
  • The nematic LC mixture N8 is formulated as follows.
    CC-3-V 28.00% cl.p. + 74.9 °C
    CC-3-V1 10.00% Δn 0.1026
    CCH-35 1.00% Δε -3.0
    CCP-3-1 6.00% ε||
    CCY-3-02 12.00% K3/K1 1.19
    CCY-4-02 3.00% γ1 90 mPa s
    CPY-3-02 12.00% V0 2.47 V
    CY-3-02 10.00%
    PY-3-02 15.00%
    PYP-2-3 3.00%
  • Example 9
  • The nematic LC mixture N9 is formulated as follows.
    CC-3-V 15.00% cl.p. + 74.4 °C
    CC-3-V1 9.00% Δn 0.1086
    CCH-23 8.00% Δε -3.2
    CCH-34 7.50% ε||
    CCY-3-02 10.00% K3/K1 1.10
    CCY-5-02 8.00% γ1 102 mPa s
    CPY-2-02 3.00% V0 2.33 V
    CPY-3-02 8.50%
    CY-3-02 7.00%
    PY-3-02 16.00%
    PYP-2-3 8.00%
  • Example 10
  • The nematic LC mixture N10 is formulated as follows.
    CC-3-V 42.00% cl.p. + 73.5 °C
    CCY-3-01 5.00% Δn 0.1007
    CCY-3-02 10.00% Δε -3.5
    CCY-4-02 2.50% ε||
    CPY-2-02 10.00% K3/K1 1.13
    CPY-3-02 10.00% γ1 85 mPa s
    CY-3-02 6.50% V0 2.15V
    PY-3-02 11.00%
    IS-18566 3.00%
  • Example 11
  • The nematic LC mixture N11 is formulated as follows.
    CC-3-V 45.50% cl.p. + 73.0 °C
    CCY-3-01 3.00% Δn 0.1011
    CCY-3-02 11.00% Δε -3.5
    CCY-4-02 3.50% ε||
    CPY-2-02 7.50% K3/K1 1.09
    CPY-3-02 10.00% γ1 79 mPa s
    CY-3-02 2.00% V0 2.15V
    PY-3-02 11.50%
    IS-18566 6.00%
  • Example 12
  • The nematic LC mixture N12 is formulated as follows.
    CC-3-V 34.50% cl.p. + 75.0 °C
    CC-3-V1 8.00% Δn 0.1075
    CCY-3-01 7.00% Δε -3.1
    CCY-3-02 11.50% ε||
    CCY-4-02 3.50% K3/K1 1.12
    CPY-3-02 11.50% γ1 84 mPa s
    PY-3-02 13.00% V0 2.41 V
    PP-1-2V1 6.00%
    IS-18566 5.00%
  • Example 13
  • The nematic LC mixture N13 is formulated as follows.
    CY-3-02 16.50% cl.p. + 74.0 °C
    CCY-4-02 10.50% Δn 0.1069
    CCY-5-02 6.00% Δε -3.2
    CPY-2-02 9.00% ε||
    CPY-3-02 9.00% K3/K1 1.06
    CCH-34 9.00% γ1 117 mPa s
    CCH-31 20.00% V0 2.18 V
    CCP-3-1 2.00%
    PYP-2-3 6.50%
    PYP-2-4 6.50%
    PCH-301 5.00%
  • Example 14
  • The nematic LC mixture N14 is formulated as follows.
    CY-3-02 12.00% cl.p. + 74.0 °C
    CY-3-04 10.00% Δn 0.1064
    CCY-3-02 6.00% Δε -3.2
    CCY-4-02 6.50% ε||
    CCH-34 9.00% K3/K1 0.99
    CCH-35 5.00% γ1 119 mPa s
    CCP-3-1 14.50% V0 2.19 V
    CCP-3-3 11.00%
    PYP-2-3 9.00%
    PYP-2-4 8.00%
    Y-40-04 9.00%
  • Example 15
  • The nematic LC mixture N15 is formulated as follows.
    CC-3-V 28.50% cl.p. +74.5 °C
    CCP-31 12.50% Δn 0.1077
    CCOY-2-02 19.00% Δε -3.2
    CCOY-3-02 11.50% εll 3.6
    PY-3-02 13.50% K3/K1 0.91
    PP-1-3 10.00% γ1 99
    PYP-2-3 5.00% V0 2.34 V
  • B) Polymerisable Mixtures Examples P1.1-P3.15
  • Polymerisable mixtures P1.1, P1.2, P1.3, P1.4, P1.5, P1.6, P1.7, P1.8, P1.9, P1.10, P1.11, P1.12, P1.13, P1.14 and P1.15 according to the invention are prepared by adding RM 1 of Example 1 to each of LC mixtures N1-N15, respectively, at a concentration of 0.3% by weight.
  • Polymerisable mixtures P2.1, P2.2, P2.3, P2.4, P2.5, P2.6, P2.7, P2.8, P2.9, P2.10, P2.11, P2.12, P2.13, P2.14 and P2.15 according to the invention are prepared by adding RM 2 of Example 2 to each of LC mixtures N1-N15, respectively, at a concentration of 0.3% by weight.
  • Polymerisable mixtures P3.1, P3.2, P3.3, P3.4, P3.5, P3.6, P3.7, P3.8, P3.9, P3.10, P3.11, P3.12, P3.13, P3.14 and P3.15 according to the invention are prepared by adding RM 3 of Example 3 to each of LC mixtures N1-N15, respectively, at a concentration of 0.3% by weight.
  • Polymerisable mixtures P4.1, P4.2 and P4.3 according to the invention are prepared by adding RM 4 of Example 4 to each of LC mixtures N1-N3, respectively, at a concentration of 0.3% by weight.
  • Polymerisable mixtures P5.1, P5.2 and P5.3 according to the invention are prepared by adding RM 5 of Example 5 to each of LC mixtures N1-N3, respectively, at a concentration of 0.3% by weight.
  • The mixture compositions are shown in Table 1 below. Table 1: Polymerisable Mixtures according to the invention
    No. P1.1 P1.2 P1.3 P1.4 P1.5 P1.6 P1.7 P1.8
    RM 1 1 1 1 1 1 1 1
    Host N1 N2 N3 N4 N5 N6 N7 N8
    No. P1.9 P1.10 P1.11 P1.12 P1.13 P1.14 P1.15
    RM 1 1 1 1 1 1 1
    Host N9 N10 N11 N12 N13 N14 N15
    No. P2.1 P2.2 P2.3 P2.4 P2.5 P2.6 P2.7 P2.8
    RM 2 2 2 2 2 2 2 2
    Host N1 N2 N3 N4 N5 N6 N7 N8
    No. P2.9 P2.10 P2.11 P2.12 P2.13 P2.14 P2.15
    RM 2 2 2 2 2 2 2
    Host N9 N10 N11 N12 N13 N14 N15
    No. P3.1 P3.2 P3.3 P3.4 P3.5 P3.6 P3.7 P3.8
    RM 3 3 3 3 3 3 3 3
    Host N1 N2 N3 N4 N5 N6 N7 N8
    No. P3.9 P3.10 P3.11 P3.12 P3.13 P3.14 P3.15
    RM 3 3 3 3 3 3 3
    Host N9 N10 N11 N12 N13 N14 N15
    No. P4.1 P4.2 P4.3 P5.1 P5.2 P5.3
    RM 4 4 4 5 5 5
    Host N1 N2 N3 N1 N2 N3
  • Comparison Examples C1.1-C2.3
  • For comparison purposes, polymerisable mixtures C1.1, C1.2 and C1.3 are prepared by adding RM C1 of prior art to each of LC mixtures N1, N2 and N3, respectively, at a concentration of 0.3% by weight, and polymerisable mixtures C2.1, C2.2 and C2.3 are prepared by adding RM C2 of prior art to each of LC mixtures N1, N2 and N3, respectively, at a concentration of 0.3% by weight.
  • The mixture compositions are shown in Table 2 below. Table 2: Polymerisable Comparison Mixtures
    No. C1.1 C1.2 C1.3 C2.1 C2.2 C2.3
    RM C1 C1 C1 C2 C2 C2
    Host N1 N2 N3 N1 N2 N3
    Figure imgb0636
    Figure imgb0637
  • Use Examples
  • The polymerisable mixtures according to the invention and the polymerisable comparison mixtures are each inserted into a VA e/o test cell, respectively. The test cells comprise a VA-polyimide alignment layer (JALS-2096-R1) which is rubbed antiparallel (for the test cells with host mixture N3 the polyimide AL64101was used). The LC-layer thickness d is approx. 4 µm. Each test cell is irradiated with UV light having an intensity of 100 mW/cm2 for the time indicated with application of a voltage of 24 Vrms (alternating current), which causes polymerisation of the RM.
  • The VHR values of the polymerisable mixtures before and after UV exposure are measured as described above. "Suntest" means a second irradiation step with lower UV intensity but longer exposure time than the first step.
  • The residual content of unpolymerised RM (in % by weight) in the test cells is measured by HPLC after various exposure times. For this purpose each mixture is polymerised in the test cell under the conditions stated above. The mixture is then rinsed out of the test cell using MEK (methyl ethyl ketone) and measured.
  • The tilt angle is measured before and after UV irradiation by a crystal rotation experiment (Autronic-Melchers TBA-105).
  • The results are shown below. Table 3: VHR value
    Mixture C1.1 (N1 + RM C1) C2.1 (N1 + RM C2) P1.1 (N1 + RM 1) P2.1 (N1 + RM 2) P3.1 (N1 + RM 3)
    VHR/%
    0 min UV 98.2 98.6 98.5 98.3 98.8
    2h Suntest 97.6 98.8 98.5 98.6 98.7
    Mixture C1.1 (N1 + RMC1) C2.1 (N1 + RM C2) P4.1 (N1 + RM 4) P5.1 (N1 + RM 5)
    VHR/%
    0 min UV 98.2 98.6 99.0 98.8
    2h Suntest 97.6 98.8 99.1 99.1
    Mixture C1.2 (N2 + RM C1) C2.2 (N2 + RM C2) P1.2 (N2 + RM 1) P2.2 (N2 + RM 2) P3.2 (N2 + RM 3)
    VHR / %
    0 min UV 98.3 97.2 97.6 97.7 98.2
    2h Suntest 85.6 94.3 91.6 89.2 94.1
    10 min UV 74.8 94.1 89.5 88.4 93.9
    Mixture C1.2 (N2 + RM C1) C2.2 (N2 + RM C2) P4.2 (N2 + RM 4) P5.2 (N2 + RM 5)
    VHR / %
    0 min UV 98.3 97.2 98.6 97.7
    2h Suntest 85.6 94.3 95.9 93.9
    10 min UV 74.8 94.1 94.3 84.3
    Mixture C1.3 (N3 + RM C1) C2.3 (N3 + RM C2) P3.3 (N3 + RM 3)
    VHR / %
    0 min UV 98.3 97.6 97.8
    2 min UV 94.8 95.4 94.9
    15 min UV 93.6 96.1 96.3
    2 min UV+ 2h suntest 95.5 96.2 95.9
  • In the host mixture N1 without an alkenyl compound all RMs show high VHR values after suntest. In the host mixture N2 containing an alkenyl compound (CC-3-V) the RMs 1-5 according to the present invention show higher VHR values after suntest compared to the RM C1. Even the VHR values for RM1 and RM2 are kept on a high level, RMs 3-5 have the highest VHR after the UV load and similar or higher values than RM C2 of prior art. In the host mixture N3 containing an alkenyl compound (CC-3-V), the trireactive RMs 3-5 and RM C2 show higher VHR values after suntest than direactive RM C1. Table 4: Residual RM content
    Mixture C1.1 (N1 + RM C1) C1.2 (N1 + RM C2) P1.1 (N1 + RM 1) P2.1 (N1 + RM 2) P3.1 (N1 + RM 3)
    Time / min Residual RM / %
    0 0.3 0.3 0.3 0.3 0.3
    2 0.264 0.296 0.242 0.242 0.275
    4 0.203 0.222 0.165 0.142 0.207
    6 0.173 0.197 0.136 0.097 0.162
    Mixture C1.1 (N1 + RM C1) C1.2 (N1 + RM C2) P4.1 (N1 + RM 4) P5.1 (N1 + RM 5)
    Time / min Residual RM / %
    0 0.3 0.3 0.3 0.3
    2 0.264 0.296 0.137 0.264
    4 0.203 0.222 0.033 0.157
    6 0.173 0.197 0.010 0.113
    Mixture C1.2 (N2 +RMC1) C2.2 (N2 + RM C2) P1.2 (N2 + RM 1) P2.2 (N2 + RM 2) P3.2 (N2 + RM 3)
    Time / min Residual RM / %
    0 0.3 0.3 0.3 0.3 0.3
    2 0.185 0.215 0.147 0.144 0.153
    6 0.067 0.110 0.061 0.055 0.055
    Mixture C1.2 (N2 + RM C1) C2.2 (N2 + RM C2) P4.2 (N2 + RM 4) P5.2 (N2 + RM 5)
    Time / min Residual RM / %
    0 0.3 0.3 0.3 0.3
    2 0.185 0.215 0.102 0.173
    6 0.067 0.110 0.022 0.062
    Mixture C1.3 (N3 + RM C1) C2.3 (N3 + RM C2) P3.3 (N3 + RM 3)
    Time / min Residual RM / %
    0 0.3 0.3 0.3
    0.5 0.256 0.273 0.269
    1 0.199 0.205 0.189
    2 0.142 0.131 0.105
    5 0.05 0.05 0.046
  • In all host mixtures N1, N2 and N3 the RMs 1-5 according to the present invention show faster polymerisation with a lower residual RM content, compared to the RMs C1 and C2 of prior art. Table 5: Pretilt Angle
    Mixture C1.1 (N1 + RM C1) C1.2 (N1 + RM C2) P1.1 (N1 + RM 1) P1.2 (N1 + RM 2) P1.3 (N1 + RM 3)
    UV-Time / sec Pretilt Angle / °
    0 89.6 88.1 88.6 88.6 88.6
    30 89.0 87.9 88.1 88.0 87.1
    60 88.2 85.8 85.3 85.9 84.6
    120 84.9 82.9 80.1 79.9 81.1
    Mixture C1.1 (N1 +RM C1) C1.2 (N1 + RM C2) P4.1 (N1 + RM 4) P5.1 (N1 + RM 5)
    UV-Time / sec Pretilt Angle / °
    0 89.6 88.1 89.3 88.3
    30 89.0 87.9 88.1 87.9
    60 88.2 85.8 86.5 84.6
    120 84.9 82.9 80.5 79.6
    Mixture C1.2 (N2 + RM C1) C2.2 (N2 + RM C2) P1.2 (N2 + RM 1) P2.2 (N2 + RM 2) P3.2 (N2 + RM 3)
    UV-Time / sec Pretilt Angle / °
    0 88.8 88.2 88.6 88.8 88.9
    120 77.2 77.6 77.3 76.3 77.7
    Mixture C1.2 (N2 + RM C1) C2.2 (N2 + RM C2) P4.2 (N2 + RM 4) P5.2 (N2 + RM 5)
    UV-Time / sec Pretilt Angle / °
    0 88.8 88.2 89.2 88.8
    120 77.2 77.6 78.4 76.7
    Mixture C1.3 (N3 + RM C1) C2.3 (N3 + RM C2) P3.3 (N3 + RM 3)
    UV-Time / sec Pretilt Angle / °
    0 89.1 89.1 89.0
    60 86.4 84.1 76.5
    120 78.0 79.0 70.8
    180 76.1 76.8 66.0
    300 73.5 74.3 66.1
  • The tilt angle measurements confirm the results of the residual RM content measurements. Thus, in all host mixtures N1, N2 and N3 the RMs 1-5 according to the present invention show faster generation of a higher tilt angle compared to the RMs C1 and C2 of prior art.
  • For the tilt stability investigation the tilt generation has been performed in a 2-step process (2 min UV light, 100 mW/cm2 + 2 h suntest). Then the testcells are subjected to a voltage of 10 VRMS (1 kHz) for a time of 7 days at 40°C. After a relaxation time of 10-20 min the tilt angle after stress was measured.
  • The pretilt angle values and the change of the pretilt angle after the stress for the individual samples are summarized in Table 6. Table 6: Tilt stability
    Mixture C1.1 (N1 +RM C1) P1.3 (N3 + RM 1) P2.3 (N3 + RM 2) P3.3 (N3 + RM 3)
    Pretilt Angle / °
    Before stress 83.6 84.4 84.2 84.7
    After stress 83.2 84.2 84.0 84.5
    Change after stress 0.4 0.2 0.2 0.2
    Mixture C1.3 (N3 + RM C1) P4.3 (N3 + RM 4)
    Pretilt Angle / °
    Before stress 84.7 83.8
    After stress 84.3 83.4
    Change after stress 0.4 0.4
  • The change of the pretilt after stress is smaller with the RMs 1-4 according to the invention, compared to the RM C1. Also RMs 1-4 according to the invention show a better tilt stability than RM C1.

Claims (20)

  1. A compound of formula I

            P1-Sp1-(A1-Z1)n-A2-Sp4-O-CH(Sp2-P2)(Sp3-P3)     I

    in which the individual radicals have the following meanings:
    P1, P2, P3 independently of each other denote a polymerisable group,
    Sp1-4 independently of each other denote a spacer group or a single bond,
    A1, A2 independently of each other, and on each occurrence identically or differently, denote an aromatic, heteroaromatic, alicyclic or heterocyclic group having 4 to 25 C atoms, which may also contain fused rings, and which is optionally mono-or polysubstituted by L,
    Z1 denotes, on each occurrence identically or differently, -O-, -S-, -CO-, -CO-O-, -O-CO-, -O-CO-O-, -OCH2-, -CH2O-, -SCH2-, -CH2S-, -CF2O-, -OCF2-, -CF2S-, -SCF2-, -(CH2)n-, -CF2CH2-, -CH2CF2-, -(CF2)n-, -CH=CH-, -CF=CF-, -CH=CF-, -CF=CH-, -C≡C-, -CH=CH-CO-O-, -O-CO-CH=CH-, -CH2-CH2-CO-O-, -O-CO-CH2-CH2-, -CR00R000-, or a single bond,
    L denotes P1-, P1-Sp1 F, Cl, Br, I, -CN, -NO2 , -NCO, -NCS, - OCN, -SCN, -C(=O)N(Rx)2, -C(=O)Y1, -C(=O)Rx, -N(Rx)2, optionally substituted silyl, optionally substituted aryl or heteroaryl having 5 to 20 ring atoms, or straight-chain or branched alkyl having 1 to 25, particularly preferably 1 to 10, C atoms, in which, in addition, one or more non-adjacent CH2 groups may each be replaced, independently of one another, by -C(R00)=C(R000)-, -C≡C-, -N(R00)-, -O-,-S-, -CO-, -CO-O-, -O-CO-, -O-CO-O- in such a way that O and/or S atoms are not linked directly to one another, and in which, in addition, one or more H atoms may be replaced by F, Cl, CN, P1- or P1-Sp1-,
    R00 and R000 each, independently of one another, denote H or alkyl having 1 to 12 C atoms,
    Y1 is halogen,
    Rx denotes P1-, P1-Sp1-, H, halogen, straight chain, branched or cyclic alkyl having 1 to 25 C atoms, wherein one or more non-adjacent CH2-groups are optionally replaced by -O-,-S-, -CO-, -CO-O-, -O-CO-, -O-CO-O- in such a manner that O-and/or S-atoms are not directly connected with each other, and wherein one or more H atoms are optionally replaced by F, Cl, P1- or P1-Sp1-, optionally substituted aryl, aryloxy, heteroaryl or heteroaryloxy having 5 to 20 ring atoms,
    n is 1, 2, 3 or 4.
  2. The compound of Claim 1, characterized in that A1, A2 each, independently of one another, denote 1,4-phenylene, naphthalene-1,4-diyl or naphthalene-2,6-diyl, where one or more CH groups in these groups are optionally replaced by N, cyclohexane-1,4-diyl, in which, in addition, one or more non-adjacent CH2 groups are optionally replaced by O and/or S, 1,4-cyclohexenylene, bicyclo[1.1.1]pentane-1,3-diyl, bicyclo[2.2.2]octane-1,4-diyl, spiro[3.3]heptane-2,6-diyl, piperidine-1,4-diyl, decahydronaphthalene-2,6-diyl, 1,2,3,4-tetrahydronaphthalene-2,6-diyl, indane-2,5-diyl, octahydro-4,7-methanoindane-2,5-diyl, anthracene-2,7-diyl, fluorene-2,7-diyl, phenanthrene-2,7-diyl or 9,10-dihydro-phenanthrene-2,7-diyl, where all these groups are unsubstituted or mono- or polysubstituted by L as defined in claim 1.
  3. The compound of Claim 1 or 2, characterized in that Sp1 is a single bond, Sp1 is -(CH2)p2- or -(CH2)p1-O-, in which p1 is 1, 2 or 3, Sp2 and Sp3 denote -(CH2)p2-, in which p2 is 1, 2 or 3, and Sp4 is -(CH2)p4-, in which p4 is 1, 2 or 3.
  4. The compound of any one of Claims 1 to 3, characterized in that P1, P2 and P3 independently of each other denote a vinyloxy, acrylate, methacrylate, fluoroacrylate, chloroacrylate, oxetane or epoxide group.
  5. The compound of any one of Claims 1 to 4, characterized in that it is selected from the group consisting of the following sub-formulae:
    Figure imgb0638
    Figure imgb0639
    Figure imgb0640
    Figure imgb0641
    Figure imgb0642
    Figure imgb0643
    Figure imgb0644
    wherein P1, P2, P3and L are as defined in claim 1 and r is 0, 1, 2, 3 or 4.
  6. A liquid crystal (LC) medium comprising one or more polymerisable compounds formula I as defined in any one of Claims 1 to 5.
  7. The LC medium of Claim 6, characterized in that it comprises
    - a polymerisable component A) comprising one or more polymerisable compounds of formula I as defined in any one or Claims 1 to 5, and
    - a liquid-crystalline LC component B) comprising one or more mesogenic or liquid-crystalline compounds.
  8. The LC medium of Claim 6 or 7, characterized in that it comprises one or more compounds of the formulae CY and/or PY:
    Figure imgb0645
    Figure imgb0646
    in which the individual radicals have the following meanings:
    a denotes 1 or 2,
    b denotes 0 or 1,
    Figure imgb0647
    denotes
    Figure imgb0648
    R1 and R2 each, independently of one another, denote alkyl having 1 to 12 C atoms, where, in addition, one or two non-adjacent CH2 groups may be replaced by -O-,-CH=CH-, -CO-, -O-CO- or-CO-O- in such a way that O atoms are not linked directly to one another,
    Zx denotes -CH=CH-, -CH2O-,-OCH2-, -CF2O-, -OCF2-, -O-, -CH2-, -CH2CH2- or a single bond, preferably a single bond,
    L1-4 each, independently of one another, denote F, Cl, OCF3, CF3, CH3, CH2F, CHF2.
  9. The LC medium of any one of Claims 7 to 8, characterized in that it comprises one or more compounds selected from the following formulae:
    Figure imgb0649
    Figure imgb0650
    in which the individual radicals, on each occurrence identically or differently, each, independently of one another, have the following meaning:
    Figure imgb0651
    Figure imgb0652
    Figure imgb0653
    Figure imgb0654
    Figure imgb0655
    Figure imgb0656
    RA1 alkenyl having 2 to 9 C atoms or, if at least one of the rings X, Y and Z denotes cyclohexenyl, also one of the meanings of RA2,
    RA2 alkyl having 1 to 12 C atoms, in which, in addition, one or two non-adjacent CH2 groups may be replaced by -O-,-CH=CH-, -CO-, -OCO- or -COO- in such a way that O atoms are not linked directly to one another,
    Zx -CH2CH2-, -CH=CH-, -CF2O-, -OCF2-, -CH2O-,-OCH2-, -CO-O-, -O-CO-, -C2F4-, -CF=CF-, -CH=CH-CH2O-, or a single bond, preferably a single bond,
    L1-4 each, independently of one another, H, F, Cl, OCF3, CF3, CH3, CH2F or CHF2H, preferably H, F or Cl,
    x 1 or 2,
    z 0 or 1.
  10. The LC medium of any one of Claims 6 to 9, characterized in that it comprises one or more compounds of the following formula:
    Figure imgb0657
    in which the individual radicals have the following meanings:
    Figure imgb0658
    denotes
    Figure imgb0659
    Figure imgb0660
    Figure imgb0661
    denotes
    Figure imgb0662
    R3 and R4 each, independently of one another, denote alkyl having 1 to 12 C atoms, in which, in addition, one or two non-adjacent CH2 groups may be replaced by -O-,-CH=CH-, -CO-, -O-CO-or -CO-O- in such a way that O atoms are not linked directly to one another,
    Zy denotes -CH2CH2-, -CH=CH-, -CF2O-, -OCF2-, -CH2O-, -OCH2-, -COO-, -OCO-, -C2F4-, -CF=CF- or a single bond.
  11. The LC medium of any one of Claims 6 to 10, characterized in that the polymerisable compounds of formula I are polymerised.
  12. An LC display comprising one or more compounds of formula I as defined in one or more of Claims 1 to 5 or comprising an LC medium as defined in any one of Claims 6 to 11.
  13. The LC display of Claim 12, which is a PSA type display.
  14. The LC display of Claim 13, which is a PS-VA, PS-OCB, PS-IPS, PS-FFS, PS-UB-FFS, PS-posi-VA or PS-TN display.
  15. The LC display of Claim 13 or 14, characterized in that it comprises two substrates, at least one which is transparent to light, an electrode provided on each substrate or two electrodes provided on only one of the substrates, and located between the substrates a layer of an LC medium, comprising one or more polymerisable compounds, as defined in any one of Claims 6 to 11, wherein the polymerisable compounds are polymerised between the substrates of the display.
  16. A process for the production of an LC display according to Claim 15, comprising the steps of filling or otherwise providing an LC medium, comprising one or more polymerisable compounds, as defined in any one of Claims 6 to 11, between the substrates of the display, and polymerising the polymerisable compounds.
  17. A compound of formula II

            Pg1-Sp1-(A1-Z1)n-A2-Sp4-O-CH(Sp2-Pg2)(Sp3-Pg3)     II

    in which Sp1 Sp2, Sp3, Sp4, A1, A2, Z1 and n have the meanings given in claim 1, and Pg1, Pg2 and Pg3 denote independently of each other OH, a protected hydroxyl group or a masked hydroxyl group.
  18. The compound of Claim 17, which is selected from the following subformulae
    Figure imgb0663
    Figure imgb0664
    Figure imgb0665
    Figure imgb0666
    Figure imgb0667
    Figure imgb0668
    Figure imgb0669
    wherein Pg1, Pg2 and Pg3 are as defined in claim 19, and L and r are as defined in claim 5.
  19. A process for preparing a compound of formula I of any one of Claims 1 to 6, by esterification or etherification of a compound of Claim 17 or 18, wherein Pg1-3 denote OH, using corresponding acids, acid derivatives, or halogenated compounds containing a group P1, in the presence of a dehydrating reagent.
  20. A process of preparing an LC medium of any one of Claims 6 to 11, comprising the steps of mixing one or more mesogenic or liquid-crystalline compounds, or a liquid-crystalline component B) as defined in Claim 7, with one or more compounds of formula I as defined in one or more of Claims 1 to 5, and optionally with further liquid-crystalline compounds and/or additives.
EP15000075.0A 2014-03-21 2015-01-14 Polymerisable compounds and the use thereof in liquid-crystal displays Active EP2921545B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP15000075.0A EP2921545B1 (en) 2014-03-21 2015-01-14 Polymerisable compounds and the use thereof in liquid-crystal displays

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP14001061 2014-03-21
EP15000075.0A EP2921545B1 (en) 2014-03-21 2015-01-14 Polymerisable compounds and the use thereof in liquid-crystal displays

Publications (3)

Publication Number Publication Date
EP2921545A2 true EP2921545A2 (en) 2015-09-23
EP2921545A3 EP2921545A3 (en) 2015-12-30
EP2921545B1 EP2921545B1 (en) 2019-08-21

Family

ID=50382196

Family Applications (1)

Application Number Title Priority Date Filing Date
EP15000075.0A Active EP2921545B1 (en) 2014-03-21 2015-01-14 Polymerisable compounds and the use thereof in liquid-crystal displays

Country Status (6)

Country Link
US (1) US20150267119A1 (en)
EP (1) EP2921545B1 (en)
JP (1) JP6869630B2 (en)
KR (1) KR102341577B1 (en)
CN (1) CN104927876B (en)
TW (1) TWI715529B (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016082922A1 (en) * 2014-11-25 2016-06-02 Merck Patent Gmbh Liquid crystal medium
JP2018009143A (en) * 2016-04-21 2018-01-18 メルク・パテント・ゲゼルシヤフト・ミツト・ベシユレンクテル・ハフツングMerck Patent GmbH Liquid crystal medium

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20160130002A (en) * 2015-04-30 2016-11-10 삼성디스플레이 주식회사 Method for manufacturing liquid crystal display and inspection device
CN107722995B (en) * 2016-08-11 2023-05-12 北京八亿时空液晶科技股份有限公司 Polymerizable liquid crystal compound and preparation method and application thereof
CN107722996B (en) * 2016-08-11 2023-06-09 北京八亿时空液晶科技股份有限公司 Polymerizable liquid crystal compound and preparation method and application thereof
CN107814783B (en) * 2016-09-14 2021-03-16 江苏和成显示科技有限公司 Polymerizable compound and preparation method and application thereof
KR102538719B1 (en) * 2016-12-08 2023-06-01 메르크 파텐트 게엠베하 Polymerisable compounds and the use thereof in liquid-crystal displays
CN108239542A (en) * 2016-12-23 2018-07-03 江苏和成显示科技有限公司 Liquid-crystal composition and its display device with negative dielectric anisotropic
CN107540645A (en) * 2017-09-11 2018-01-05 西安近代化学研究所 A kind of benzofurans liquid-crystal compounds and combinations thereof
CN110343531A (en) * 2018-04-02 2019-10-18 北京八亿时空液晶科技股份有限公司 A kind of dibenzothiophenes class can poly- property compound and its application
CN110358547A (en) * 2018-04-10 2019-10-22 北京八亿时空液晶科技股份有限公司 A kind of novel polymerizable compound and its application
CN110527521A (en) * 2018-05-23 2019-12-03 北京八亿时空液晶科技股份有限公司 A kind of polymerizability compound and the preparation method and application thereof containing indane structural

Citations (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2209127A1 (en) 1972-02-26 1973-09-06 Merck Patent Gmbh MODIFIED NEMATIC PHASES
DE2338281A1 (en) 1972-08-03 1974-02-21 Ibm PROCESS FOR THE CONTROLLED CHANGE OF THE ELECTRICAL PROPERTIES OF NEMATIC LIQUIDS AND DOPING AGENTS THEREFORE
DE2240864A1 (en) 1972-08-19 1974-02-28 Merck Patent Gmbh NEMATIC ESTERS AND THEIR USE TO INFLUENCE THE ELECTROOPTICAL PROPERTIES OF NEMATIC PHASES
DE2321632A1 (en) 1973-04-28 1974-11-21 Merck Patent Gmbh MODIFIED NEMATIC MIXTURES WITH POSITIVE DIELECTRIC ANISOTROPY
DE2450088A1 (en) 1974-10-22 1976-04-29 Merck Patent Gmbh Liquid crystalline dielectrics for electronic components - contg biphenylyl carboxylic acid phenyl ester or benzoic acid biphenylyl ester components
DE2636684A1 (en) 1976-08-14 1978-02-16 Merck Patent Gmbh CYCLOHEXAN DERIVATIVES
DE2637430A1 (en) 1976-08-20 1978-02-23 Merck Patent Gmbh Heterocyclic diaza cpd. in liquid crystalline dielectric - for electrooptical registration devices, giving stable orientation parallel to electrode surfaces
DE2853728A1 (en) 1978-12-13 1980-07-17 Merck Patent Gmbh LIQUID CRYSTALLINE CARBONIC ACID ESTER, METHOD FOR THE PRODUCTION THEREOF, ITS CONTAINING DIELECTRICS AND ELECTRO-OPTICAL DISPLAY ELEMENT
DE3321373A1 (en) 1983-06-14 1984-12-20 Merck Patent Gmbh, 6100 Darmstadt BICYCLOHEXYLE
EP0364538A1 (en) 1988-03-10 1990-04-25 Merck Patent Gmbh Difluorobenzol derivatives.
US6177972B1 (en) 1999-02-04 2001-01-23 International Business Machines Corporation Polymer stabilized in-plane switched LCD
EP1170626A2 (en) 2000-07-07 2002-01-09 Fujitsu Limited Liquid crystal display device and production method thereof
DE10224046A1 (en) 2001-06-26 2003-01-02 Merck Patent Gmbh Liquid crystalline medium, useful in liquid crystal devices, is based on a mixture of polar compounds having a positive dielectric anisotropy and contains at least one substituted diaryl compound.
EP1306418A1 (en) 2001-10-23 2003-05-02 MERCK PATENT GmbH Liquid crystalline medium and liquid crystal display
EP1378557A1 (en) 2002-07-06 2004-01-07 MERCK PATENT GmbH Liquid crystalline medium
US20040191428A1 (en) 2003-03-26 2004-09-30 Fujitsu Display Technologies Corporation Liquid crystal panel
US20060066793A1 (en) 2004-09-24 2006-03-30 Fujitsu Display Technologies Corporation Liquid crystal display device
US20060103804A1 (en) 2004-11-12 2006-05-18 Sharp Kabushiki Kaisha Liquid crystal display device and method of manufacture of the same
US7060200B1 (en) 1999-09-03 2006-06-13 Merck Patent Gmbh Multireactive polymerizable mesogenic compounds
US20060172090A1 (en) 2005-01-28 2006-08-03 Ryushi Syundo Liquid crystal polyfunctional acrylate derivative and polymer thereof
US7169449B2 (en) 2002-04-16 2007-01-30 Sharp Kabushiki Kaisha Liquid crystal display device

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4105446B2 (en) * 2002-02-20 2008-06-25 富士フイルム株式会社 Optical element using polymerizable compound and matrix thereof
GB0407661D0 (en) * 2004-04-03 2004-05-05 Univ Hull Liquid crystalline interpenetrating polymer networks
WO2009030329A1 (en) * 2007-08-30 2009-03-12 Merck Patent Gmbh Liquid crystal display
KR20110003312A (en) * 2008-04-01 2011-01-11 가부시키가이샤 아데카 Trifunctional (meth)acrylate compound and polymerizable composition containing the compound
JP2010186979A (en) * 2008-12-03 2010-08-26 Fujifilm Corp Curable composition for imprints, patterning method, and pattern
DE102011015546A1 (en) * 2010-04-26 2012-01-26 Merck Patent Gmbh Polymerizable compounds and their use in liquid crystal media and liquid crystal displays
CN103459554B (en) * 2011-03-29 2018-07-10 默克专利股份有限公司 Liquid crystal media
JP6136932B2 (en) * 2011-11-24 2017-05-31 Jnc株式会社 Polymerizable compound
DE102012024126A1 (en) * 2011-12-20 2013-06-20 Merck Patent Gmbh Liquid crystalline medium
GB201301786D0 (en) * 2012-02-15 2013-03-20 Merck Patent Gmbh Liquid-crystalline medium
CN104136576B (en) * 2012-02-22 2020-10-16 默克专利股份有限公司 Liquid-crystalline medium
KR102113052B1 (en) * 2012-06-02 2020-05-20 메르크 파텐트 게엠베하 Liquid crystal medium
CN102911052B (en) * 2012-10-13 2015-03-25 江苏和成显示科技股份有限公司 Polymerized star compound and polymerized product and application thereof in liquid crystal device
US10550327B2 (en) * 2012-11-21 2020-02-04 Merck Patent Gmbh Polymerisable compounds and the use thereof in liquid-crystal displays

Patent Citations (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2209127A1 (en) 1972-02-26 1973-09-06 Merck Patent Gmbh MODIFIED NEMATIC PHASES
DE2338281A1 (en) 1972-08-03 1974-02-21 Ibm PROCESS FOR THE CONTROLLED CHANGE OF THE ELECTRICAL PROPERTIES OF NEMATIC LIQUIDS AND DOPING AGENTS THEREFORE
DE2240864A1 (en) 1972-08-19 1974-02-28 Merck Patent Gmbh NEMATIC ESTERS AND THEIR USE TO INFLUENCE THE ELECTROOPTICAL PROPERTIES OF NEMATIC PHASES
DE2321632A1 (en) 1973-04-28 1974-11-21 Merck Patent Gmbh MODIFIED NEMATIC MIXTURES WITH POSITIVE DIELECTRIC ANISOTROPY
DE2450088A1 (en) 1974-10-22 1976-04-29 Merck Patent Gmbh Liquid crystalline dielectrics for electronic components - contg biphenylyl carboxylic acid phenyl ester or benzoic acid biphenylyl ester components
DE2636684A1 (en) 1976-08-14 1978-02-16 Merck Patent Gmbh CYCLOHEXAN DERIVATIVES
DE2637430A1 (en) 1976-08-20 1978-02-23 Merck Patent Gmbh Heterocyclic diaza cpd. in liquid crystalline dielectric - for electrooptical registration devices, giving stable orientation parallel to electrode surfaces
DE2853728A1 (en) 1978-12-13 1980-07-17 Merck Patent Gmbh LIQUID CRYSTALLINE CARBONIC ACID ESTER, METHOD FOR THE PRODUCTION THEREOF, ITS CONTAINING DIELECTRICS AND ELECTRO-OPTICAL DISPLAY ELEMENT
DE3321373A1 (en) 1983-06-14 1984-12-20 Merck Patent Gmbh, 6100 Darmstadt BICYCLOHEXYLE
EP0364538A1 (en) 1988-03-10 1990-04-25 Merck Patent Gmbh Difluorobenzol derivatives.
US6177972B1 (en) 1999-02-04 2001-01-23 International Business Machines Corporation Polymer stabilized in-plane switched LCD
US7060200B1 (en) 1999-09-03 2006-06-13 Merck Patent Gmbh Multireactive polymerizable mesogenic compounds
EP1170626A2 (en) 2000-07-07 2002-01-09 Fujitsu Limited Liquid crystal display device and production method thereof
DE10224046A1 (en) 2001-06-26 2003-01-02 Merck Patent Gmbh Liquid crystalline medium, useful in liquid crystal devices, is based on a mixture of polar compounds having a positive dielectric anisotropy and contains at least one substituted diaryl compound.
EP1306418A1 (en) 2001-10-23 2003-05-02 MERCK PATENT GmbH Liquid crystalline medium and liquid crystal display
US7169449B2 (en) 2002-04-16 2007-01-30 Sharp Kabushiki Kaisha Liquid crystal display device
EP1378557A1 (en) 2002-07-06 2004-01-07 MERCK PATENT GmbH Liquid crystalline medium
US6861107B2 (en) 2002-07-06 2005-03-01 Merck Patent Gmbh Liquid-crystalline medium
US20040191428A1 (en) 2003-03-26 2004-09-30 Fujitsu Display Technologies Corporation Liquid crystal panel
US20060066793A1 (en) 2004-09-24 2006-03-30 Fujitsu Display Technologies Corporation Liquid crystal display device
US20060103804A1 (en) 2004-11-12 2006-05-18 Sharp Kabushiki Kaisha Liquid crystal display device and method of manufacture of the same
US20060172090A1 (en) 2005-01-28 2006-08-03 Ryushi Syundo Liquid crystal polyfunctional acrylate derivative and polymer thereof

Non-Patent Citations (11)

* Cited by examiner, † Cited by third party
Title
"Merck Liquid Crystals, Physical Properties of Liquid Crystals", November 1997, MERCK KGAA
APPL. PHYS. LETT., vol. 75, no. 21, 1999, pages 3264
C. TSCHIERSKE; G. PELZL; S. DIELE, ANGEW. CHEM., vol. 116, 2004, pages 6340 - 6368
HALLER ET AL., MOL. CRYST. LIQ. CRYST., vol. 24, 1973, pages 249 - 258
OPTICS EXPRESS, vol. 12, no. 7, 2004, pages 1221
PURE APPL. CHEM., vol. 73, no. 5, 2001, pages 888
S. H. KIM; L.-C-CHIEN, JPN. J. APPL. PHYS., vol. 43, 2004, pages 7643 - 7647
S.H. JUNG ET AL., JPN. J. APPL. PHYS., vol. 43, no. 3, 2004, pages 1028
S.H. LEE ET AL., APPL. PHYS. LETT., vol. 73, no. 20, 1998, pages 2882 - 2883
S.H. LEE ET AL., LIQUID CRYSTALS, vol. 39, no. 9, 2012, pages 1141 - 1148
T.-J-CHEN ET AL., JPN. J. APPL. PHYS., vol. 45, 2006, pages 2702 - 2704

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016082922A1 (en) * 2014-11-25 2016-06-02 Merck Patent Gmbh Liquid crystal medium
EP3663378A1 (en) * 2014-11-25 2020-06-10 Merck Patent GmbH Liquid crystalline medium
JP2018009143A (en) * 2016-04-21 2018-01-18 メルク・パテント・ゲゼルシヤフト・ミツト・ベシユレンクテル・ハフツングMerck Patent GmbH Liquid crystal medium
JP2022101586A (en) * 2016-04-21 2022-07-06 メルク・パテント・ゲゼルシヤフト・ミツト・ベシユレンクテル・ハフツング Liquid-crystalline medium

Also Published As

Publication number Publication date
CN104927876A (en) 2015-09-23
KR102341577B1 (en) 2021-12-22
EP2921545B1 (en) 2019-08-21
TWI715529B (en) 2021-01-11
US20150267119A1 (en) 2015-09-24
JP2015183188A (en) 2015-10-22
EP2921545A3 (en) 2015-12-30
KR20150110369A (en) 2015-10-02
CN104927876B (en) 2021-12-03
JP6869630B2 (en) 2021-05-12
TW201546247A (en) 2015-12-16

Similar Documents

Publication Publication Date Title
EP2990459B1 (en) Polymerisable compounds and the use thereof in liquid-crystal displays
EP3048159B1 (en) Liquid crystal medium
EP3112440B1 (en) Liquid-crystal medium
EP2922933B1 (en) Polymerisable compounds and the use thereof in liquid-crystal displays
EP3121247B1 (en) Polymerisable compounds and the use thereof in liquid-crystal displays
EP3162875B1 (en) Polymerisable compounds and the use thereof in liquid-crystal displays
EP3124465B1 (en) Polymerisable compounds and the use thereof in liquid-crystal displays
EP2921545B1 (en) Polymerisable compounds and the use thereof in liquid-crystal displays
EP2818531B1 (en) Polymerisable compounds and the use thereof in liquid-crystal displays
EP3247774B1 (en) Polymerisable compounds and the use thereof in liquid-crystal displays
EP2990461B1 (en) Liquid crystal medium
EP2665798B1 (en) Polymerisable compounds and the use thereof in liquid-crystal displays
EP3387089B1 (en) Polymerisable compounds and the use thereof in liquid-crystal displays
EP3029127B1 (en) Liquid crystal medium
EP2682448B1 (en) Polymerisable compounds and the use thereof in liquid-crystal displays
EP3284803B1 (en) Liquid-crystal medium
EP2848676B1 (en) Liquid crystal medium
JP7438695B2 (en) Liquid crystal media containing polymerizable compounds
EP3020785B1 (en) Liquid crystal medium
EP3333243B1 (en) Polymerisable compounds and the use thereof in liquid-crystal displays
EP3877485B1 (en) Liquid crystal media comprising polymerisable compounds
EP3298105B1 (en) Liquid-crystal medium
EP3688118B1 (en) Polymerisable compounds and the use thereof in liquid-crystal displays
EP3322769B1 (en) Method of reducing odf mura in polymer stabilised liquid crystal displays
EP3149109B1 (en) Polymerisable compounds and the use thereof in liquid-crystal displays

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20150114

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

PUAL Search report despatched

Free format text: ORIGINAL CODE: 0009013

AK Designated contracting states

Kind code of ref document: A3

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

RIC1 Information provided on ipc code assigned before grant

Ipc: C09K 19/32 20060101AFI20151124BHEP

Ipc: C09K 19/30 20060101ALI20151124BHEP

Ipc: C09K 19/12 20060101ALI20151124BHEP

Ipc: C09K 19/34 20060101ALI20151124BHEP

Ipc: C09K 19/04 20060101ALI20151124BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

17Q First examination report despatched

Effective date: 20161206

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: GRANT OF PATENT IS INTENDED

INTG Intention to grant announced

Effective date: 20180928

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

GRAJ Information related to disapproval of communication of intention to grant by the applicant or resumption of examination proceedings by the epo deleted

Free format text: ORIGINAL CODE: EPIDOSDIGR1

GRAL Information related to payment of fee for publishing/printing deleted

Free format text: ORIGINAL CODE: EPIDOSDIGR3

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

GRAL Information related to payment of fee for publishing/printing deleted

Free format text: ORIGINAL CODE: EPIDOSDIGR3

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: GRANT OF PATENT IS INTENDED

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

INTC Intention to grant announced (deleted)
INTG Intention to grant announced

Effective date: 20181221

INTG Intention to grant announced

Effective date: 20190102

GRAJ Information related to disapproval of communication of intention to grant by the applicant or resumption of examination proceedings by the epo deleted

Free format text: ORIGINAL CODE: EPIDOSDIGR1

GRAL Information related to payment of fee for publishing/printing deleted

Free format text: ORIGINAL CODE: EPIDOSDIGR3

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE PATENT HAS BEEN GRANTED

INTG Intention to grant announced

Effective date: 20190712

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

REG Reference to a national code

Ref country code: GB

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: CH

Ref legal event code: EP

REG Reference to a national code

Ref country code: DE

Ref legal event code: R096

Ref document number: 602015036111

Country of ref document: DE

REG Reference to a national code

Ref country code: AT

Ref legal event code: REF

Ref document number: 1169752

Country of ref document: AT

Kind code of ref document: T

Effective date: 20190915

REG Reference to a national code

Ref country code: IE

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: LT

Ref legal event code: MG4D

REG Reference to a national code

Ref country code: NL

Ref legal event code: MP

Effective date: 20190821

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: NL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20190821

Ref country code: LT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20190821

Ref country code: BG

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20191121

Ref country code: NO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20191121

Ref country code: SE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20190821

Ref country code: PT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20191223

Ref country code: HR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20190821

Ref country code: FI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20190821

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20191221

Ref country code: ES

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20190821

Ref country code: GR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20191122

Ref country code: RS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20190821

Ref country code: AL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20190821

Ref country code: LV

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20190821

REG Reference to a national code

Ref country code: AT

Ref legal event code: MK05

Ref document number: 1169752

Country of ref document: AT

Kind code of ref document: T

Effective date: 20190821

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: TR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20190821

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: RO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20190821

Ref country code: DK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20190821

Ref country code: AT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20190821

Ref country code: EE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20190821

Ref country code: IT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20190821

Ref country code: PL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20190821

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20190821

Ref country code: CZ

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20190821

Ref country code: IS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200224

Ref country code: SM

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20190821

REG Reference to a national code

Ref country code: DE

Ref legal event code: R097

Ref document number: 602015036111

Country of ref document: DE

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

PG2D Information on lapse in contracting state deleted

Ref country code: IS

26N No opposition filed

Effective date: 20200603

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MC

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20190821

Ref country code: SI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20190821

REG Reference to a national code

Ref country code: CH

Ref legal event code: PL

GBPC Gb: european patent ceased through non-payment of renewal fee

Effective date: 20200114

REG Reference to a national code

Ref country code: BE

Ref legal event code: MM

Effective date: 20200131

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: FR

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20200131

Ref country code: GB

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20200114

Ref country code: LU

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20200114

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: CH

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20200131

Ref country code: LI

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20200131

Ref country code: BE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20200131

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20200114

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20190821

Ref country code: CY

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20190821

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20190821

P01 Opt-out of the competence of the unified patent court (upc) registered

Effective date: 20230518

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: DE

Payment date: 20231205

Year of fee payment: 10